DGE	Genes	Process~name	num_of_Genes	gene_group	percentage%	P-value	Benjamini and Hochberg (FDR)	 Hommel singlewise process	Bonferroni single-step process	Hommel singlewise process	Hochberg step-up process	Benjamini and Yekutieli
up	TRAV19; IGKV1-12; CD300LB; NCR3; TYROBP; SH2D1A; LILRA1; NCR1; CRTAM; CD160; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; CD8A; TRBV12-3; TRAV8-4; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; TRAC; TRBC1; HLA-H; CD3D; IGKV1-16; IGKV3-11; TRBV7-9; TRAV29DV5; ITGB2; IGKV2-30; IGHV4-34; CD3E; FCGR3A; CD3G; IGLC2; IFITM1; ICAM2; ITGA4; SELL; CD1D; HLA-G; LAG3; CD33; CD22; ITGAL; CD247; IGHV1-2; ITGB7; CD40LG; HLA-F; CD96; KIR2DL3; KIR3DL1; KIR3DL2; CD300C; KLRD1; MICB; CD300E; TREML2; LAIR1; LAIR2; JAML; TREML1; OSCAR; LILRB2; LILRB1; CD200R1; CD300LF; SLAMF6; KIR2DL4; TREM1; KLRF1; HCST; CD300A; CLEC2D; PILRA; ICAM5; SIGLEC9; BTN3A1; HHLA2;	GO:0050776~regulation of immune response	87	216	40.2777777777778	0	0	0	0	0	0	0
down	MEIS1; HOXA3; HS6ST1; SRPX2; RAMP2; RAPGEF3; TSPAN12; ANG; APOD; FGF1; ANXA2; CEACAM1; GLUL; VEGFA; EFNA1; SAT1; EPHA1; FGFR2; S100A7; HOXA7; APLNR; SOX18; KDR; GJA5; ACVRL1; COL15A1; ID1; LEPR; MEOX2; PLCD1; EPHB3; YWHAZ; ACTG1; TEK; FOXC1; ADAM15; FZD5; GAB1; AAMP; KLF5; IL18; SHB; ECM1; HIF1A; ECSCR; RASIP1; DAB2IP; EPGN; CXCL17; ADM2; UNC5B; PLCD3; ROBO4; HOXB13; MYDGF; EPAS1; OVOL2; ANGPTL4; RHOJ; SOX17; DLL4; TMEM100; VAV3; HIF3A; HEY1; ADGRG1; AMOTL2; AMOTL1; RAMP3; CLIC4;	GO:0001525~angiogenesis	70	230	30.4347826086957	0	0	0	0	0	0	0
down	TRABD2B; TMPRSS2; KLK10; TMPRSS11D; KLK8; ADAM11; ZMPSTE24; REN; LTF; CAPNS1; CTSD; CAPN1; CTSB; CTSG; MMP7; C1S; CTSE; CPA3; ENDOU; KEL; PSMB5; CASP14; PRSS3; GGT5; MMP12; KLK7; MMP15; METAP1; BACE1; RHBDL3; UBE2N; HTRA3; TMPRSS15; ACY1; SCRN3; ADAM15; WFDC2; HABP2; ESPL1; CLCA4; PRSS8; MMEL1; CPZ; GGT6; THSD4; TMPRSS11A; TMPRSS11F; TMPRSS11B; ATG4D; FBXL6; GGH; RHBDF1; CAPNS2; LGMN; PRSS27; TMEM59; TMPRSS13; ADAM33; PRSS22; MMP28; RNPEP; CHMP1A; FBXO6; TMPRSS4; RHBDL2; DPP3; KLK11; KLK12; KLK13; TMPRSS11E; DNPEP; ADAMTS5; KLK5; ST14; BACE2; CAPN8; PGA5; CAPN5; F12; TPSAB1; MIPEP; CPA6; CAPN13; TPSB2; CAPN6; PRSS16; PGC; THOP1; CPA4; TPSD1; ERMP1; PRSS21;	GO:0006508~proteolysis	92	436	21.1009174311927	0	0	0	0	0	0	0
down	CCL21; CCL22; CXCL11; WNT9B; EFNA2; CXCL13; MPZL1; CXCL14; POMC; C1QA; CXCL10; INHA; S100A9; GJB1; CGB7; AR; BMP2; EDN3; GJA1; ADCYAP1; NTF3; EFNA1; FGFR2; FGFR3; GJB2; GJA4; TNFSF9; NAMPT; XCL1; TNFSF10; EFNA3; EFNB2; AFDN; CCL18; FGF12; CX3CL1; TNFAIP6; TEK; CXCL9; PCDH1; IL18; IHH; GPNMB; EFNB3; CTF1; CCL17; TFAP2C; FGF14; SFRP2; GDF15; GJB4; IL36G; HCN2; FZD1; ADGRG1; ADRA2C; ADRA2A; FGFBP1; PANX2;	GO:0007267~cell-cell signaling	59	230	25.6521739130435	0	0	0	0	0	0	0
down	WIPF3; UPK2; ACKR2; WNT9B; GALR2; EDIL3; PRICKLE3; CREG1; RECQL4; SPDEF; FGF1; HOXD4; HOXC6; EDN3; HOXB1; LEPR; HOXA1; MEOX2; GATM; FOXA3; TPI1; ELF3; FGD1; BEX3; TLE1; C19orf57; CSRP2; ODF4; CEP55; KCTD11; SPATA19; SPRED2; PAQR7; CATSPER3; EGFL6; PRR15; LTBP4; MINK1; VANGL1; CCL17; CREB3L1; CCDC120; PIWIL1; KCTD15; WDR18; AMN; TDRD1; PDGFD; PPDPF; PAQR5; EHF; THEG; DKK4; DKK2; NKX1-2; GTF2IRD1; OSGIN1; WIF1; EPHA2; NR1D1; RARG; FGFR2; CDH12; TYRO3; ROR1; ERBB2; CDH5; DDR1; EPHA1; FGFR3; CDH6; CDH19; FST; ZNF296; PDGFRA; EGFR; ERBB3; LDB2; EPHA3; MST1R; FGFR4; SPINK6; EPHA6; CDH17; CDH1; CDK2; TEK; EPHB3; KDR; EPHA10; SPINK5;	GO:0007275~multicellular organism development	91	513	17.7387914230019	0	0	0	0	0	0	0
down	CLDN5; BIRC5; HOXA3; CHP2; LRP5; CLDN7; EGFR; HRAS; KRT6A; CXCL10; S100B; CAPNS1; SLC25A5; FGF1; CAPN1; ADRA2A; AR; BMP4; RARG; EDN3; VEGFA; PDGFRA; EPCAM; ADCYAP1; NTF3; EDN2; PTN; EPHA1; FGFR2; BMP5; FGFR4; FGFR3; CDK2; SERPINB3; PRDX3; ALDH3A1; TTK; SHMT2; KDR; AVPR1A; CEACAM6; PBX1; MATK; NAMPT; ID4; UBE2A; EFNB2; AKR1C2; CRIP2; MVD; EMP2; RAB25; ROMO1; EIF5A; CX3CL1; HMGN5; MST1R; PRKCZ; FOXM1; CDC20; BAMBI; KLF5; HES1; CTF1; RNF187; HES5; EPGN; NCCRP1; SAPCD2; CARM1; DYNAP; TRPM4; BRK1; TFAP2B; TSLP; SFRP2; NACC1; LGMN; S100A13; PRMT1; ROGDI; WWTR1; ZNF703; PDF; ARNT2; ACER3; CLEC11A; HILPDA; ERBB2; ERBB3; PDGFD; TGFA; BTC; RTKN2;	GO:0008284~positive regulation of cell population proliferation	94	490	19.1836734693878	0	0	0	0	0	0	0
down	EVPLL; AGPAT2; FOXN1; TGM5; KRT34; SCEL; GJB5; KRT14; KRT5; DSP; KRT15; SPRR1B; SPRR2E; SPRR2D; CRABP2; S100A7; CASP14; NTF4; SPRR1A; SPRR2B; SPRR2A; KRT9; KRT2; KLK7; ALDH3A2; EMP1; ELF3; FABP5; PLOD1; KRT32; KRT31; CST6; ZNF750; GRHL2; CERS3; ACER1; GRHL3; EVPL; HOXB13; SPRR2F; SPRR2G; GRHL1; CALML5; SPRR3; POU2F3; KLK5; KRTDAP;	GO:0008544~epidermis development	47	82	57.3170731707317	0	0	0	0	0	0	0
down	DAPL1; CFAP69; WIPF3; SRRM4; SOX15; KRT6A; TFF1; INHA; FGF1; MGP; SRD5A1; COL15A1; ADCYAP1R1; TPPP2; KRTDAP; NHLH2; MECOM; AAMP; SIM2; CBX2; ANGPT1; SHB; INA; CSRP2; MEA1; ECSCR; ODF4; ZNF750; MORN2; NKAPL; NXN; CXCL17; SPATA19; EGFL6; ACER1; ATOH8; RARRES2; TWSG1; UNC45A; PPDPF; ASF1B; THEG; MOSPD1; OSGIN1; NDRG2; RFNG; CLIC4; BZW2; FST; SOX17; POU3F1; NKX2-8; KIAA1522; HES5; POU2F3; FOXA1; RXRA; SPINK6; ETV1; FOXI2; NR1D1; ID1; HNF4A; FOXA3; SPDEF; FOXC1; HES1; CCDC160; SOX18; EGFR; NKX6-2; FOXQ1; EYA2; ELF5; HEY1; PTK6; NHSL1; NKX2-3; SOX2; SRC; NR2F6; ETV7; FRK; SOX7; EHF; DLX5; HES2; NKX1-2; SOX21; SPINK5; BHLHE40; HES4; ID4; ELF3; RARG; SRMS; DLX3; FOXE1;	GO:0030154~cell differentiation	98	572	17.1328671328671	0	0	0	0	0	0	0
down	IRF6; FOXN1; SCEL; CSTA; ANXA1; IVL; KRT16; KRT10; DSP; SPRR1B; TGM1; EPHA2; S100A7; SPRR1A; SPRR2B; SPRR2A; YAP1; POU3F1; TGM3; ADAM9; CERS3; ACER1; EVPL; SPRR2F; SPRR2G; TP63; SPRR3; INTU; ST14; CLIC4;	GO:0030216~keratinocyte differentiation	30	53	56.6037735849057	0	0	0	0	0	0	0
down	PGRMC1; QSOX1; SLC27A2; AGPAT2; PSMD3; SYNGR1; CPNE3; CREG1; IDH1; NFASC; NDUFC2; RAB3D; CYB5R3; PIGR; LTF; SLPI; FUCA1; ALDOA; CSTB; KRT1; S100A8; GSN; S100A9; GPI; CTSD; ANXA2; CAPN1; TUBB; CTSB; CTSG; CD63; GSTP1; HSPA1B; MGST1; PYGB; ANXA3; CEACAM1; CD59; MIF; PKM; JUP; DSP; TIMP2; GM2A; LGALS3; PSMC3; AOC1; TCN1; RAB6A; CXCR1; S100P; SERPINB3; PRDX6; SERPINB1; CHRNB4; S100A7; S100A11; PRSS3; SERPINB6; PSMC2; CEACAM3; CEACAM6; FRK; CRISP3; RAB5B; RAB10; RAP1A; RAC1; VAMP2; DYNLL1; TUBB4B; LCN2; TNFAIP6; FABP5; DSG1; CKAP4; PRDX4; PLD1; PKP1; FLG2; NAPRT; CYFIP1; HRNR; GGH; OSTF1; ATP6V0A1; PGM2; VAT1; FUCA2; VAMP8; TOLLIP; PTGES2; RAB18; ACTR10; CALML5; LAMTOR3; DERA; ATP6V1D; HEBP2;	GO:0043312~neutrophil degranulation	99	483	20.4968944099379	0	0	0	0	0	0	0
down	WASL; UBE2C; NDC80; CETN3; BIRC5; OIP5; BUB1B; CCNB2; ZWINT; PTTG1; CHEK2; CDK1; TUBB; CLTA; RALA; RALB; CCNB1; RCC1; CCNA2; CCNO; CCND1; CDK2; WEE1; CDC25C; CKS2; CCNF; CETN2; CDK7; NEK2; KIF11; BCAR1; GNAI1; TUBA1B; CCNA1; GPSM2; CDC20; MAD2L1; CCNG2; PLK5; CDCA8; CENPW; FIGN; CDCA2; LLGL2; PSRC1; NCAPG2; KIF18B; MISP; SPC24; SKA2; CCDC124; CDCA5; CDCA3; KIF2C; CDC6; NCAPG; TUBA1C; KIFC1; PARD6G; CDT1; FAM83D; REEP4; SPC25; CHMP1A; ARL8B; KLHL13; FBXL7; TPX2; TIMELESS; AURKC; ANAPC7;	GO:0051301~cell division	71	347	20.4610951008646	0	0	0	0	0	0	0
up	PIK3CD; PRKCB; LYN; PTPRC; MS4A1; CD79A; CTLA4; PTPN6; BLK; NCKAP1L; BTK; RFTN1; LAT2; IGHV4-34; IGHM; IGHV3-33; IGHV3-11; IGHG1; IGHV1-2; IGHV2-5; IGHV3-35; IGHV3-30; IGHV3-13; TRBC2; ITK; IGHV1-18; LCK; TRBC1; IGHV3-74; IGHD; IGHV3-48; IGLC2; IGHV4-31; IGKC;	GO:0050853~B cell receptor signaling pathway	34	125	27.2	0.00010303728333038	0.0274980749887971	0.438423640570798	0.439969199820753	0.438217566004137	0.438423640570798	0.245742097969539
down	RAMP2; CEACAM1; CD34; KDR; RAP1A; RIN2; TMEM100;	GO:2001214~positive regulation of vasculogenesis	7	12	58.3333333333333	0.00010335686692819	0.00281148421712832	0.631097029463557	0.655075822590899	0.417768456123763	0.631097029463557	0.0262356829293983
down	SLC9A3R1; CA2; KRT6A; KRT16; SERPINB5; RIPK4; FREM2; TIMELESS;	GO:0002009~morphogenesis of an epithelium	8	17	47.0588235294118	0.00010411111182628	0.00281989840493596	0.63559833769949	0.659856226755015	0.419151336212637	0.63559833769949	0.0263142008745053
down	TBCA; MPDU1; FKBP9; HSPA4L; CRYAB; NPPC; CCT6A; CCT3; RAD23B; HSPE1; GNB2; GNAI1; FKBP4; PDIA6; FUT10; LTBP4; ERO1A; SIL1; PPIL3; SPHK1; HSPBP1; RUVBL2; QSOX1; P4HB; PDIA4;	GO:0006457~protein folding	25	150	16.6666666666667	0.00011845021122236	0.00310327803958176	0.722309388033982	0.75073743872735	0.439905801423203	0.722309388033982	0.0289585899832621
down	TLCD2; SLC9A3R1; MTSS1; BAIAP2L2; TLCD1; A4GALT; BAIAP2L1; BAIAP2; FER1L6;	GO:0007009~plasma membrane organization	9	23	39.1304347826087	0.00011898020883849	0.00310327803958176	0.725422333288291	0.754096563618367	0.440593026646479	0.725303353079452	0.0289585899832621
down	PIP5K1C; ENTPD5; EGFR; CEACAM1; MAPK3; PTPN13; CEP55; PIP4K2C; CRNN;	GO:0014066~regulation of phosphatidylinositol 3-kinase signaling	9	23	39.1304347826087	0.00011898020883849	0.00310327803958176	0.725422333288291	0.754096563618367	0.440593026646479	0.725303353079452	0.0289585899832621
down	CFTR; AQP1; SCNN1A; SCNN1B; SCNN1G; TRPV4;	GO:0050891~multicellular organismal water homeostasis	6	8	75	0.00012332124893399	0.00318689483427517	0.751643012252694	0.781610075743655	0.44653161304958	0.751643012252694	0.0297388695593608
down	TUBB; TUBB4B; PRDX1; IL18; RAET1G; RAET1E; ULBP3; ULBP2;	GO:0042267~natural killer cell mediated cytotoxicity	8	18	44.4444444444444	0.00014205254027799	0.00355861264933564	0.864531760131863	0.900329000281917	0.471991622413187	0.864531760131863	0.0332075963890267
down	APOE; APOD; GSTP1; S100A7; HYAL1; HYAL2; NUDT15;	GO:0000302~response to reactive oxygen species	7	13	53.8461538461538	0.00015032231362144	0.00369280164237482	0.914410633759236	0.952742823732704	0.483238259954533	0.914109989131993	0.034459796153316
down	DNPEP; THOP1; MIPEP; CPZ; CPM; CPXM1; CPE;	GO:0006518~peptide metabolic process	7	13	53.8461538461538	0.00015032231362144	0.00369280164237482	0.914410633759236	0.952742823732704	0.483238259954533	0.914109989131993	0.034459796153316
down	E2F8; CYP1A1; HNF1B; HNF4A; PCK1; PCK2; ANXA1;	GO:0070365~hepatocyte differentiation	7	13	53.8461538461538	0.00015032231362144	0.00369280164237482	0.914410633759236	0.952742823732704	0.483238259954533	0.914109989131993	0.034459796153316
up	IGKV1-12; F2; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; IGHG1; C4BPA; IGKV1-16; IGKV3-11; CFI; IGKV2-30; IGHV4-34; IGLC2; CR1; C5AR1; IGHV1-2; CFP; C3AR1; CR1L; C5AR2;	GO:0030449~regulation of complement activation	31	113	27.4336283185841	0.00017861991224543	0.0448651191345891	0.759849106692088	0.762707025288015	0.757884287657388	0.759849106692088	0.400946193734616
down	WASL; MYO5B; MYO5C; MYO1D; MYO6; MYO1B; MYO1E; MYO1C;	GO:0030050~vesicle transport along actin filament	8	19	42.1052631578947	0.0001906919823712	0.00452661342422733	1	1	0.526914323554541	0.999999999989094	0.0422406050933793
down	AKR7A3; AKR1A1; ALDH3A1; ALDH9A1; ALDH7A1; ALDH3A2;	GO:0006081~cellular aldehyde metabolic process	6	9	66.6666666666667	0.00019451147622318	0.00460005125486014	1	1	0.530980145429122	0.999999999989094	0.0429258985151838
down	PAPSS1; INHA; BMP2; PAX1; NPR3; BMP7; FST; BMP5; FGFR3; EPHA2; GNA11; GJA5; DLX5; PITX1; PRDX1; IHH; EBP; TEAD4; FRZB; TP63; HOXA4; HOXD4; HOXC4;	GO:0001501~skeletal system development	23	137	16.7883211678832	0.00019767622766186	0.00462048073526719	1	1	0.533624400048004	0.999999999989094	0.0431165385220195
down	CYP1A1; CYP2E1; CYP2C9; CBR1; UGT1A1; CYP2C19; FMO2; UGT1A7; CYP4F12;	GO:0017144~drug metabolic process	9	25	36	0.00019829137898275	0.00462048073526719	1	1	0.534163531011335	0.999999999989094	0.0431165385220195
down	CYP2C9; CYP4B1; CYP2C19; NUDT15; CYP2F1; CYP2J2; CYP2C18; CYP2S1; CYP2E1;	GO:0042738~exogenous drug catabolic process	9	25	36	0.00019829137898275	0.00462048073526719	1	1	0.534163531011335	0.999999999989094	0.0431165385220195
down	PIR; DVL1; MEIS2; ZBTB7B; FOXN1; NKX2-8; KLF4; PTTG1; PAX1; POLR2E; BTF3; POLR2I; ETV1; CDK7; LMO4; POLR2L; ELF3; MLLT1; KLF5; TRIM29; NFIX; TRIP13; HIF1A; GTF2H5; NCAPG2; NELFB; TFAP2B; EPAS1; ZNF768; ELL3; EHF; GTF2IRD1; MAFF; HIF3A; YBX2; ETV7;	GO:0006366~transcription by RNA polymerase II	36	266	13.5338345864662	0.00021008806765332	0.00484195699195189	1	1	0.544096535807909	0.999999999989094	0.0451832692585359
down	AGR2; EGFR; EPHB3; HIF1A; SFRP2; STRA6; VANGL2;	GO:0048546~digestive tract morphogenesis	7	14	50	0.00021317605421367	0.00486010730793613	1	1	0.546663046154807	0.999999999989094	0.0453526409848042
down	COBL; BMP7; PTN; BMP5; VLDLR; DAB2IP; CYFIP1;	GO:1900006~positive regulation of dendrite development	7	14	50	0.00021317605421367	0.00486010730793613	1	1	0.546663046154807	0.999999999989094	0.0453526409848042
down	MYO1C; CLDN5; GJA1; PRKACA; TJP1; FZD5; OCLN;	GO:2000810~regulation of bicellular tight junction assembly	7	14	50	0.00021317605421367	0.00486010730793613	1	1	0.546663046154807	0.999999999989094	0.0453526409848042
down	SPTBN2; YKT6; CNIH1; TGFA; PROS1; CD59; FOLR1; ARF4; KDELR1; NSF; TMED10; RAB2A; COPZ1; DYNLL1; DCTN2; GAS6; TMED2; CNIH2; GOLT1A; GORASP1; TMED9; RAB1B; ACTR10; COPZ2; TMED3; LMAN2; YIF1A; KDELR2; BCAP31;	GO:0006888~endoplasmic reticulum to Golgi vesicle-mediated transport	29	196	14.7959183673469	0.00022487347247723	0.0050901716734312	1	1	0.556553147998627	0.999999999989094	0.0474995126299336
down	ABLIM3; GSN; CCNO; TMEM107; TMEM17; SPAG16; TTC8; FBF1; IFT81; FOXJ1; WDR34; WDR90; FOPNL; TMEM237; FHDC1; WWTR1; CCDC113; RAB17; CELSR2; STK36; PARVA; PLA2G3; EHD3; INTU; B9D1; ATP6V1D; TEKT4; CDKN3;	GO:0060271~cilium assembly	28	187	14.9732620320856	0.00024016162445117	0.00534085745884751	1	1	0.569423211573733	0.999999999989094	0.0498388153871823
down	CDK2AP1; MAPK13; KLK10; OIP5; USP2; FAM107A; PAK4; KRT18; CLTA; RALA; RALB; SRC; MAPK3; SIK1; GNAI1; PLK5; FIGN; DAB2IP; STEAP3; KCTD11; CDCA2; TMPRSS11A; NCAPG2; SIAH1; MRPL41; SPC24; HJURP; PARD3; CCDC124; CDCA3; ARL8B; TXNL4B; HMG20B; KLHL13;	GO:0007049~cell cycle	34	248	13.7096774193548	0.0002502637625763	0.0055120148068861	1	1	0.57711843923466	0.999999999989094	0.0514359895369855
down	NDUFA4; MT-CO2; COX8A; COX5B; COX6B1; COX5A; COX7B; COX4I2;	GO:0006123~mitochondrial electron transport, cytochrome c to oxygen	8	20	40	0.00025220642063694	0.0055120148068861	1	1	0.578485720792102	0.999999999989094	0.0514359895369855
down	WASL; NOS1AP; DDAH1; DDAH2; EGFR; SPR; NOSTRIN; ZDHHC21;	GO:0050999~regulation of nitric-oxide synthase activity	8	20	40	0.00025220642063694	0.0055120148068861	1	1	0.578485720792102	0.999999999989094	0.0514359895369855
down	CCL21; CLDN7; EPCAM; DUOXA2; CCL19; DUOX2; DUOX1; PHPT1;	GO:2000147~positive regulation of cell motility	8	20	40	0.00025220642063694	0.0055120148068861	1	1	0.578485720792102	0.999999999989094	0.0514359895369855
down	CCL22; CXCL11; DEFB4A; CXCL14; HRAS; CXCL10; RALA; CCL11; CCL18; DEFB1; CX3CL1; PLP2; CXCL9; PLD1; ECSCR; CCL17; RARRES2; PLGRKT; LTB4R2; CXCR1; ACKR2;	GO:0006935~chemotaxis	21	122	17.2131147540984	0.00027234664126885	0.00589123895004086	1	1	0.592105948614311	0.999999999989094	0.0549747625161714
down	ELOVL7; SCD; SCD5; ELOVL1; ELOVL4; ELOVL6; DECR2;	GO:0006636~unsaturated fatty acid biosynthetic process	7	15	46.6666666666667	0.00029561063298788	0.00628718185193699	1	1	0.607934556730313	0.999999999989094	0.0586695484833154
down	PRDX6; PLA2G4D; ABHD12; GDPD3; PLA2G4A; PLA2G4F; PLA2G4E;	GO:0046475~glycerophospholipid catabolic process	7	15	46.6666666666667	0.00029561063298788	0.00628718185193699	1	1	0.607934556730313	0.999999999989094	0.0586695484833154
down	KRT1; KRT10; RRM2; GRIN1; HSD17B8; FARSB; FARSA;	GO:0051290~protein heterotetramerization	7	15	46.6666666666667	0.00029561063298788	0.00628718185193699	1	1	0.607934556730313	0.999999999989094	0.0586695484833154
down	PPP1R3G; OAS1; POMC; NGFR; ADRA2A; FGFR4; PCK1; HNF4A; LEPR; FOXA1; FAM3B; FABP5; HIF1A; ADGRF5; MCU; TFAP2B; BAD; TRPV4; BACE2; GCKR;	GO:0042593~glucose homeostasis	20	114	17.5438596491228	0.00030276185141653	0.00641774118487621	1	1	0.612789987267063	0.999999999989094	0.0598878776638953
down	ALOX15B; ALOX12B; EPHX1; MAPK3; PLA2G4A; MGLL; ALOXE3; CYP4F11; CYP4F12;	GO:0019369~arachidonic acid metabolic process	9	27	33.3333333333333	0.00031725050678077	0.00668017844510483	1	1	0.622015830416914	0.999999999989094	0.0623368406373565
down	CTNND1; CDH5; AFDN; PLEKHA7; CDH19; CDH12; CDH17; CDH6; CDH1;	GO:0044331~cell-cell adhesion mediated by cadherin	9	27	33.3333333333333	0.00031725050678077	0.00668017844510483	1	1	0.622015830416914	0.999999999989094	0.0623368406373565
down	FMO2; CYP2F1; CYP2J2; CYP2C19; CYP2E1; CYP2S1; CYP2C9; CYP2C18;	GO:0006082~organic acid metabolic process	8	21	38.0952380952381	0.00032904335946693	0.00686012109309671	1	1	0.627275280358858	0.999999999989094	0.0640159958072238
down	EI24; CRYAB; ENO1; HSPA1B; GJA1; ACVR1B; ACVRL1; CDKN1A; HNF4A; CDKN2C; BDKRB1; HYAL1; HYAL2; ADAM15; SERTAD2; PSRC1; FRZB; RERG; SFRP2; SOX17; OSGIN1;	GO:0030308~negative regulation of cell growth	21	124	16.9354838709677	0.00033026298659466	0.00686297314438356	1	1	0.627829937516458	0.999999999989094	0.0640426100463522
down	CLIC1; CACNA1G; KCNK5; CLIC3; CLCN1; KCNC3; CATSPER3; TMEM37; KCNB2; CLIC6; KCNS3; TMEM109; KCNK15; HCN3; HCN2; KCNK6; KCNK7; CLIC4; CLCA3P; KCNJ5;	GO:0034765~regulation of ion transmembrane transport	20	115	17.3913043478261	0.00033455378845304	0.0068986337304467	1	1	0.629739871225962	0.999999999989094	0.0643753808381386
down	DSP; DSG2; NECTIN1; GRHL1; PERP;	GO:0002934~desmosome organization	5	6	83.3333333333333	0.00033850979649241	0.0068986337304467	1	1	0.631536099695543	0.999999999989094	0.0643753808381386
down	GJA1; CD34; GJA4; KDR; GJA5;	GO:0003158~endothelium development	5	6	83.3333333333333	0.00033850979649241	0.0068986337304467	1	1	0.631536099695543	0.999999999989094	0.0643753808381386
down	BMP7; BMP5; BMPR1A; ROBO2; ROBO1;	GO:0003272~endocardial cushion formation	5	6	83.3333333333333	0.00033850979649241	0.0068986337304467	1	1	0.631536099695543	0.999999999989094	0.0643753808381386
down	UGT1A9; UGT1A1; UGT1A7; UGT1A10; UGT1A8;	GO:0051552~flavone metabolic process	5	6	83.3333333333333	0.00033850979649241	0.0068986337304467	1	1	0.631536099695543	0.999999999989094	0.0643753808381386
down	CLDN1; ASS1; NR1D1; GPD1; MAPK3; PCK1; LCN2; HYAL1; HYAL2; OCLN; DAB2IP; NPNT; XCL2; CCL22; CX3CL1; CCL17; CCL21; CCL19; CCL18; CCL11; XCL1;	GO:0071356~cellular response to tumor necrosis factor	21	125	16.8	0.00036306158991128	0.00732829413012013	1	1	0.642546531037069	0.999999999989094	0.0683848054489815
down	KCNK1; ATP1B1; AQP1; SLC1A3; KCNC3; KCNMB1; LRRC55; KCNB2; CCDC51; P2RY12; TMEM38A; SLC24A3; HCN3; KCNG1; HCN2; KCNS3; KCNK15; KCNK5; KCNK6; KCNK7; KCNN3;	GO:0071805~potassium ion transmembrane transport	21	125	16.8	0.00036306158991128	0.00732829413012013	1	1	0.642546531037069	0.999999999989094	0.0683848054489815
down	CHEK2; EGFR; ERBB2; SRC; PDGFRA; PRKACA; EPHA1; FGFR2; FGFR4; FGFR3; TTK; KDR; ACVR1B; NEK2; EPHB3; SIK1; TEK; TYRO3; DDR1; PTK6; MELK; ULK3; MINK1; MYO3A; AURKB; SLK;	GO:0046777~protein autophosphorylation	26	173	15.028901734104	0.00037292309768899	0.0075034495020725	1	1	0.6469693465923	0.999999999989094	0.070019287611082
down	TLR3; RPS6KA4; ZBTB7A; LTF; S100A8; S100A9; HSPA1B; AR; PRDX3; RIPK4; MTPN; UBE2N; CX3CL1; ROR1; PRKCZ; IL18; CARM1; TICAM1; RTKN2; RAB7B; CARD14; SPHK1; CRNN; IL1RAP;	GO:0051092~positive regulation of NF-kappaB transcription factor activity	24	154	15.5844155844156	0.00038611895449924	0.00771994300825311	1	1	0.652882835506602	0.999999999989094	0.0720395212477587
down	ATP6V0E1; ATP6V1E1; RAB38; ATP6V1F; ATP6V1C2; ATP6V0A1; ATP6V0A4; SLAMF8; ATP6V1D;	GO:0090383~phagosome acidification	9	28	32.1428571428571	0.00039582943054905	0.00785981109247315	1	1	0.657160730413691	0.999999999989094	0.0733447160936637
down	AR; RAB25; IHH; DACT2; GRHL2; POF1B; PALLD;	GO:0003382~epithelial cell morphogenesis	7	16	43.75	0.00040179532880424	0.00785981109247315	1	1	0.65983056641512	0.999999999989094	0.0733447160936637
down	IDH1; GOT2; GOT1; IDH2; AADAT; GPT2; L2HGDH;	GO:0006103~2-oxoglutarate metabolic process	7	16	43.75	0.00040179532880424	0.00785981109247315	1	1	0.65983056641512	0.999999999989094	0.0733447160936637
down	SQLE; PMVK; CYB5R2; CYB5R1; EBP; MSMO1; TM7SF2;	GO:0016126~sterol biosynthetic process	7	16	43.75	0.00040179532880424	0.00785981109247315	1	1	0.65983056641512	0.999999999989094	0.0733447160936637
down	INHA; BMP4; BMP7; CDKN1A; CDKN2B; CDKN2C; DYNLL1;	GO:0042326~negative regulation of phosphorylation	7	16	43.75	0.00040179532880424	0.00785981109247315	1	1	0.65983056641512	0.999999999989094	0.0733447160936637
down	AR; VEGFA; PRLR; HOXA5; CCND1; DDR1; PHB2;	GO:0060749~mammary gland alveolus development	7	16	43.75	0.00040179532880424	0.00785981109247315	1	1	0.65983056641512	0.999999999989094	0.0733447160936637
down	SLC9A3R1; RARG; KEL; XK; MTPN; RAC1; IQGAP3; VAV3;	GO:0008361~regulation of cell size	8	22	36.3636363636364	0.00042392871166696	0.00811740234001579	1	1	0.669807364433805	0.999999999989094	0.075748457951699
down	KRT18; KRT16; KRT3; KRT6C; FAM83H; EVPLL; DSP; EVPL;	GO:0045104~intermediate filament cytoskeleton organization	8	22	36.3636363636364	0.00042392871166696	0.00811740234001579	1	1	0.669807364433805	0.999999999989094	0.075748457951699
down	SRC; EFNA5; EPHB3; WNT4; MINK1; CELSR2;	GO:0022407~regulation of cell-cell adhesion	6	11	54.5454545454545	0.00043085848542245	0.00820054378560823	1	1	0.672912523160002	0.999999999989094	0.0765243017539037
down	APOE; ACHE; NSG1; KLK6; APH1A; PSENEN;	GO:0042982~amyloid precursor protein metabolic process	6	11	54.5454545454545	0.00043085848542245	0.00820054378560823	1	1	0.672912523160002	0.999999999989094	0.0765243017539037
down	NEURL1B; UBE2C; SOCS6; PEX10; PCNA; CCNF; USP5; UBE2A; UBE2E1; PLK1; UBE2M; UBE2N; UBE2G1; CDC20; KEAP1; UBE2V2; HIF1A; FBXO43; DCST1; KCTD11; TRAF7; KLHL17; NCCRP1; ZNF598; FBXL6; WDSUB1; LNX1; RNF128; ASB13; FBXW5; TSPAN17; TRIM47; RAB40C; CDCA3; EPAS1; UBAC1; RNF26; TRIM31; TRIM7; WWTR1; WSB2; KLHL13; FBXL7; RNF150; CBLC; STUB1; PDZRN3; HIF3A; UBE2J1; MIB2; ANAPC7;	GO:0016567~protein ubiquitination	51	444	11.4864864864865	0.00046942428632512	0.00882851966388324	1	1	0.690080588354628	0.999999999989094	0.0823843296812742
down	CYP1A1; PRLR; FDXR; FDFT1; PBX1; LSS; DHRS11; TFCP2L1; SRD5A1;	GO:0006694~steroid biosynthetic process	9	29	31.0344827586207	0.00048975139134788	0.00907615297766922	1	1	0.699302214940779	0.999999999989094	0.0846951479542934
down	IL33; SCGB1A1; XCL1; C1QBP; GAS6; IL20RB; PGLYRP3; LGALS9B; LGALS9C;	GO:0032689~negative regulation of interferon-gamma production	9	29	31.0344827586207	0.00048975139134788	0.00907615297766922	1	1	0.699302214940779	0.999999999989094	0.0846951479542934
down	FOXE1; CTSB; IYD; DIO2; SLC5A5; DUOX2; DUOX1;	GO:0006590~thyroid hormone generation	7	17	41.1764705882353	0.00053637832575681	0.00977631226590582	1	1	0.714161156522799	0.999999999989094	0.0912287635351096
down	KIF20A; CEP55; CHMP4C; CHMP4B; CHMP1A; CHMP5; CHMP3;	GO:0061952~midbody abscission	7	17	41.1764705882353	0.00053637832575681	0.00977631226590582	1	1	0.714161156522799	0.999999999989094	0.0912287635351096
down	FOXP2; LRP5; VEGFA; FGFR2; BMPR1A; FOXF1; IHH; SMO;	GO:0002053~positive regulation of mesenchymal cell proliferation	8	23	34.7826086956522	0.00053987208789319	0.00977631226590582	1	1	0.71509528087202	0.999999999989094	0.0912287635351096
down	PRMT5; OBSL1; RCC1; CDC25C; NEK2; FBXW5; PKMYT1; FBXO43;	GO:0007088~regulation of mitotic nuclear division	8	23	34.7826086956522	0.00053987208789319	0.00977631226590582	1	1	0.71509528087202	0.999999999989094	0.0912287635351096
down	APOE; VEGFA; GJA5; HOXA1; FOXC1; HES1; STRA6; NOTCH3;	GO:0048844~artery morphogenesis	8	23	34.7826086956522	0.00053987208789319	0.00977631226590582	1	1	0.71509528087202	0.999999999989094	0.0912287635351096
down	RHOD; EPHA3; DUSP3; EFNA5; ACTG1; SLK; CAMSAP3; LIMCH1;	GO:0051893~regulation of focal adhesion assembly	8	23	34.7826086956522	0.00053987208789319	0.00977631226590582	1	1	0.71509528087202	0.999999999989094	0.0912287635351096
down	HSPA1B; PLK1; CHMP4C; CHMP4B; CHMP1A; CHMP5; CHMP3; RCC1;	GO:1901673~regulation of mitotic spindle assembly	8	23	34.7826086956522	0.00053987208789319	0.00977631226590582	1	1	0.71509528087202	0.999999999989094	0.0912287635351096
up	PIK3CD; IL2RA; CD4; IGHG1; FN1; PF4; MMP1; ITGB2; FYN; HCK; VIM; IL6R; ALOX5; CSF3; ITGAM; CCL4; CCL2; CCL5; OSM; MMP9; ALOX15; CD36; TNFRSF1B; ITGAX; S1PR1; FPR1; IL10; GATA3; IL32; PRTN3; PTAFR; PTPN6; IL2RG; CCR1; CSF2RB; CD80; FLT3; CD86; STAT5A; IL12RB1; FLT3LG; CCR5; STAT5B; JAK3; IL5RA; IL10RA; IL16; IL13RA2; IRF4; PTPRN; IL31RA; INPP5D; CSF3R; IL20; IFNA5; IFNW1; IFNAR2;	GO:0019221~cytokine-mediated signaling pathway	57	278	20.5035971223022	0.00054776702352299	0.111379294783009	1	1	0.999999999999978	0.999999999999978	0.995363551139317
down	MVD; DOLPP1; SRD5A3; DOLK; DPAGT1;	GO:0006489~dolichyl diphosphate biosynthetic process	5	7	71.4285714285714	0.00055003310954782	0.00984776793309064	1	1	0.717243174850358	0.999999999989094	0.0918955601745318
down	S100A8; SERPINB3; CX3CL1; FZD1; HILPDA;	GO:0035425~autocrine signaling	5	7	71.4285714285714	0.00055003310954782	0.00984776793309064	1	1	0.717243174850358	0.999999999989094	0.0918955601745318
down	UGT1A9; UGT1A1; UGT1A7; UGT1A8; UGT1A10;	GO:0052696~flavonoid glucuronidation	5	7	71.4285714285714	0.00055003310954782	0.00984776793309064	1	1	0.717243174850358	0.999999999989094	0.0918955601745318
down	SPRY2; SPRY1; BMP4; FGFR2; YAP1;	GO:0060449~bud elongation involved in lung branching	5	7	71.4285714285714	0.00055003310954782	0.00984776793309064	1	1	0.717243174850358	0.999999999989094	0.0918955601745318
down	TMPRSS11D; COX5B; ELN; EDNRA; SFTPD; HNMT; NDST1; SFTPA2; MAFB;	GO:0007585~respiratory gaseous exchange by respiratory system	9	30	30	0.00060120301157262	0.0105260350479207	1	1	0.728172328614333	0.999999999989094	0.0982248864633686
down	RALA; NSF; HAP1; VAMP2; LGI3; PCLO; RAB3D; RAB10; RAB13;	GO:0017157~regulation of exocytosis	9	30	30	0.00060120301157262	0.0105260350479207	1	1	0.728172328614333	0.999999999989094	0.0982248864633686
down	VPS37C; RAB11A; CHMP4C; MVB12A; VPS25; CHMP4B; CHMP1A; CHMP5; CHMP3;	GO:0036258~multivesicular body assembly	9	30	30	0.00060120301157262	0.0105260350479207	1	1	0.728172328614333	0.999999999989094	0.0982248864633686
down	ZMPSTE24; CHEK2; HRAS; CRYAB; CDKN1A; YAP1; RAD51; GTF2H5; TMEM109;	GO:0071480~cellular response to gamma radiation	9	30	30	0.00060120301157262	0.0105260350479207	1	1	0.728172328614333	0.999999999989094	0.0982248864633686
down	HFE; CHST9; DIO2; CHST8; DUOX2; DUOX1;	GO:0042446~hormone biosynthetic process	6	12	50	0.00061176019994002	0.0106520223824722	1	1	0.730441678728391	0.999999999989094	0.0994005515239353
down	TP73; TGFA; FGF1; CDK1; SAA1; GHR; BMP2; NTF3; MAPK3; PRDX2; UBE2N; PEA15; EPGN; CXCL17; IQGAP3; LPAR1; PBK; GDF15; LPAR3; MUC20;	GO:0000187~activation of MAPK activity	20	122	16.3934426229508	0.00065038214791923	0.0112934850781154	1	1	0.738770428197481	0.999999999989094	0.105386433212833
down	PLK1; CDC20; MAD2L1; TRIP13; PSMG2; AURKB; TTK; BUB1B;	GO:0007094~mitotic spindle assembly checkpoint	8	24	33.3333333333333	0.00068016938092863	0.0116826925103676	1	1	0.745081982908056	0.999999999989094	0.109018366383265
down	EFNA1; BMP5; FOXA1; DAB2IP; VASN; SFRP2; OVOL2; STRAP;	GO:0010719~negative regulation of epithelial to mesenchymal transition	8	24	33.3333333333333	0.00068016938092863	0.0116826925103676	1	1	0.745081982908056	0.999999999989094	0.109018366383265
down	CYP1A1; AOC1; GJB2; ID1; SLC1A3; HYAL1; HYAL2; ENDOG;	GO:0046677~response to antibiotic	8	24	33.3333333333333	0.00068016938092863	0.0116826925103676	1	1	0.745081982908056	0.999999999989094	0.109018366383265
down	CES2; GSTA1; AKR1C2; PTGR1; PTGR2; CYP2S1; AKR1C1;	GO:0006693~prostaglandin metabolic process	7	18	38.8888888888889	0.00070448224231833	0.0119066892048363	1	1	0.75027358806903	0.999999999989094	0.111108616870005
down	CTSV; NDUFS6; CRYAB; TH; HYAL2; RNF165; TP63;	GO:0010259~multicellular organism aging	7	18	38.8888888888889	0.00070448224231833	0.0119066892048363	1	1	0.75027358806903	0.999999999989094	0.111108616870005
down	ALOX12B; GSTA1; GSTP1; CYP2J2; ELOVL1; ALOXE3; ALOX15B;	GO:0043651~linoleic acid metabolic process	7	18	38.8888888888889	0.00070448224231833	0.0119066892048363	1	1	0.75027358806903	0.999999999989094	0.111108616870005
down	DSP; DES; KRT9; KRT20; KRT2; KRT17; TCHH;	GO:0045109~intermediate filament organization	7	18	38.8888888888889	0.00070448224231833	0.0119066892048363	1	1	0.75027358806903	0.999999999989094	0.111108616870005
down	GLI3; PDGFRA; FGFR2; HNF1B; FOXF1; IHH; OVOL2;	GO:0048557~embryonic digestive tract morphogenesis	7	18	38.8888888888889	0.00070448224231833	0.0119066892048363	1	1	0.75027358806903	0.999999999989094	0.111108616870005
down	BUB1B; ZWINT; HRAS; CDKN2B; MAD2L1; TICRR; NABP2; PLK2; WEE1;	GO:0007093~mitotic cell cycle checkpoint	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	EGFR; ANG; EDNRA; GNA15; NTF4; AVPR1A; ADCYAP1R1; LPAR1; P2RY12;	GO:0007202~activation of phospholipase C activity	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	MID1; HOXB1; FST; BMP5; SOSTDC1; GRHL3; SHROOM3; FOXJ1; RFNG;	GO:0007389~pattern specification process	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	EGFR; MAPK3; KDR; TEC; DDR1; SRMS; SRC; PTK6; FRK;	GO:0038083~peptidyl-tyrosine autophosphorylation	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	CCL21; SRC; PDGFRA; FGFR3; TEK; TNFAIP8L3; CCL19; P2RY12; VAV3;	GO:0043552~positive regulation of phosphatidylinositol 3-kinase activity	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	FGFR2; BMPR1A; RAD23B; WNT7B; EPN1; TEAD4; RARG; GTPBP3; TEAD3;	GO:0048568~embryonic organ development	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	PLXNB1; S100A8; S100A9; MAPK3; TJP1; ARHGEF5; CLIC4; CAPN6; STMN1;	GO:0051493~regulation of cytoskeleton organization	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	PRMT5; CLDN1; EGFR; GLI3; PCNA; CCND1; RAP1A; IHH; HFE;	GO:0097421~liver regeneration	9	31	29.0322580645161	0.00073255774914537	0.0121225875041342	1	1	0.756272854914115	0.999999999989094	0.113123296266342
down	SLC16A8; IGHA1; ATP1B1; CEACAM5; PROS1; SRC; CEACAM1; MIF; EPCAM; SDC1; CD34; SDC4; GPC1; CEACAM3; CEACAM6; F2RL1; CXADR; SLC7A5; TEK; GAS6; GRB14; GRB7; ANGPT1; NKX2-3; FOXJ1; ESAM; SLC7A8;	GO:0050900~leukocyte migration	27	193	13.9896373056995	0.00078048461891111	0.0127822002962756	1	1	0.766459604464494	0.999999999989094	0.119278547633348
down	PLPP3; DVL1; TSPAN1; CTNND1; USP2; CHEK2; CRYAB; GAPDH; ATP1B1; HSPA1B; EFNA1; PFN2; CDKN1A; CCT6A; PEX19; CCT3; CDK7; DSG1; STK3; STX12; GPIHBP1; PHB2; SMO; SOX17; GTSE1; FKBPL;	GO:0050821~protein stabilization	26	183	14.207650273224	0.0007890802785474	0.012856531633505	1	1	0.767775111026625	0.999999999989094	0.119972178913008
up	IGKV1-12; FCN1; CFD; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; IGHG1; IGKV1-16; IGKV3-11; IGKV2-30; IGHV4-34; IGLC2; IGHV1-2; CFP;	GO:0006956~complement activation	25	92	27.1739130434783	0.00080461192923497	0.156167860810607	1	1	0.999999999999978	0.999999999999978	1
down	EML2; MAP2; STMN1; CDH5; FKBP4; INPP5J;	GO:0031115~negative regulation of microtubule polymerization	6	13	46.1538461538462	0.00084640789211554	0.013442938891372	1	1	0.774490984566462	0.999999999989094	0.12544430455795
down	CCL21; F2RL1; CDC42EP1; CDC42EP5; CDC42EP4; C15orf62;	GO:0031274~positive regulation of pseudopodium assembly	6	13	46.1538461538462	0.00084640789211554	0.013442938891372	1	1	0.774490984566462	0.999999999989094	0.12544430455795
down	ELOVL7; HACD2; ELOVL1; ELOVL4; TECR; ELOVL6;	GO:0042761~very long-chain fatty acid biosynthetic process	6	13	46.1538461538462	0.00084640789211554	0.013442938891372	1	1	0.774490984566462	0.999999999989094	0.12544430455795
down	IRF6; PRLR; HOXA5; SMO; ZNF703; ELF5;	GO:0060644~mammary gland epithelial cell differentiation	6	13	46.1538461538462	0.00084640789211554	0.013442938891372	1	1	0.774490984566462	0.999999999989094	0.12544430455795
down	PLPP1; PLPP3; PLPP2; SGPP2; SPHK1;	GO:0006670~sphingosine metabolic process	5	8	62.5	0.00084726096125975	0.013442938891372	1	1	0.77461738681126	0.999999999989094	0.12544430455795
down	CEACAM1; GLUL; PTN; EMP2; RHOJ;	GO:0010594~regulation of endothelial cell migration	5	8	62.5	0.00084726096125975	0.013442938891372	1	1	0.77461738681126	0.999999999989094	0.12544430455795
down	GOT2; AGXT; ALDH4A1; HOGA1; GRHPR;	GO:0046487~glyoxylate metabolic process	5	8	62.5	0.00084726096125975	0.013442938891372	1	1	0.77461738681126	0.999999999989094	0.12544430455795
down	ADCYAP1; PTN; TSPO; IDH2; HES1;	GO:0060253~negative regulation of glial cell proliferation	5	8	62.5	0.00084726096125975	0.013442938891372	1	1	0.77461738681126	0.999999999989094	0.12544430455795
down	BMP4; FOLR1; BMPR1A; HES1; ADGRF5;	GO:0061626~pharyngeal arch artery morphogenesis	5	8	62.5	0.00084726096125975	0.013442938891372	1	1	0.77461738681126	0.999999999989094	0.12544430455795
down	CTSV; CTSB; SPP1; GJA1; PTN; MAPK3; GJB2; STC1;	GO:0046697~decidualization	8	25	32	0.00084840258071139	0.013442938891372	1	1	0.774744107049128	0.999999999989094	0.12544430455795
down	GALR2; CXCL13; ADGRL2; TSPAN12; EGFR; HRAS; CXCL10; ERBB2; INHA; CD59; EDN3; MIF; EDN2; EPHA1; CXCR1; BDKRB2; ADCYAP1R1; LEPR; TNFSF10; ADGRF1; GPR157; ADGRG6; ADGRF5; ADGRF4; ADGRF2; CLEC1A; MAGI1; PRMT1; ADGRL4; CBLC; ADGRG1; MAPK3; CTF1; ANXA1;	GO:0007166~cell surface receptor signaling pathway	34	268	12.6865671641791	0.00086451539228926	0.013664086175385	1	1	0.776683901459556	0.999999999989094	0.127507965448775
down	ZNF205; MT-CO2; DUOXA1; DUOXA2;	GO:0010729~positive regulation of hydrogen peroxide biosynthetic process	4	4	100	0.00091143135295856	0.0141973253261667	1	1	0.782241150311054	0.999999999989094	0.132483946889546
down	AGR2; VAMP2; VAMP3; VAMP8;	GO:0070254~mucus secretion	4	4	100	0.00091143135295856	0.0141973253261667	1	1	0.782241150311054	0.999999999989094	0.132483946889546
down	ELOVL7; ACSL3; HACD2; ELOVL1; ELOVL4; ELOVL6; TECR;	GO:0035338~long-chain fatty-acyl-CoA biosynthetic process	7	19	36.8421052631579	0.00091169318519246	0.0141973253261667	1	1	0.782241150311054	0.999999999989094	0.132483946889546
down	EPHA2; TCF15; SCRIB; TMED2; SFRP2; TP63; VANGL2;	GO:0036342~post-anal tail morphogenesis	7	19	36.8421052631579	0.00091169318519246	0.0141973253261667	1	1	0.782241150311054	0.999999999989094	0.132483946889546
up	ACOD1; LILRA1; LILRB3; OR2H2; HP; MPO; INHBA; CD48; GATA3; IL32; WAS; TAP1; SP140; LILRA2; IL31RA; NLRP3; CSF3R; CLEC1B; CD84; STAT5A; STAT5B;	GO:0006952~defense response	21	72	29.1666666666667	0.00096924666788289	0.179942750950433	1	1	0.999999999999978	0.999999999999978	1
down	GSN; GSTP1; CD9; HES5; LPAR1; HDAC11; WASF3; ZNF488;	GO:0014003~oligodendrocyte development	8	26	30.7692307692308	0.00104843679665767	0.0160895700174729	1	1	0.798588796038283	0.999999999989094	0.150141642224807
down	SPINT1; SPINT2; BMP2; BMP4; BMP7; BMPR1A; ACVRL1; DLX5; TMEM100;	GO:0071773~cellular response to BMP stimulus	9	33	27.2727272727273	0.00106541206512878	0.016259817693436	1	1	0.800301019946317	0.999999999989094	0.151730327666761
up	CYBA; NCF1; NCF2; CD52; SLC11A1; NCF4; NCF1B; NCF1C;	GO:0045730~respiratory burst	8	13	61.5384615384615	0.00113121622292556	0.201262219662172	1	1	0.999999999999978	0.999999999999978	1
down	RAMP3; ANXA2; NSG1; NSF; SCRIB; VAMP3;	GO:0001921~positive regulation of receptor recycling	6	14	42.8571428571429	0.00114473028291928	0.0171926552918067	1	1	0.808375096088293	0.999999999989094	0.160435207212723
down	FGFR2; SFN; EFNB2; SLURP1; KDF1; INTU;	GO:0010839~negative regulation of keratinocyte proliferation	6	14	42.8571428571429	0.00114473028291928	0.0171926552918067	1	1	0.808375096088293	0.999999999989094	0.160435207212723
down	"NAMPT; RNLS; NAPRT; SLC5A8; NAXE; NUDT12;"	GO:0034356~NAD biosynthesis via nicotinamide riboside salvage pathway	6	14	42.8571428571429	0.00114473028291928	0.0171926552918067	1	1	0.808375096088293	0.999999999989094	0.160435207212723
down	SAA1; LGALS3; EDN2; SFTPD; CX3CL1; CXCL17;	GO:0048246~macrophage chemotaxis	6	14	42.8571428571429	0.00114473028291928	0.0171926552918067	1	1	0.808375096088293	0.999999999989094	0.160435207212723
down	FOXP2; BMP4; ITGA8; IHH; SMO; STRA6;	GO:0048745~smooth muscle tissue development	6	14	42.8571428571429	0.00114473028291928	0.0171926552918067	1	1	0.808375096088293	0.999999999989094	0.160435207212723
down	CYP1A1; CYP2C9; PDGFRA; COMT; UGT1A1; SULT1E1; HSD17B4;	GO:0008210~estrogen metabolic process	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	EDN3; EDN2; AVPR1A; SLC1A1; NMU; RGS4; TRPM4;	GO:0010460~positive regulation of heart rate	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	NEFH; CYFIP1; PARVA; NCKAP1; RHOV; RHOJ; RAC1;	GO:0030031~cell projection assembly	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	SRC; CCNA2; PTN; HYAL1; CORO1B; PDGFD; ERRFI1;	GO:0036120~cellular response to platelet-derived growth factor stimulus	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	NGFR; SRC; NTF4; HAP1; BCAR1; AKT1S1; NDN;	GO:0048011~neurotrophin TRK receptor signaling pathway	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	EGFR; GJA1; ADCYAP1; NPPC; GJA5; F2RL1; KCNMB1;	GO:0097755~positive regulation of blood vessel diameter	7	20	35	0.00116404360607225	0.017237636390855	1	1	0.810335189269352	0.999999999989094	0.160854953425509
down	G6PD; TP53I3; FMO2; IDH1; IDH2;	GO:0006739~NADP metabolic process	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	SLC2A1; EDNRA; OCLN; FFAR4; TRIB3;	GO:0010827~regulation of glucose transmembrane transport	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	PLTP; ABCA12; CPTP; GLTPD2; GLTP;	GO:0035627~ceramide transport	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	VEGFA; SFTPD; ABCA12; ADGRF5; EPAS1;	GO:0043129~surfactant homeostasis	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	UGT1A9; UGT1A1; UGT1A7; UGT1A8; UGT1A10;	GO:0052697~xenobiotic glucuronidation	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	HRAS; RAP1A; PRKCZ; IQSEC2; GPC4;	GO:0098696~regulation of neurotransmitter receptor localization to postsynaptic specialization membrane	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	FZD9; SLC25A5; MPV17L; BOK; TMEM14A;	GO:1901029~negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	5	9	55.5555555555556	0.00124944969031482	0.0181628718743471	1	1	0.81911138265494	0.999999999989094	0.16948889297674
down	ADCY6; PRKACA; AQP1; RAB11A; ADCY2; TFAP2B; AQP3; CYP4F12; MYO5B;	GO:0003091~renal water homeostasis	9	34	26.4705882352941	0.00127259913651712	0.0182935261406226	1	1	0.821452592780669	0.999999999989094	0.170708108038484
down	TUBB; TUBA1B; TUBA1C; TUBB2B; GTSE1; TUBG1; TUBB4B; TUBB6; TUBB2A;	GO:0007017~microtubule-based process	9	34	26.4705882352941	0.00127259913651712	0.0182935261406226	1	1	0.821452592780669	0.999999999989094	0.170708108038484
down	DVL1; RBFOX2; HPRT1; MAP2; VLDLR; MAPK8IP2; PREX2; MINK1; CELSR2;	GO:0048813~dendrite morphogenesis	9	34	26.4705882352941	0.00127259913651712	0.0182935261406226	1	1	0.821452592780669	0.999999999989094	0.170708108038484
down	GFRA3; NFASC; ERBB2; ERBB3; ALDH3A2; UGT8; NTF3; NTF4;	GO:0007422~peripheral nervous system development	8	27	29.6296296296296	0.00128441450498218	0.0182935261406226	1	1	0.822655774978864	0.999999999989094	0.170708108038484
down	CDK1; CCNB1; CCND1; PBX1; HSPA2; RAB11A; DTL; CDC25C;	GO:0010971~positive regulation of G2/M transition of mitotic cell cycle	8	27	29.6296296296296	0.00128441450498218	0.0182935261406226	1	1	0.822655774978864	0.999999999989094	0.170708108038484
down	NDUFS4; RAPGEF3; ADCYAP1; ADCYAP1R1; DEFB1; ADCY2; ADGRG6; PCLO;	GO:0019933~cAMP-mediated signaling	8	27	29.6296296296296	0.00128441450498218	0.0182935261406226	1	1	0.822655774978864	0.999999999989094	0.170708108038484
down	YAP1; TJP1; STK3; TEAD4; AMOTL1; TEAD3; WWTR1; AMOTL2;	GO:0035329~hippo signaling	8	27	29.6296296296296	0.00128441450498218	0.0182935261406226	1	1	0.822655774978864	0.999999999989094	0.170708108038484
down	SRPX2; CD34; EPHA2; RAC1; CTTN; PLD1; PLD2; BRK1;	GO:0048870~cell motility	8	27	29.6296296296296	0.00128441450498218	0.0182935261406226	1	1	0.822655774978864	0.999999999989094	0.170708108038484
up	IGKV1-12; HP; HPR; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; ALB; IGKV1-16; IGKV3-11; ITGB2; IGKV2-30; IGHV4-34; ASGR1; CD14; IGLC2; ITGAM; CD36; IGHV1-2; FPR2; TGFBR2; HBB; LDLRAP1; CD163; SORL1; NLGN3;	GO:0006898~receptor-mediated endocytosis	36	160	22.5	0.00137721516228606	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
down	RAB11A; DCTN2; RAB11B; MLPH; RAB17; RAB27B; MREG;	GO:0032402~melanosome transport	7	21	33.3333333333333	0.00146798933458214	0.0204936484638362	1	1	0.836753920711821	0.999999999989094	0.191238798314483
down	PLA2G2A; PLA2G4A; PLA2G4E; LPCAT4; PLA2G4F; PLA2G4D; OSBPL10;	GO:0036150~phosphatidylserine acyl-chain remodeling	7	21	33.3333333333333	0.00146798933458214	0.0204936484638362	1	1	0.836753920711821	0.999999999989094	0.191238798314483
down	SRPX2; ANXA1; VEGFA; KDR; FGFBP1; RHOJ; PLK2;	GO:0090050~positive regulation of cell migration involved in sprouting angiogenesis	7	21	33.3333333333333	0.00146798933458214	0.0204936484638362	1	1	0.836753920711821	0.999999999989094	0.191238798314483
down	MAPK8IP2; CNIH2; MINK1; CACNG4; GSG1L; SHISA9; SHISA6;	GO:2000311~regulation of AMPA receptor activity	7	21	33.3333333333333	0.00146798933458214	0.0204936484638362	1	1	0.836753920711821	0.999999999989094	0.191238798314483
up	LPXN; CD22; GPS2; FCRL3; CD300A; PLCL2;	GO:0050859~negative regulation of B cell receptor signaling pathway	6	7	85.7142857142857	0.00149873127391886	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
down	NGFR; BMP2; BMPR1A; KLF5; SMAD1; HIF1A; ATOH8; SREBF1; SREBF2;	GO:1902895~positive regulation of pri-miRNA transcription by RNA polymerase II	9	35	25.7142857142857	0.00151106031879988	0.0208159671293238	1	1	0.840036694412192	0.999999999989094	0.194246551393246
down	OPLAH; GGCT; GGT5; GGT6; MGST2; CHAC1;	GO:0006750~glutathione biosynthetic process	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	SULT1C3; CHST9; CHST3; CHST6; CHST8; SUOX;	GO:0006790~sulfur compound metabolic process	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	IL1R2; GAS1; CHAC1; TMEM59; SNX12; TMEM98;	GO:0010955~negative regulation of protein processing	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	CTSV; NGFR; SEMA3F; NRTN; NTF4; NTF3;	GO:0021675~nerve development	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	CRAT; HSD17B4; EHHADH; DECR2; AMACR; CROT;	GO:0033540~fatty acid beta-oxidation using acyl-CoA oxidase	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	APOE; ADRA2A; ADAM9; SH3D19; SNX33; PACSIN3;	GO:0051044~positive regulation of membrane protein ectodomain proteolysis	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	COBL; HRAS; CYFIP1; EPS8L1; P2RY12; EPS8L2;	GO:1900029~positive regulation of ruffle assembly	6	15	40	0.00151735197440006	0.0208159671293238	1	1	0.840495291449929	0.999999999989094	0.194246551393246
down	IDO1; TDO2; AFMID; IDO2;	GO:0019441~tryptophan catabolic process to kynurenine	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
down	LTF; FAM3A; RARRES2; IL36RN;	GO:0019732~antifungal humoral response	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
down	APOC1; APOA4; TSPO; OSBPL6;	GO:0032374~regulation of cholesterol transport	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
down	CD1A; CD1C; CD1E; CD1B;	GO:0048006~antigen processing and presentation, endogenous lipid antigen via MHC class Ib	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
down	FUT1; CEACAM6; TSTA3; RIN2;	GO:1904906~positive regulation of endothelial cell-matrix adhesion via fibronectin	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
down	GJB5; GJB1; GJA1; GJB2;	GO:1905867~epididymis development	4	5	80	0.00155834438449787	0.0209698231612473	1	1	0.843329010459228	0.999999999989094	0.195682276355075
up	S1PR4; CALCA; PTH; GHRH; PF4; GNAI2; PTHLH; LHCGR; ADORA2A; PTGER2; PTGIR; GLP1R; GPR65; GPHA2; LGR5; CALCB; TBXA2R; ADGRE1; ADGRG5; ADGRE2; ADGRE3; ADGRG3; PTGDR; ADGRG7; ADGRE4P; RXFP2;	GO:0007189~adenylate cyclase-activating G protein-coupled receptor signaling pathway	26	103	25.2427184466019	0.00157636817756224	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
up	CD4; CD3E; PTPRC; CD80; CD86; STAT5B; IRF4; CARD11;	GO:0045086~positive regulation of interleukin-2 biosynthetic process	8	14	57.1428571428571	0.00160789059629596	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
up	TRAV19; PSMB11; PIK3CD; BTN3A1; LAT; GRAP2; CD4; TRBV12-3; TRAV8-4; TRAC; TRBC1; CD3D; TRBV7-9; TRAV29DV5; LCK; FYN; CD3E; PTPRC; CD3G; CD247; GATA3; PSMB8; PSMB9; PSMB10; WAS; ZAP70; ITK; PTPRJ; RFTN1; TRAT1; SKAP1; PSMA8; INPP5D; CARD11; THEMIS2; PRAM1; HHLA2; CTLA4;	GO:0050852~T cell receptor signaling pathway	38	174	21.8390804597701	0.0016380597894361	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
up	S1PR4; OXT; CALCA; CD36; GATA2; CD52; CCR1; GLP1R; CAV3; C1QTNF1; HRH4; PROK2; TRPC5; FPR2; PTGDR; ADRA1D; CCR10; TBXA2R; CXCR4; CMKLR1; CXCR2; CXCR3; CCR7; PTGER2; CCR6; CCR5; FPR1; CXCR5; PTGIR; CCR3; C5AR1; C3AR1; C5AR2; CX3CR1;	GO:0007204~positive regulation of cytosolic calcium ion concentration	34	150	22.6666666666667	0.00165396120790429	0.214012556295494	1	1	0.999999999999978	0.999999999999978	1
down	UBE2C; BUB1B; USP2; PTTG1; PSMC2; USP5; UBE2A; UBE2E1; PLK1; CDC20; MAD2L1; KEAP1; DCST1; USP43; SIAH1; TP53INP2; LNX1; RNF128; AURKB; DTL; FBXL7; ANAPC7; CBLC; STUB1; RNF11; UBE2G1; RNF167; RNF185; NDFIP2; TOLLIP; RNF150; RMND5B; ADRM1; PSMD3; FBXL16;	GO:0006511~ubiquitin-dependent protein catabolic process	35	291	12.0274914089347	0.00167671399046831	0.0223256581335886	1	1	0.849789801311185	0.999999999989094	0.208334403733997
down	PSEN2; BACE1; DHCR24; APH1A; PSENEN;	GO:0042987~amyloid precursor protein catabolic process	5	10	50	0.00177691879735842	0.0233628325771875	1	1	0.854068101446576	0.999999999989094	0.218012914350902
down	BMP5; DDR1; TCF15; SHROOM2; STRA6;	GO:0043583~ear development	5	10	50	0.00177691879735842	0.0233628325771875	1	1	0.854068101446576	0.999999999989094	0.218012914350902
down	SPRY2; DCN; XDH; DAB2IP; CADM4;	GO:1900747~negative regulation of vascular endothelial growth factor signaling pathway	5	10	50	0.00177691879735842	0.0233628325771875	1	1	0.854068101446576	0.999999999989094	0.218012914350902
down	RNF165; SIAH1; PRSS16; PGC; BACE2; BACE1; CTSD; PGA5; CTSE;	GO:0030163~protein catabolic process	9	36	25	0.00178409765972842	0.0233628325771875	1	1	0.854418336320045	0.999999999989094	0.218012914350902
down	KLF4; SPRY2; TFAP2A; SIK1; HES5; LTBP4; TFAP2B; KLK6; BCL6B;	GO:0045595~regulation of cell differentiation	9	36	25	0.00178409765972842	0.0233628325771875	1	1	0.854418336320045	0.999999999989094	0.218012914350902
down	FZD9; GGCT; SFN; PMAIP1; TIMM50; BOK; BAD;	GO:0001836~release of cytochrome c from mitochondria	7	22	31.8181818181818	0.00183038123573609	0.0237724513772445	1	1	0.856403549991072	0.999999999989094	0.221835318508373
down	BMP7; FGFR2; SIM2; IHH; SMAD1; SMAD5; RIPPLY3;	GO:0009880~embryonic pattern specification	7	22	31.8181818181818	0.00183038123573609	0.0237724513772445	1	1	0.856403549991072	0.999999999989094	0.221835318508373
down	REN; TFF1; CYP1A1; TH; GOT1; HNMT; LRP11;	GO:0035902~response to immobilization stress	7	22	31.8181818181818	0.00183038123573609	0.0237724513772445	1	1	0.856403549991072	0.999999999989094	0.221835318508373
down	BMP4; VEGFA; BMP7; HNF1B; RASIP1; TIMELESS; CLIC4;	GO:0048754~branching morphogenesis of an epithelial tube	7	22	31.8181818181818	0.00183038123573609	0.0237724513772445	1	1	0.856403549991072	0.999999999989094	0.221835318508373
down	SPRY1; GLI3; BMP7; ITGA8; IRX3; APH1A; SOX17; ROBO2;	GO:0001656~metanephros development	8	29	27.5862068965517	0.00188210366761066	0.0242454736693422	1	1	0.858494258108386	0.999999999989094	0.226249379522269
down	DVL1; PHGDH; PLXNA2; EPHA2; HES5; ZNF358; INTU; GRHL2;	GO:0021915~neural tube development	8	29	27.5862068965517	0.00188210366761066	0.0242454736693422	1	1	0.858494258108386	0.999999999989094	0.226249379522269
down	WASL; COBL; FAM107A; ANG; GSN; RAC1; CTTN; WASF3;	GO:0030041~actin filament polymerization	8	29	27.5862068965517	0.00188210366761066	0.0242454736693422	1	1	0.858494258108386	0.999999999989094	0.226249379522269
down	CXCL11; CXCL10; APLNR; BDKRB1; XCL1; CX3CL1; CXCL9; CEMIP;	GO:0051281~positive regulation of release of sequestered calcium ion into cytosol	8	29	27.5862068965517	0.00188210366761066	0.0242454736693422	1	1	0.858494258108386	0.999999999989094	0.226249379522269
down	MIF; EDN2; PTGS1; PLA2G4A; PLA2G4F; MGST1;	GO:0001516~prostaglandin biosynthetic process	6	16	37.5	0.00197550497738386	0.0250916844622423	1	1	0.862594631665647	0.999999999989094	0.234145891236156
down	MT1X; MT1B; MT1A; MT1H; MT1M; MT1G;	GO:0010273~detoxification of copper ion	6	16	37.5	0.00197550497738386	0.0250916844622423	1	1	0.862594631665647	0.999999999989094	0.234145891236156
down	TACSTD2; PFN2; PTPRR; DAB2IP; MARVELD3; STRAP;	GO:0010633~negative regulation of epithelial cell migration	6	16	37.5	0.00197550497738386	0.0250916844622423	1	1	0.862594631665647	0.999999999989094	0.234145891236156
down	SPRY1; NGFR; GPC1; WNT4; CREB3L1; SPRY2;	GO:0040037~negative regulation of fibroblast growth factor receptor signaling pathway	6	16	37.5	0.00197550497738386	0.0250916844622423	1	1	0.862594631665647	0.999999999989094	0.234145891236156
down	EDN3; EDN2; KEL; EDNRA; BDKRB2; TRPM4;	GO:0042310~vasoconstriction	6	16	37.5	0.00197550497738386	0.0250916844622423	1	1	0.862594631665647	0.999999999989094	0.234145891236156
down	TP73; PHGDH; ATP1B1; CDH1; EDN3; TSPAN8; SOX2; PPP2CB; HIF1A; PHLDA2; NHLRC1; ZNF683; TSKU; TMPRSS4; TREM2; CRNN; HMG20B; MAPK3; MECOM; MAPK13; IHH; CDK2; YBX2;	GO:0010468~regulation of gene expression	23	166	13.855421686747	0.00204452313903847	0.0259163753104516	1	1	0.865490722280499	0.999999999989094	0.241841587152421
down	MT1X; MT1A; MT1H; SLC39A7; MT1B; MT1G; MT1M; SLC39A4;	GO:0006882~cellular zinc ion homeostasis	8	30	26.6666666666667	0.00225339760809984	0.0277739208222272	1	1	0.874369577233549	0.999999999989094	0.259175483169681
down	UNC13B; GIPC1; PPFIA3; GJA1; SLC1A3; SLC1A1; VAMP2; RIMS1;	GO:0014047~glutamate secretion	8	30	26.6666666666667	0.00225339760809984	0.0277739208222272	1	1	0.874369577233549	0.999999999989094	0.259175483169681
down	OIP5; CENPA; CENPW; CENPU; HJURP; CENPI; CENPH; CENPM;	GO:0034080~CENP-A containing nucleosome assembly	8	30	26.6666666666667	0.00225339760809984	0.0277739208222272	1	1	0.874369577233549	0.999999999989094	0.259175483169681
down	SLC27A2; ACSL3; SLC27A4; ACOT4; CYP4F12; PNPLA3; SLC27A6;	GO:0001676~long-chain fatty acid metabolic process	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
down	SLC16A8; VDAC1; ME1; GLO1; PCK1; PC; PCK2;	GO:0006090~pyruvate metabolic process	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
down	PSEN2; BACE1; ADAM9; HM13; APH1A; PSENEN; BACE2;	GO:0006509~membrane protein ectodomain proteolysis	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
down	FABP12; FABP1; PNPLA4; FABP6; FABP5; MGLL; PNPLA3;	GO:0019433~triglyceride catabolic process	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
down	KALRN; OPHN1; ARHGDIA; KANK1; ARHGEF25; EPS8L1; EPS8L2;	GO:0035023~regulation of Rho protein signal transduction	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
down	FAM107A; MT-ND3; ANXA1; GSTP1; ADCYAP1; UGT1A1; STC1;	GO:0071385~cellular response to glucocorticoid stimulus	7	23	30.4347826086957	0.00225843200389431	0.0277739208222272	1	1	0.874649729923993	0.999999999989094	0.259175483169681
up	MYO1G; S1PR1; ITGB7; ZAP70; GPR15; CCR6;	GO:0072678~T cell migration	6	8	75	0.00238040480224688	0.29040938587412	1	1	0.999999999999978	0.999999999999978	1
down	EEF1E1; AIMP2; PPA1; MARS2; PPA2; FARSB; FARSA; TARS2; VARS2;	GO:0006418~tRNA aminoacylation for protein translation	9	38	23.6842105263158	0.00244797623621185	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	CACNA1G; SCN2B; JUP; DSP; GJA5; KCNJ5; DSC2; DSG2; TRPM4;	GO:0086091~regulation of heart rate by cardiac conduction	9	38	23.6842105263158	0.00244797623621185	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	LDOC1; RXRA; PRDX3; TMED2; STOX2;	GO:0001893~maternal placenta development	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	RAPGEF3; RAP2A; RAP1A; SGSM3; PLK2;	GO:0032486~Rap protein signal transduction	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	FUT1; FUT3; FUT2; FUT6; FUT10;	GO:0036065~fucosylation	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	IRF6; KLK8; FST; KRT2; SDR16C5;	GO:0043616~keratinocyte proliferation	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	CCT3; AFDN; PDZD11; PLEKHA7; BAD;	GO:0046931~pore complex assembly	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	JUP; DSP; DSC2; DSG2; TRPM4;	GO:0098911~regulation of ventricular cardiac muscle cell action potential	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	ADCY6; CFTR; EFNA5; GNAI1; ADCY2;	GO:1904322~cellular response to forskolin	5	11	45.4545454545455	0.00245072382493328	0.0290449087454094	1	1	0.882879875943264	0.999999999989094	0.271035850713826
down	GJB6; GJA1; GJB2; DBN1;	GO:0010644~cell communication by electrical coupling	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	F12; CLEC3B; ENO1; PLGRKT;	GO:0010756~positive regulation of plasminogen activation	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	TICRR; WRNIP1; CDT1; WDR18;	GO:0030174~regulation of DNA-dependent DNA replication initiation	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	ID1; FOXF1; STRA6; ERRFI1;	GO:0060426~lung vasculature development	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	JUP; DSP; DSC2; DSG2;	GO:0086073~bundle of His cell-Purkinje myocyte adhesion involved in cell communication	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	ITSN1; CYFIP1; CTTNBP2; BAIAP2;	GO:1905274~regulation of modification of postsynaptic actin cytoskeleton	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	GJB6; GJB2; GJB4; GJA3;	GO:1990349~gap junction-mediated intercellular transport	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	OVOL1; FBLN1; KDF1; OVOL2;	GO:2000647~negative regulation of stem cell proliferation	4	6	66.6666666666667	0.00246736002521675	0.0290449087454094	1	1	0.883545464404738	0.999999999989094	0.271035850713826
down	CHCHD10; KCNK6; KCNK1; KCNK7; KCNK15; KCNK5;	GO:0030322~stabilization of membrane potential	6	17	35.2941176470588	0.00253093191213738	0.0293792059690965	1	1	0.886294258310566	0.999999999989094	0.27415538306311
down	SLC9A3R1; OPHN1; RAP2A; TCF15; FOXF1; CAMSAP3;	GO:0045198~establishment of epithelial cell apical/basal polarity	6	17	35.2941176470588	0.00253093191213738	0.0293792059690965	1	1	0.886294258310566	0.999999999989094	0.27415538306311
down	CTSV; KRT36; AQP3; GRHL1; SERPINB13; ERRFI1;	GO:0045616~regulation of keratinocyte differentiation	6	17	35.2941176470588	0.00253093191213738	0.0293792059690965	1	1	0.886294258310566	0.999999999989094	0.27415538306311
down	CCL21; F2RL1; CCL19; RARRES2; P2RY12; TREM2;	GO:0050921~positive regulation of chemotaxis	6	17	35.2941176470588	0.00253093191213738	0.0293792059690965	1	1	0.886294258310566	0.999999999989094	0.27415538306311
down	SDC4; HES1; USH1G; HES5; VANGL2; USH1C;	GO:0060122~inner ear receptor cell stereocilium organization	6	17	35.2941176470588	0.00253093191213738	0.0293792059690965	1	1	0.886294258310566	0.999999999989094	0.27415538306311
up	LAT; TYROBP; ITGB3; ITGB2; ITGA2B; PLEK; HCK; ITGA5; FGR; ITGAM; ITGA4; ITGAL; ITGAX; ITGB7; CD40LG; FCER1G; NEDD9; PRKD1; FERMT3; TSPAN32; CCM2; ADAMTS1; LAMA3; PRAM1;	GO:0007229~integrin-mediated signaling pathway	24	96	25	0.00259364106525584	0.299320198611957	1	1	0.999999999999978	0.999999999999978	1
down	CA2; ASS1; KRT14; S100A8; TH; PLN; GGH; KHK;	GO:0010043~response to zinc ion	8	31	25.8064516129032	0.00267977040717537	0.0308246548832623	1	1	0.89263726555374	0.999999999989094	0.287643753074815
down	PSMD10; EGFR; SRC; CCNB1; CCND1; PSRC1; CDC6; CKS2;	GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity	8	31	25.8064516129032	0.00267977040717537	0.0308246548832623	1	1	0.89263726555374	0.999999999989094	0.287643753074815
down	GLUL; ZDHHC20; ABHD17C; ZDHHC21; ZDHHC12; ZDHHC5; ZDHHC9;	GO:0018345~protein palmitoylation	7	24	29.1666666666667	0.00275967864610982	0.031458351185331	1	1	0.896304936825763	0.999999999989094	0.293557161783753
down	TOM1L1; RAP2A; SRC; VEGFA; GPNMB; TNKS1BP1; PDGFD;	GO:0031954~positive regulation of protein autophosphorylation	7	24	29.1666666666667	0.00275967864610982	0.031458351185331	1	1	0.896304936825763	0.999999999989094	0.293557161783753
down	CXCL14; CXCL10; BMP4; IL18; SOSTDC1; CCL17; ANKRD2;	GO:0045662~negative regulation of myoblast differentiation	7	24	29.1666666666667	0.00275967864610982	0.031458351185331	1	1	0.896304936825763	0.999999999989094	0.293557161783753
down	DVL1; HOXA1; TIFAB; MYO3A; GRHL3; FRZB; VANGL2;	GO:0090103~cochlea morphogenesis	7	24	29.1666666666667	0.00275967864610982	0.031458351185331	1	1	0.896304936825763	0.999999999989094	0.293557161783753
down	SOCS6; RGS12; RGS5; RGS11; ERBB3; PTK6; RGS9BP; DDIT4L; SRMS;	GO:0009968~negative regulation of signal transduction	9	39	23.0769230769231	0.00284626690767775	0.0322136422515386	1	1	0.899767361286943	0.999999999989094	0.300605245785685
down	APOE; GSTP1; BMP4; BMP7; HYAL2; DAB2IP; CBLC; SPRY1; SPRY2;	GO:0043407~negative regulation of MAP kinase activity	9	39	23.0769230769231	0.00284626690767775	0.0322136422515386	1	1	0.899767361286943	0.999999999989094	0.300605245785685
down	EGFR; MT1A; GSN; MT1G; MAPK3; MT1H; MT1X; MT1M; MT1B;	GO:0071276~cellular response to cadmium ion	9	39	23.0769230769231	0.00284626690767775	0.0322136422515386	1	1	0.899767361286943	0.999999999989094	0.300605245785685
up	MEFV; IL10; ARRB2; JAK3; SLAMF1; TIGIT; CMKLR1;	GO:0032695~negative regulation of interleukin-12 production	7	12	58.3333333333333	0.00289157046884303	0.324921207946309	1	1	0.999999999999978	0.999999999999978	1
down	CDK1; AR; NR2F6; ESRRA; RARG; CCNB1; POLR2E; RXRA; NR1D1; CCND1; POLR2I; CDKN1A; HNF4A; YAP1; CDK7; ESRRG; POLR2L; TEAD4; GTF2H5; TEAD3; WWTR1; NOTCH3;	GO:0006367~transcription initiation from RNA polymerase II promoter	22	161	13.6645962732919	0.00293470736534773	0.0330376115125647	1	1	0.903889868527102	0.999999999989094	0.308294208129544
up	TYROBP; CTLA4; IL10; BTK; PKN1; INPP5D; CD300A; LYN;	GO:0030889~negative regulation of B cell proliferation	8	16	50	0.00302727428271876	0.331447722748952	1	1	0.999999999999978	0.999999999999978	1
up	ITGB2; ITGAM; CD36; FCER1G; ARHGAP25; AIF1; ELMO1; BIN2; IGHV1-2; IGHV3-33; IGHV3-30; IGHG1; IGLC2; IGHV3-74; IGHV2-5; TRBC2; IGHV3-11; IGHV3-13; IGHV3-48; IGHV3-35; IGKC; IGHV4-34; IGHV1-18; IGHD; TRBC1; IGHM; IGHV4-31;	GO:0006911~phagocytosis, engulfment	27	115	23.4782608695652	0.00310679385483015	0.331650244003118	1	1	0.999999999999978	0.999999999999978	1
down	PSMD3; PSMD10; PSMC3; PSMB6; PSMB5; PSMC2; IFI27; PSMD8; PSMB2; PPP2CB; RNF187; FBXL22; NHLRC1; SIAH1; ZNRF1; FBXW5; AGAP3; STUB1; KCTD5; UBE2G1; RMND5B; RAD23B; UBE2A; TRIM2;	GO:0043161~proteasome-mediated ubiquitin-dependent protein catabolic process	24	183	13.1147540983607	0.00314826090130904	0.0353162435265428	1	1	0.911620693746839	0.999999999989094	0.329557520463756
down	TBX6; PRKACA; BMP7; BMPR1A; WLS; TWSG1; MESP1; MESP2;	GO:0001707~mesoderm formation	8	32	25	0.00316657357162919	0.0353340551003272	1	1	0.911984807990115	0.999999999989094	0.329723731178876
down	KCNK5; SCNN1B; SCNN1G; AMN; UGT1A7; ATP6V0A4; GRHPR; CLDN16;	GO:0007588~excretion	8	32	25	0.00316657357162919	0.0353340551003272	1	1	0.911984807990115	0.999999999989094	0.329723731178876
down	WNT9B; TFAP2A; BMP4; PDGFRA; FGFR2; EIF4A3; IRX5; GRHL2;	GO:0048701~embryonic cranial skeleton morphogenesis	8	32	25	0.00316657357162919	0.0353340551003272	1	1	0.911984807990115	0.999999999989094	0.329723731178876
down	NFIB; BMP7; BMP5; HNF1B; SMAD1; WLS;	GO:0030902~hindbrain development	6	18	33.3333333333333	0.00319578310761037	0.0354726328126699	1	1	0.913094218575094	0.999999999989094	0.331016884773678
down	PLA2G2A; PLA2G4A; LPCAT4; PLA2G4F; PLA2G4D; PLA2G3;	GO:0036148~phosphatidylglycerol acyl-chain remodeling	6	18	33.3333333333333	0.00319578310761037	0.0354726328126699	1	1	0.913094218575094	0.999999999989094	0.331016884773678
down	RAPGEF3; SOX18; F2RL1; RAP1A; MARVELD2; ROBO4;	GO:0061028~establishment of endothelial barrier	6	18	33.3333333333333	0.00319578310761037	0.0354726328126699	1	1	0.913094218575094	0.999999999989094	0.331016884773678
down	EDN3; EDN2; PTN; XCL1; F2RL1;	GO:0002690~positive regulation of leukocyte chemotaxis	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	ADH1B; ADH1C; ALDH2; ADH7; ACSS2;	GO:0006069~ethanol oxidation	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	UQCRQ; SRD5A1; PTN; SMO; CNTNAP2;	GO:0021794~thalamus development	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	SCD; SLC25A1; SCD5; HSD17B8; PPT2;	GO:0046949~fatty-acyl-CoA biosynthetic process	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	STMN1; BCAR1; RAC1; MST1R; MUC20;	GO:0048012~hepatocyte growth factor receptor signaling pathway	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	OPHN1; EFNB2; SCRIB; GSG1L; ARC;	GO:0099149~regulation of postsynaptic neurotransmitter receptor internalization	5	12	41.6666666666667	0.00329233438304422	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	ACSL3; ABCD3; FA2H; MCAT; FADS6; ACOT4; HSD17B8; MGLL; ELOVL4;	GO:0006633~fatty acid biosynthetic process	9	40	22.5	0.00329401500161131	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	SPP1; SCGB1A1; PRLR; RXRA; FBLN1; STC1; EMP2; FKBP4; DDR1;	GO:0007566~embryo implantation	9	40	22.5	0.00329401500161131	0.0359336782791953	1	1	0.915786804104636	0.999999999989094	0.335319182685259
down	IL20RB; IL36A; IL1RN; IL36RN; IL1F10; IL36G; IL36B;	GO:0002437~inflammatory response to antigenic stimulus	7	25	28	0.00334194124037712	0.0362072197974533	1	1	0.917394505318776	0.999999999989094	0.337871766298328
down	PIGZ; PYURF; TMEM246; PIGU; PGAP2; CWH43; PIGN;	GO:0006506~GPI anchor biosynthetic process	7	25	28	0.00334194124037712	0.0362072197974533	1	1	0.917394505318776	0.999999999989094	0.337871766298328
down	VEGFA; SDC4; KDR; WNT4; S100A10; RAC1; TEK;	GO:0051894~positive regulation of focal adhesion assembly	7	25	28	0.00334194124037712	0.0362072197974533	1	1	0.917394505318776	0.999999999989094	0.337871766298328
down	MT1A; MT1B; MT1G; TSPO; MT1H; MT1X; MT1M;	GO:0071294~cellular response to zinc ion	7	25	28	0.00334194124037712	0.0362072197974533	1	1	0.917394505318776	0.999999999989094	0.337871766298328
down	LDOC1; ASS1; CXCL10; CTSG; GSTP1; SRC; NR1D1; TSPO; NOS2; LCN2; ADAM9; DAB2IP; TICAM1; CHMP5; IL36B; CXCL13; IL1F10; CXCL11; IL36RN; CXCL9; IL36G; IL36A;	GO:0071222~cellular response to lipopolysaccharide	22	163	13.4969325153374	0.0033536022765035	0.0362715549974047	1	1	0.917804666796563	0.999999999989094	0.338472117492492
up	PIK3CD; ITGB2; C5AR1; CXCR2; NCKAP1L; TGFB2; JAML; PREX1; CSF3R; CKLF; CCL4; PF4; PPBP; FCER1G; CCL5; CXCL5; CCL26; CCL24; CCL7; CCL2;	GO:0030593~neutrophil chemotaxis	20	76	26.3157894736842	0.00347474979231854	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
up	IGKV1-12; PSMB11; LAT; GRAP2; NFATC1; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; IGKV1-16; IGKV3-11; IGKV2-30; IGHV4-34; LYN; IGLC2; IGHV1-2; PSMB8; PSMB9; FCER1G; PSMB10; LILRA4; BTK; ITK; PSMA8; CARD11; LAT2;	GO:0038095~Fc-epsilon receptor signaling pathway	36	171	21.0526315789474	0.00358399818692168	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
down	BMP4; EPHA2; ACVRL1; NRARP;	GO:0002043~blood vessel endothelial cell proliferation involved in sprouting angiogenesis	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	CXCL13; S100A8; GJA1; CCL11;	GO:0002544~chronic inflammatory response	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	HAT1; PCK1; MDH2; EHHADH;	GO:0006475~internal protein amino acid acetylation	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	DDAH1; DDAH2; FAH; NOS2;	GO:0006527~arginine catabolic process	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	PHGDH; SHMT2; PSPH; PSAT1;	GO:0006564~L-serine biosynthetic process	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	ELOVL7; ELOVL1; ELOVL4; ELOVL6;	GO:0019367~fatty acid elongation, saturated fatty acid	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	ELOVL1; ELOVL6; ELOVL7; ELOVL4;	GO:0034625~fatty acid elongation, monounsaturated fatty acid	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	ELOVL7; ELOVL4; ELOVL6; ELOVL1;	GO:0034626~fatty acid elongation, polyunsaturated fatty acid	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	BMP2; BMP4; APCDD1; DMRT3;	GO:0042487~regulation of odontogenesis of dentin-containing tooth	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	CD1C; CD1A; CD1B; CD1E;	GO:0048007~antigen processing and presentation, exogenous lipid antigen via MHC class Ib	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	KIF4A; AURKB; RACGAP1; AURKC;	GO:0051256~mitotic spindle midzone assembly	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	FZD9; SRC; GOT1; BOK;	GO:0051902~negative regulation of mitochondrial depolarization	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	AR; RARG; ID4; FOXA1;	GO:0060740~prostate gland epithelium morphogenesis	4	7	57.1428571428571	0.00368384587017323	0.0387200914181724	1	1	0.927763091865376	0.999999999989094	0.361320912013543
down	BMP4; SRC; SDC1; FGFR2; AQP1; AQP5; PAX9; AQP3;	GO:0042476~odontogenesis	8	33	24.2424242424242	0.00371934840778265	0.0389640168735974	1	1	0.92876716447562	0.999999999989094	0.363597129986937
down	YAP1; CX3CL1; HES5; DLL4; HES1; HEY1; BHLHE40; HES2;	GO:0050767~regulation of neurogenesis	8	33	24.2424242424242	0.00371934840778265	0.0389640168735974	1	1	0.92876716447562	0.999999999989094	0.363597129986937
up	NCR3; SH2D1A; IL18RAP; CRTAM; CD160; LAG3; STAT5B; SLAMF6; IL21;	GO:0045954~positive regulation of natural killer cell mediated cytotoxicity	9	21	42.8571428571429	0.00379235992859384	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
down	KIF20A; CETN2; PLK1; RAB11A; KLHL13; AURKC; PLK2; PLK4; AURKB;	GO:0032465~regulation of cytokinesis	9	41	21.9512195121951	0.0037953152052056	0.0396288431146509	1	1	0.930764995449384	0.999999999989094	0.369801031242067
down	NGFR; GJA1; FCGR2B; NAMPT; BACE1; GRIN1; BCL2L2; LGMN; TREM2;	GO:1904646~cellular response to amyloid-beta	9	41	21.9512195121951	0.0037953152052056	0.0396288431146509	1	1	0.930764995449384	0.999999999989094	0.369801031242067
down	KPNA7; PSMC3; NEK2; DAD1; ELF3; HORMAD1;	GO:0001824~blastocyst development	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	FBXW5; CHMP4C; CHMP4B; CHMP1A; CHMP5; CHMP3;	GO:0010824~regulation of centrosome duplication	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	MYO1B; MYO1E; MYH14; MYO6; WASL; WIPF3;	GO:0030048~actin filament-based movement	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	WNT9B; PDGFRA; SRD5A1; BMP5; DHCR24; LGR4;	GO:0030539~male genitalia development	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	PLA2G2A; PLA2G4A; PLA2G4E; PLA2G4F; PLBD1; PLA2G4D;	GO:0036149~phosphatidylinositol acyl-chain remodeling	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	UNC13B; GABRB3; NTF4; GABRB2; RNF165; SLITRK6;	GO:0060384~innervation	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	RHOD; RAPGEF3; PDGFRA; ARHGDIA; ESAM; PHPT1;	GO:2000249~regulation of actin cytoskeleton reorganization	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	HRAS; NTF3; TEK; BAIAP2L1; BAIAP2L2; BAIAP2;	GO:2000251~positive regulation of actin cytoskeleton reorganization	6	19	31.5789473684211	0.00398250969668101	0.0408432790575474	1	1	0.935889778720038	0.999999999989094	0.381133677586581
down	PLPP3; SNX3; HNF1B; TMEM237; GSKIP; VANGL2; DACT2;	GO:0030111~regulation of Wnt signaling pathway	7	26	26.9230769230769	0.00401327857183587	0.0408941472480639	1	1	0.936290324612922	0.999999999989094	0.381608359859187
down	TP73; YWHAQ; SFN; YWHAZ; PMAIP1; BAD; TP63;	GO:1900740~positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway	7	26	26.9230769230769	0.00401327857183587	0.0408941472480639	1	1	0.936290324612922	0.999999999989094	0.381608359859187
down	SASH1; BMP2; VEGFA; XDH; MINK1; PRMT1; SPHK1;	GO:1900745~positive regulation of p38MAPK cascade	7	26	26.9230769230769	0.00401327857183587	0.0408941472480639	1	1	0.936290324612922	0.999999999989094	0.381608359859187
down	DVL1; RGS4; CACNB3; PRKCZ; GRIN1; RIMS1; BAIAP2;	GO:2000463~positive regulation of excitatory postsynaptic potential	7	26	26.9230769230769	0.00401327857183587	0.0408941472480639	1	1	0.936290324612922	0.999999999989094	0.381608359859187
up	CCL5; CXCR2; CCR1; CCR7; GPR183; CCR5; CCR6; CXCR4;	GO:0002407~dendritic cell chemotaxis	8	17	47.0588235294118	0.00402899515633959	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
up	ADA; CD4; CD3E; CCL4; ZAP70; TRAT1; P2RX5; P2RX4;	GO:0050850~positive regulation of calcium-mediated signaling	8	17	47.0588235294118	0.00402899515633959	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; FCN1; FFAR2; TLR2; CD2; CD14; TLR1; CD244;	GO:2000484~positive regulation of interleukin-8 secretion	8	17	47.0588235294118	0.00402899515633959	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
up	CR1; C3AR1; FPR1; CMKLR1; FPR2; C5AR1; C5AR2;	GO:0002430~complement receptor mediated signaling pathway	7	13	53.8461538461538	0.00403161923134232	0.351326818731259	1	1	0.999999999999978	0.999999999999978	1
up	PTH; FLT3LG; HMGA2; MAP3K3; LEF1;	GO:0071864~positive regulation of cell proliferation in bone marrow	5	6	83.3333333333333	0.0041330856612678	0.35296551547227	1	1	0.999999999999978	0.999999999999978	1
down	DDAH2; NQO1; NOS2; SPR; SLC7A2;	GO:0006809~nitric oxide biosynthetic process	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	APOA4; NQO1; PRDX2; SOD3; PRDX1;	GO:0019430~removal of superoxide radicals	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	CLDN5; RAMP2; DDAH1; CEACAM1; ANGPT1;	GO:0043116~negative regulation of vascular permeability	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	AK4; CMPK1; AK7; AK8; AK3;	GO:0046940~nucleoside monophosphate phosphorylation	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	SRC; EPHA2; CCL11; DDR1; LRP5;	GO:0060444~branching involved in mammary gland duct morphogenesis	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	HES1; HES5; FBF1; PARD3; FRMD4B;	GO:0090162~establishment of epithelial cell polarity	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	GRHL3; SFRP2; VANGL2; FZD1; DVL1;	GO:0090179~planar cell polarity pathway involved in neural tube closure	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	SHISA9; SRC; CNIH2; SHISA6; CACNG4;	GO:0098962~regulation of postsynaptic neurotransmitter receptor activity	5	13	38.4615384615385	0.00432332445345707	0.042574826923521	1	1	0.94170493889822	0.999999999989094	0.397291812322675
down	CFTR; VSNL1; RAC1; HIF1A; TRPM4; BAD; PHPT1; SYBU;	GO:0035774~positive regulation of insulin secretion involved in cellular response to glucose stimulus	8	34	23.5294117647059	0.00434380401788204	0.042574826923521	1	1	0.942072117429442	0.999999999989094	0.397291812322675
down	DDAH1; DDAH2; ASS1;	GO:0000052~citrulline metabolic process	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	PGC; KLK7; KLK5;	GO:0002803~positive regulation of antibacterial peptide production	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	SFN; KDF1; TP63;	GO:0010482~regulation of epidermal cell division	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	MVK; PMVK; MVD;	GO:0019287~isopentenyl diphosphate biosynthetic process, mevalonate pathway	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	BMP7; BMP5; HIF1A;	GO:0021502~neural fold elevation formation	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	IL18; PAWR; IL1RAP;	GO:0042094~interleukin-2 biosynthetic process	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	TMEM79; DUOX2; DUOX1;	GO:0042335~cuticle development	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	AGXT; GPT; GPT2;	GO:0042853~L-alanine catabolic process	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	TGM1; TGM3; HRNR;	GO:0043163~cell envelope organization	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	PEX11A; PEX11B; PEX11G;	GO:0044375~regulation of peroxisome size	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	PLEKHA7; KIFC3; CAMSAP3;	GO:0045218~zonula adherens maintenance	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	SPDEF; AGR2; HOXA5;	GO:0060480~lung goblet cell differentiation	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	SRC; FAM110C; CCL19;	GO:0060491~regulation of cell projection assembly	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	SPINT2; GRHL2; ST14;	GO:0060672~epithelial cell morphogenesis involved in placental branching	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	HES1; HES5; LGR4;	GO:0072282~metanephric nephron tubule morphogenesis	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	EIF4E; EIF4A3; CYFIP1;	GO:0099578~regulation of translation at postsynapse, modulating synaptic transmission	3	3	100	0.00437973921649348	0.042574826923521	1	1	0.942442986197158	0.999999999989094	0.397291812322675
down	CCL21; JUP; FUT1; EPHA1; EMP2; CX3CL1; PRKCZ;	GO:0001954~positive regulation of cell-matrix adhesion	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	BMP4; CDH1; SRD5A1; ADCYAP1; BMPR1A; SOX2; PITX1;	GO:0021983~pituitary gland development	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	RIDA; NR1D1; SREBF1; RARG; PCK1; SREBF2; PCK2;	GO:0033993~response to lipid	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	GJB6; TH; SRC; NQO1; EEF1A2; CYFIP1; S100A13;	GO:0051602~response to electrical stimulus	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	ALDOA; GAPDH; ENO1; GPI; PKM; HK1; TPI1;	GO:0061621~canonical glycolysis	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	APOE; HNF4A; IL18; GCKR; GPIHBP1; ANGPTL4; APOA4;	GO:0070328~triglyceride homeostasis	7	27	25.9259259259259	0.00478194125431808	0.0457133388685792	1	1	0.949371303835818	0.999999999989094	0.426579191479574
down	TBX6; PDGFRA; EPCAM; HNF4A; MESP1; SOX17;	GO:0023019~signal transduction involved in regulation of gene expression	6	20	30	0.00490375465014381	0.046596697110362	1	1	0.951328402127899	0.999999999989094	0.434822348813801
down	F12; KRT1; SERPINB2; SERPING1; PROS1; ANXA2;	GO:0042730~fibrinolysis	6	20	30	0.00490375465014381	0.046596697110362	1	1	0.951328402127899	0.999999999989094	0.434822348813801
down	LGALS3; CCL11; CX3CL1; CCL18; XCL1; XCL2;	GO:0048245~eosinophil chemotaxis	6	20	30	0.00490375465014381	0.046596697110362	1	1	0.951328402127899	0.999999999989094	0.434822348813801
down	CNP; G6PD; COX6B1; S100A1; MAOB; YWHAQ; DYNLL1; INA; NDRG2;	GO:0021762~substantia nigra development	9	43	20.9302325581395	0.00497557778545521	0.0471378355817864	1	1	0.952615386683096	0.999999999989094	0.439872043658502
down	EGFR; ERBB2; GSTP1; ID1; DUSP3; FOXC1; DAB2IP; ERRFI1; BAIAP2;	GO:0071364~cellular response to epidermal growth factor stimulus	9	43	20.9302325581395	0.00497557778545521	0.0471378355817864	1	1	0.952615386683096	0.999999999989094	0.439872043658502
down	DEFB4A; LTF; GAPDH; ROMO1; LCE3C; LCE3A; PGLYRP4; PGLYRP3;	GO:0031640~killing of cells of other organism	8	35	22.8571428571429	0.00504579370497138	0.0475896436043283	1	1	0.953655010239591	0.999999999989094	0.444088141316867
down	GABRD; ADCYAP1; GABRB2; GRIK4; FGF14; GABRA3; GABRE; GABRA4;	GO:0060078~regulation of postsynaptic membrane potential	8	35	22.8571428571429	0.00504579370497138	0.0475896436043283	1	1	0.953655010239591	0.999999999989094	0.444088141316867
up	TLR4; IL18RAP; EOMES; AVPR2; ITK; LILRB1;	GO:0032609~interferon-gamma production	6	10	60	0.00523274049331057	0.414078936958834	1	1	0.999999999999978	0.999999999999978	1
up	PTPN6; ZFP36L2; NFAM1; FCRL3; CARD11; IKZF3;	GO:0045577~regulation of B cell differentiation	6	10	60	0.00523274049331057	0.414078936958834	1	1	0.999999999999978	0.999999999999978	1
up	HLA-G; HLA-F; ARRB2; CLEC12B; LILRB1; KIR2DL4;	GO:0045953~negative regulation of natural killer cell mediated cytotoxicity	6	10	60	0.00523274049331057	0.414078936958834	1	1	0.999999999999978	0.999999999999978	1
down	CCL21; SCRIB; CCL19; CYP26B1;	GO:0001768~establishment of T cell polarity	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	FUT1; ACVRL1; FUT2; ANGPT1;	GO:0001936~regulation of endothelial cell proliferation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	HK1; MAPK3; F2RL1; TRIM6;	GO:0002741~positive regulation of cytokine secretion involved in immune response	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	FGFR2; FGFR3; ECM1; BNC2;	GO:0003416~endochondral bone growth	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	GOT2; GOT1; PCK1; MDH2;	GO:0006107~oxaloacetate metabolic process	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	KLF4; SPINK5; OVOL1; OVOL2;	GO:0009913~epidermal cell differentiation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	PLEKHG5; VEGFA; RAB13; CORO1B;	GO:0035767~endothelial cell chemotaxis	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	BMPR1A; ACVRL1; DLL4; HEY1;	GO:0035912~dorsal aorta morphogenesis	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	MAOA; COMT; MAOB; PRIMA1;	GO:0042135~neurotransmitter catabolic process	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	MAOA; COMT; MAOB; MOXD1;	GO:0042420~dopamine catabolic process	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	EGFR; NHLH2; TYRO3; TIMP4;	GO:0042698~ovulation cycle	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	NGFR; SOX2; BEX3; TP63;	GO:0043281~regulation of cysteine-type endopeptidase activity involved in apoptotic process	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	SULT2B1; BMP4; SFN; KDF1;	GO:0045606~positive regulation of epidermal cell differentiation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	TOM1L1; BMP4; BMP7; TOM1L2;	GO:0045839~negative regulation of mitotic nuclear division	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	RAB5B; RAB11A; USP6NL; SGSM3;	GO:0048227~plasma membrane to endosome transport	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	CRABP2; RND2; EFNA5; LPAR3;	GO:0048672~positive regulation of collateral sprouting	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	BMP2; BMP7; FGFR2; WWTR1;	GO:0048762~mesenchymal cell differentiation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	CYP1A1; MAOB; DUOX2; DUOX1;	GO:0050665~hydrogen peroxide biosynthetic process	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	AR; SPP1; SRD5A1; AACS;	GO:0071394~cellular response to testosterone stimulus	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	C1QA; C1QB; C1QC; CX3CL1;	GO:0098883~synapse pruning	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	SMIM22; SQLE; CDS1; TMEM159;	GO:0140042~lipid droplet formation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	PTPRF; ADAM15; HFE; CRTAC1;	GO:1900121~negative regulation of receptor binding	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	BMP2; DLX5; SMAD1; SMAD5;	GO:1901522~positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	XCL1; TWSG1; LGALS9B; LGALS9C;	GO:2000562~negative regulation of CD4-positive, alpha-beta T cell proliferation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
down	WASL; CYFIP1; BRK1; NCKAP1;	GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation	4	8	50	0.00525075225049898	0.0476780340453618	1	1	0.957188370937693	0.999999999989094	0.444912966713651
up	TLR4; ITGB2; LYN; CD14; ITGAM; SCIMP; PIK3AP1; LY96;	GO:0034142~toll-like receptor 4 signaling pathway	8	18	44.4444444444444	0.00526785002384123	0.414078936958834	1	1	0.999999999999978	0.999999999999978	1
down	CCL21; CCL22; DEFB4A; CXCL13; CNIH1; CXCL14; C1R; IGHA1; C1QC; SLPI; HLA-DQB2; CD1A; CTSG; CD1E; IL1RN; ENDOU; IL1R2; FCGR2B; BMPR1A; LTBR; TNFSF9; TNFSF10; CCL18; DEFB1; CX3CL1; MS4A2; C1QBP; NECTIN1; GBP6; CCL19; IL1RAP; IL36B; IL36A; CXCR1; ACKR2; ULBP2; CD1C; CXCL10; RAET1G; RAET1L; ULBP3; CXCL9; CD1B; RAET1E; CXCL11;	GO:0006955~immune response	45	433	10.3926096997691	0.00541155809059934	0.0488581982595707	1	1	0.959949834859551	0.999999999989094	0.455925802546048
down	GRHL3; DLG3; TP63; INTU; VANGL2;	GO:0001736~establishment of planar polarity	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	MPDU1; ALG14; DPAGT1; SRD5A3; ALG6;	GO:0006488~dolichol-linked oligosaccharide biosynthetic process	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	CHEK2; MUC1; CDKN1A; FOXM1; RPS6KA6;	GO:0006978~DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	ATP6V0E1; ATP6V0A1; CLIC4; ROGDI; ATP6V0A4;	GO:0007035~vacuolar acidification	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	MPDU1; FUT3; ST3GAL4; ST6GALNAC5; B3GALNT1;	GO:0009312~oligosaccharide biosynthetic process	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	GSTP1; CX3CL1; FFAR4; TREM2; ERRFI1;	GO:0032691~negative regulation of interleukin-1 beta production	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	GHR; ALDH9A1; FOXA1; WNT4; KLK6;	GO:0042445~hormone metabolic process	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	UGT1A9; UGT2B7; UGT1A1; UGT1A7; UGT1A10;	GO:0052695~cellular glucuronidation	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	SCNN1A; SCNN1B; SCNN1G; TFAP2B; CYP4F12;	GO:0055078~sodium ion homeostasis	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	E2F8; PLK4; SOX15; GJB5; MDFI;	GO:0060707~trophoblast giant cell differentiation	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	MEIS2; ANXA3; EPHA2; SOX2; LUM;	GO:0070848~response to growth factor	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	ATP1B1; GJA1; PRKACA; GJA5; GJD3;	GO:0086064~cell communication by electrical coupling involved in cardiac conduction	5	14	35.7142857142857	0.00556508036823677	0.0493998310558609	1	1	0.962758903704962	0.999999999989094	0.460980110239138
down	COBL; CYP1A1; CCNB1; FGFR2; CLDN18; FOXF1; LGR4;	GO:0048565~digestive tract development	7	28	25	0.00565632294157692	0.0499917900792196	1	1	0.964117134959809	0.999999999989094	0.466504042811627
down	GAPDH; S100A8; S100A9; CTSG; NLRP10; IL17RC; RNASE7;	GO:0050832~defense response to fungus	7	28	25	0.00565632294157692	0.0499917900792196	1	1	0.964117134959809	0.999999999989094	0.466504042811627
down	ZMPSTE24; CLEC3B; BMP2; PTN; FGFR2; FGFR3; GPNMB; LGR4; SLC24A3;	GO:0030282~bone mineralization	9	44	20.4545454545455	0.00566331733620695	0.0499917900792196	1	1	0.964117134959809	0.999999999989094	0.466504042811627
down	UNC13B; GIPC1; GRM6; CACNA1G; SCN2B; HTR3B; CNP; SLC6A1; SLC1A3; SLC1A1; HTR3A; HAP1; FGF12; GRIK4; KCNMB1; SYPL1; MINK1; LPAR3; PCDHB14; GABRA4; GABRB3; GABRQ; GABRE; GABRB2; CHRNB4; CACNB3; GRIN1; GABRA3; GABRD;	GO:0007268~chemical synaptic transmission	29	249	11.6465863453815	0.00589994062585375	0.0518638331299044	1	1	0.968002860728969	0.999999999989094	0.483973224252779
down	VEGFA; KDR; EFNB2; CLEC14A; MMRN2; ROBO1;	GO:0002042~cell migration involved in sprouting angiogenesis	6	21	28.5714285714286	0.00597224351977643	0.052066134014227	1	1	0.9690229138575	0.999999999989094	0.485861017833511
down	PLPP1; PLPP3; PLPP2; FUT3; FUT6; ORMDL2;	GO:0006672~ceramide metabolic process	6	21	28.5714285714286	0.00597224351977643	0.052066134014227	1	1	0.9690229138575	0.999999999989094	0.485861017833511
down	VPS37C; CHMP4C; MVB12A; CHMP4B; CHMP1A; CHMP3;	GO:0039702~viral budding via host ESCRT complex	6	21	28.5714285714286	0.00597224351977643	0.052066134014227	1	1	0.9690229138575	0.999999999989094	0.485861017833511
down	CLDN1; CXADR; TJP1; OCLN; MARVELD2; MARVELD3;	GO:0045216~cell-cell junction organization	6	21	28.5714285714286	0.00597224351977643	0.052066134014227	1	1	0.9690229138575	0.999999999989094	0.485861017833511
down	TRIAP1; NOL3; PSMD10; LMNA; BCL2L2; HIGD1A;	GO:0090201~negative regulation of release of cytochrome c from mitochondria	6	21	28.5714285714286	0.00597224351977643	0.052066134014227	1	1	0.9690229138575	0.999999999989094	0.485861017833511
down	MYO1C; CETN3; CETN2; EIF5AL1; ARC; BICD2; KHSRP; RANBP17; NXT2;	GO:0051028~mRNA transport	9	45	20	0.00642213504276978	0.0556819314652187	1	1	0.975138916712318	0.999999999989094	0.519602240666354
down	VEGFA; EDNRA; KDR; IHH; SFRP2; DLL4; NRARP;	GO:0001569~branching involved in blood vessel morphogenesis	7	29	24.1379310344828	0.0066449102194871	0.0572071345845248	1	1	0.977610028976891	0.999999999989094	0.533834846062913
down	VAMP2; VAMP3; RIMS1; SYT17; SYT15; SYT7; SYT8;	GO:0017156~calcium-ion regulated exocytosis	7	29	24.1379310344828	0.0066449102194871	0.0572071345845248	1	1	0.977610028976891	0.999999999989094	0.533834846062913
down	B4GALT2; LUM; FMOD; ST3GAL4; SLC35D2; CHST6; B3GNT2;	GO:0018146~keratan sulfate biosynthetic process	7	29	24.1379310344828	0.0066449102194871	0.0572071345845248	1	1	0.977610028976891	0.999999999989094	0.533834846062913
down	TP73; NUPR1; CHEK2; CDKN1A; TP63; PHLDA3; TMEM109;	GO:0042771~intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	7	29	24.1379310344828	0.0066449102194871	0.0572071345845248	1	1	0.977610028976891	0.999999999989094	0.533834846062913
down	SLC9A3R1; EGFR; TIMP2; GAS1; FOXC1; MAD2L1; SCRIB;	GO:0045930~negative regulation of mitotic cell cycle	7	29	24.1379310344828	0.0066449102194871	0.0572071345845248	1	1	0.977610028976891	0.999999999989094	0.533834846062913
down	E2F8; DLX3; GJB3; ANG; DCN; CCNF; ETNK2; PHLDA2;	GO:0001890~placenta development	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	CLIC1; CLIC3; TSPO; FXYD3; SLC26A9; WNK4; CLIC4; CLCN1;	GO:0006821~chloride transport	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	CLDN7; CRYAB; SRC; LMO4; PRKCZ; EIF4EBP1; CTNNBIP1; IMPACT;	GO:0031333~negative regulation of protein-containing complex assembly	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	RAB27B; PIP5K1C; SCRIB; ITSN1; SYT8; ACTG1; OPHN1; FCHO2;	GO:0048488~synaptic vesicle endocytosis	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	RAMP3; EGFR; SRD5A1; CCNA2; UGT1A1; BCL2L2; ZNF703; RUVBL2;	GO:0071392~cellular response to estradiol stimulus	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	F2RL1; HYAL2; NLRP10; IL17RC; TRPV4; IL1RAP; LGALS9B; LGALS9C;	GO:2000778~positive regulation of interleukin-6 secretion	8	37	21.6216216216216	0.00670635862989932	0.0572071345845248	1	1	0.97875567853239	0.999999999989094	0.533834846062913
down	DHRS3; LRAT; EML2; OAT; TH; TACSTD2; CNGA1; LUM; IRX5; PITPNA; GUCY2D; CRYZ; EFEMP1; TRPM1; RIMS1; RP1L1; MYO3A; RABGGTA; RDH12; EPAS1; KIFC3; SLITRK6; DLL4; OCLM; GJA3;	GO:0007601~visual perception	25	207	12.0772946859903	0.0067426932290684	0.0574397710831122	1	1	0.97875567853239	0.999999999989094	0.536005719858883
up	TLR2; CD14; TLR1; SCIMP;	GO:0038123~toll-like receptor TLR1:TLR2 signaling pathway	4	4	100	0.0070177649546177	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
up	TLR2; CD14; CD36; TLR6;	GO:0038124~toll-like receptor TLR6:TLR2 signaling pathway	4	4	100	0.0070177649546177	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
up	TLR2; CD14; CD36; TLR6;	GO:0071726~cellular response to diacyl bacterial lipopeptide	4	4	100	0.0070177649546177	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
down	BMP4; STRA6; ROBO2; HEY1; ROBO1;	GO:0003184~pulmonary valve morphogenesis	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	UQCRQ; UQCRH; CYC1; UQCRC1; UQCC3;	GO:0006122~mitochondrial electron transport, ubiquinol to cytochrome c	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	ENTPD3; ENTPD5; ENTPD8; NUDT15; ENTPD2;	GO:0034656~nucleobase-containing small molecule catabolic process	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	KRT14; KRT16; KRT33B; MPZL3; PPP1R13L;	GO:0042633~hair cycle	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	SHISA9; UNC13B; SYNGR1; PPFIA3; SHISA6;	GO:0048172~regulation of short-term neuronal synaptic plasticity	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	TH; BMP7; FOXF2; FZD5; IHH;	GO:0048596~embryonic camera-type eye morphogenesis	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	TEK; FHL2; OVOL2; HEY1; ADGRG6;	GO:0060347~heart trabecula formation	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	BMP4; HOXA5; FOXA1; FOXF1; ESRP2;	GO:0060441~epithelial tube branching involved in lung morphogenesis	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	TUSC3; NIPAL1; ZDHHC13; NIPAL2; CLDN16;	GO:1903830~magnesium ion transmembrane transport	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
down	YAP1; HES1; HES5; NELFB; TRIM6;	GO:2000737~negative regulation of stem cell differentiation	5	15	33.3333333333333	0.00703853039669489	0.0578713070319249	1	1	0.982185532773822	0.999999999989094	0.540032646368629
up	IGKV1-12; IGKV1-17; IGKV1D-16; IGKV1-5; IGKV3-20; IGKV3-15; IGLV2-14; IGLV2-11; IGHV3-11; IGHV3-48; IGHV3-13; IGHV3-30; IGHV3-33; IGHV2-5; IGKC; IGHG1; C4BPA; IGKV1-16; IGKV3-11; CFI; IGKV2-30; IGHV4-34; IGLC2; CR1; IGHV1-2; IGHV1-18; IGHV3-35; IGHD; IGHV4-31; TRBC2; TRBC1; IGHV3-74; IGHM;	GO:0006958~complement activation, classical pathway	33	161	20.4968944099379	0.00717493559186322	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
down	APOE; DCN; ACVRL1; STC1; DAB2IP; DLL4;	GO:0010596~negative regulation of endothelial cell migration	6	22	27.2727272727273	0.00720067647940481	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	ARF4; VANGL2; DLG3; PARD3; LRRC1; SCRIB;	GO:0045197~establishment or maintenance of epithelial cell apical/basal polarity	6	22	27.2727272727273	0.00720067647940481	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	NUPR2; FZD9; CHEK2; MIF; CCND1; HMGN5;	GO:0071157~negative regulation of cell cycle arrest	6	22	27.2727272727273	0.00720067647940481	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	YAP1; HES1; MESP1; SOX17;	GO:0003143~embryonic heart tube morphogenesis	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	HIF1A; GRHL2; DLL4; HEY1;	GO:0003208~cardiac ventricle morphogenesis	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	SFN; KRT2; KDF1; PALLD;	GO:0003334~keratinocyte development	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	IDO1; TDO2; IDO2; AADAT;	GO:0006569~tryptophan catabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	PLA2G4A; CYP2J2; CYP4F22; CYP2S1;	GO:0006690~icosanoid metabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	MATN2; CD9; TSPO; NDN;	GO:0008347~glial cell migration	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	CES2; AFMID; NCEH1; AADACL2;	GO:0009056~catabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	AK4; CMPK1; AK7; AK8;	GO:0009142~nucleoside triphosphate biosynthetic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	PEX11A; PEX11B; PEX19; PEX11G;	GO:0016559~peroxisome fission	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	CYB5A; CYB5R3; SLC2A1; GSTO2;	GO:0019852~L-ascorbic acid metabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	FUT1; FUT6; FUT2; FUT10;	GO:0042355~L-fucose catabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	AKR1B10; AKR1A1; AKR1C2; AKR1C1;	GO:0044597~daunorubicin metabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	AKR1B10; AKR1A1; AKR1C2; AKR1C1;	GO:0044598~doxorubicin metabolic process	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	KCNK1; KCNK5; TREM2; KCNK6;	GO:0060075~regulation of resting membrane potential	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	PEX19; TIMM10; TIMM8B; TIMM13;	GO:0072321~chaperone-mediated protein transport	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	GSN; MCU; EFS; BCAR1;	GO:0090527~actin filament reorganization	4	9	44.4444444444444	0.00720785949016389	0.0578713070319249	1	1	0.984022954688875	0.999999999989094	0.540032646368629
down	MYO1D; CNP; SRC; DNAJB1; SOX2; NDST1; POU3F1; TWSG1; NOTCH3;	GO:0030900~forebrain development	9	46	19.5652173913043	0.00725662868312416	0.0578713070319249	1	1	0.984655027827653	0.999999999989094	0.540032646368629
up	TESPA1; RAB29; ADA; LCK; CCR7; TRAT1; CARD11;	GO:0050862~positive regulation of T cell receptor signaling pathway	7	15	46.6666666666667	0.00728965480056987	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
down	GJA1; F2RL1; GAS6;	GO:0003104~positive regulation of glomerular filtration	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	SPDEF; SOSTDC1; NKX6-2;	GO:0010454~negative regulation of cell fate commitment	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	CA2; AQP1; AQP5;	GO:0015670~carbon dioxide transport	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	PRMT5; PRMT1; PRMT8;	GO:0018216~peptidyl-arginine methylation	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	GOT2; ALDH4A1; HOGA1;	GO:0019470~4-hydroxyproline catabolic process	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	LMNA; KIF2C; CAMSAP3;	GO:0030951~establishment or maintenance of microtubule cytoskeleton polarity	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	KLF4; VEGFA; FZD5;	GO:0031077~post-embryonic camera-type eye development	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	METAP2; METAP1; PDF;	GO:0031365~N-terminal protein amino acid modification	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	UBE2C; CDCA5; PHB2;	GO:0031536~positive regulation of exit from mitosis	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	ERBB2; BMP4; IHH;	GO:0033088~negative regulation of immature T cell proliferation in thymus	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	MESP1; ROBO2; ROBO1;	GO:0035481~positive regulation of Notch signaling pathway involved in heart induction	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	CIDEA; APOA4; LY6D;	GO:0035634~response to stilbenoid	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	VEGFA; KDR; DAB2IP;	GO:0036324~vascular endothelial growth factor receptor-2 signaling pathway	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	GPR37; HPRT1; MAOB;	GO:0045964~positive regulation of dopamine metabolic process	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	PLD2; PLD1; TNFAIP8L3;	GO:0048017~inositol lipid-mediated signaling	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	BMPR1A; YAP1; MESP1;	GO:0048368~lateral mesoderm development	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	SOX18; OVOL2; SOX17;	GO:0060214~endocardium formation	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	TSPO; YAP1; SMO;	GO:0060242~contact inhibition	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	BMP2; BMP7; BNC2;	GO:0060485~mesenchyme development	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	HOXA5; CDKN1A; HIF1A;	GO:0060574~intestinal epithelial cell maturation	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	TEK; HES1; ANGPT1;	GO:0072012~glomerulus vasculature development	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	RAB6A; MREG; BICD2;	GO:0072385~minus-end-directed organelle transport along microtubule	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	CLDN5; CLDN12; ACTG1;	GO:0120192~tight junction assembly	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	PLA2R1; ANXA1; ANXA8L1;	GO:1900138~negative regulation of phospholipase A2 activity	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
down	TJP1; ANGPT1; OCLN;	GO:1905605~positive regulation of maintenance of permeability of blood-brain barrier	3	4	75	0.00730467744170715	0.0578713070319249	1	1	0.985297295694477	0.999999999989094	0.540032646368629
up	CD3D; PTPRC; ZAP70; DOCK2; CD3E; CD3G;	GO:0045059~positive thymic T cell selection	6	11	54.5454545454545	0.00734531023515717	0.514171716461002	1	1	0.999999999999978	0.999999999999978	1
up	PF4; S1PR1; IL10; CORO1A; GPR183; CXCR5; CXCL5; PPBP; IL16;	GO:0030595~leukocyte chemotaxis	9	24	37.5	0.00755875437936482	0.520578729030448	1	1	0.999999999999978	0.999999999999978	1
down	FANCG; ANG; INHA; VEGFA; ADCYAP1; CTNNA1; FOXC1; DMRTA1;	GO:0001541~ovarian follicle development	8	38	21.0526315789474	0.00767713138897752	0.0606703974355854	1	1	0.98937950671242	0.999999999989094	0.566152675026007
down	BMP7; PLK1; CEMIP; TRIM6; TNKS1BP1; SPHK1; TRPC6;	GO:0010800~positive regulation of peptidyl-threonine phosphorylation	7	30	23.3333333333333	0.00775623174817741	0.060991311191003	1	1	0.990100581023282	0.999999999989094	0.569147318027567
down	KLF4; ANG; APOD; NPR3; COMT; CTNNBIP1; NDRG2;	GO:0048662~negative regulation of smooth muscle cell proliferation	7	30	23.3333333333333	0.00775623174817741	0.060991311191003	1	1	0.990100581023282	0.999999999989094	0.569147318027567
down	PEX11A; MB; ARL4A; FFAR4; METRNL; DIO2; ERO1A;	GO:0050873~brown fat cell differentiation	7	30	23.3333333333333	0.00775623174817741	0.060991311191003	1	1	0.990100581023282	0.999999999989094	0.569147318027567
down	RAMP2; PAK4; KDR; TEK; GAS6; ANGPT1; ANGPTL4;	GO:2000352~negative regulation of endothelial cell apoptotic process	7	30	23.3333333333333	0.00775623174817741	0.060991311191003	1	1	0.990100581023282	0.999999999989094	0.569147318027567
down	CEACAM5; CEACAM6; LGALS7; CXADR; NECTIN1; CD209; PVR; NECTIN4; IGSF21;	GO:0007157~heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules	9	47	19.1489361702128	0.00817145164448907	0.0637816016290292	1	1	0.994699865816886	0.999999999989094	0.59518522881042
down	LRP5; TFF1; TH; GJA1; BMP7; GNAI1; TEK; TIMP4; ANXA1;	GO:0043434~response to peptide hormone	9	47	19.1489361702128	0.00817145164448907	0.0637816016290292	1	1	0.994699865816886	0.999999999989094	0.59518522881042
down	TGFA; FGF1; VEGFA; PTN; FGFR2; BTC; MACC1; PDGFD; GKN1;	GO:0051781~positive regulation of cell division	9	47	19.1489361702128	0.00817145164448907	0.0637816016290292	1	1	0.994699865816886	0.999999999989094	0.59518522881042
down	CIDEA; NPR3; NR1D1; ID1; ACOT11; PGAM5; LGR4; ADAMTS5; NOVA2;	GO:0120163~negative regulation of cold-induced thermogenesis	9	47	19.1489361702128	0.00817145164448907	0.0637816016290292	1	1	0.994699865816886	0.999999999989094	0.59518522881042
up	ACOD1; TLR4; SERPINE1; CD14; VIM; CSF3; RARA; CCL2; CD36; TNFRSF1B; TBXA2R; IL10; CX3CR1; CCR5; IRF8; CARD16; LILRB2; LILRB1; NLRP7; NLRP3; GFI1; LITAF; STAP1; DEFA4; PF4; PDCD1LG2; LY96; CD80; CD86; DEFA3; CXCL5; CD180; PPBP;	GO:0071222~cellular response to lipopolysaccharide	33	163	20.2453987730061	0.0083590994296916	0.540808402496714	1	1	0.999999999999978	0.999999999999978	1
down	VDAC1; MCU; MCUR1; PHB2; SLC25A23; STOML2;	GO:0006851~mitochondrial calcium ion transmembrane transport	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	SLC35A2; PEA15; SLC35D2; SLC35C1; SLC35A4; SLC50A1;	GO:0008643~carbohydrate transport	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	CYP11A1; FDXR; EBPL; CYP39A1; ARV1; CYP26B1;	GO:0016125~sterol metabolic process	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	SRC; PRKACA; PLK1; PCBD1; ANGPT1; PRMT8;	GO:0043393~regulation of protein binding	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	PRMT5; TP73; PTN; PTPRZ1; ZNF365; ZNF488;	GO:0048714~positive regulation of oligodendrocyte differentiation	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	SRC; VDAC2; RTKN2; NOC2L; BCL2L2; BCL2L10;	GO:2001243~negative regulation of intrinsic apoptotic signaling pathway	6	23	26.0869565217391	0.00860162306469148	0.0663940152850566	1	1	0.998930340037419	0.999999999989094	0.619563262285554
down	FZD9; TFAP2A; BMP2; BMP4; BMP7; PTN; BMPR1A; WNT4;	GO:0030501~positive regulation of bone mineralization	8	39	20.5128205128205	0.00874977859986104	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	MPHOSPH6; EXOSC4; WDR12; EIF6; FBXW9;	GO:0000460~maturation of 5.8S rRNA	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	FZD9; EML1; PLXNB2; ID4; RACGAP1;	GO:0007405~neuroblast proliferation	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	CSTA; CSTB; SERPINB3; SERPINB4; ECM1;	GO:0010466~negative regulation of peptidase activity	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	CCL21; CXCL13; S100A7; XCL1; XCL2;	GO:0010820~positive regulation of T cell chemotaxis	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	ADRA2A; EDN3; EDN2; BDKRB2; ACE2;	GO:0019229~regulation of vasoconstriction	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	PDLIM1; AQP1; RND2; RHOD; RND3;	GO:0030950~establishment or maintenance of actin cytoskeleton polarity	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	CXCL10; SPP1; BMP7; STC1; AQP3;	GO:0033280~response to vitamin D	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	ALOX15B; TRIM16; FOXC1; OVOL2; H2AFY2;	GO:0045618~positive regulation of keratinocyte differentiation	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	CDC20; DBN1; KNDC1; RAB17; MARK1;	GO:0050773~regulation of dendrite development	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	ROBO4; CNTN4; VSTM2L; PALLD; IGSF9;	GO:0070593~dendrite self-avoidance	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	NOS1AP; ACTG1; INA; CTTN; DBN1;	GO:0098974~postsynaptic actin cytoskeleton organization	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	NUPR1; PSMC2; ECSCR; DAB2IP; TREM2;	GO:1901800~positive regulation of proteasomal protein catabolic process	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
down	TRIAP1; MIF; MUC1; ZNF385A; ELL3;	GO:1902166~negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	5	16	31.25	0.00876389865366067	0.066442092902992	1	1	0.999999999989094	0.999999999989094	0.620011904014528
up	DOK2; CD4; CD8A; CD3E; LYN; CD7; TRAT1; IL31RA; RASGRP4; DOK1; STAP1; SH2B3; FYN; SLA; NEDD9; FGR; FES; HCK; LTK; EPHB1; NTRK1; BLK; CASS4; FLT3; LCK; SHC4;	GO:0007169~transmembrane receptor protein tyrosine kinase signaling pathway	26	120	21.6666666666667	0.00881338073231319	0.56168859293996	1	1	0.999999999999978	0.999999999999978	1
up	F2; PF4; ITGB3; PRKCB; LCK; FYN; GP1BA; LYN; PRKCA; PTPN6; CD40LG; FCER1G; ARRB2; GP5; P2RX1; GNG2; GNA12; TRPC3; DGKD; DGKK; TREML1; PIK3R5; CLEC1B;	GO:0030168~platelet activation	23	102	22.5490196078431	0.0089719022872361	0.56338268774262	1	1	0.999999999999978	0.999999999999978	1
down	IGHA1; LTF; SLPI; CTSG; DEFB1; RPL39; RNASE7;	GO:0019731~antibacterial humoral response	7	31	22.5806451612903	0.00899880719930934	0.0678981428919317	1	1	0.999999999989094	0.999999999989094	0.633599199154385
down	FOXP2; NME1; PLN; TSPO; PSPH; HOXB13; BAD;	GO:0033574~response to testosterone	7	31	22.5806451612903	0.00899880719930934	0.0678981428919317	1	1	0.999999999989094	0.999999999989094	0.633599199154385
down	KALRN; CSTB; CNP; HOXD9; NTF4; FGF12; GRIN1; PREX2; SLITRK6;	GO:0008344~adult locomotory behavior	9	48	18.75	0.00917129643174652	0.0691173326806296	1	1	0.999999999989094	0.999999999989094	0.644976206548618
up	SH2B2; F2; PLAU; SERPINA1; IFNA5; SLC4A1; F11; ITGB3; FYN; SERPINE2; GP1BA; LYN; F5; CD36; GATA2; GATA3; PRTN3; ADORA2A; FCER1G; PRKAR2B; GP5; WAS; TFPI2; P2RX1; HBB; GNA12; NFE2; DOCK8; MICAL1; P2RX5; P2RX4; P2RX7; SERPINA10; SH2B3;	GO:0007596~blood coagulation	34	171	19.8830409356725	0.00943144586275724	0.583656142521354	1	1	0.999999999999978	0.999999999999978	1
down	BMP4; FGFR2; VANGL2; FZD1;	GO:0003149~membranous septum morphogenesis	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	EGFR; ASS1; FOXF1; SMO;	GO:0007494~midgut development	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	PCSK6; TFAP2B; TWSG1; FST;	GO:0030510~regulation of BMP signaling pathway	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	ALOX15B; GLI3; FKBP4; ANXA1;	GO:0030850~prostate gland development	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	EMP1; EMP2; LPAR1; LPAR3;	GO:0032060~bleb assembly	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	GOT1; NPPC; RAP1A; ERRFI1;	GO:0032966~negative regulation of collagen biosynthetic process	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	ETFA; ACADS; ETFB; ACADVL;	GO:0033539~fatty acid beta-oxidation using acyl-CoA dehydrogenase	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	VEGFA; YWHAZ; DAB2IP; ATOH8;	GO:0035148~tube formation	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	SRD5A1; AKR1C2; AKR1C1; DHRS9;	GO:0042448~progesterone metabolic process	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	GRIN1; NECTIN1; PDLIM5; RAB17;	GO:0051963~regulation of synapse assembly	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	LMNA; CDK1; CCNB1; FHL2;	GO:0055015~ventricular cardiac muscle cell development	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	PSCA; LYNX1; SLURP1; LYPD6;	GO:0099601~regulation of neurotransmitter receptor activity	4	10	40	0.00959122341009011	0.0712651511994738	1	1	0.999999999989095	0.999999999989094	0.665018817958986
down	PIGR; IGHA1; LTF; KRT1; HSPB1; ACTG1; PRDX1; ZG16B;	GO:0001895~retina homeostasis	8	40	20	0.00993048093848403	0.0736995177846742	1	1	0.999999999989095	0.999999999989094	0.687735385056943
up	PRF1; CD6; CORO1A; EPHB1; DOCK8; DOCK2;	GO:0001771~immunological synapse formation	6	12	50	0.0100101854875772	0.602021014534569	1	1	0.999999999999978	0.999999999999978	1
up	IL2RA; LYN; CTLA4; HLA-G; PDCD1; INPP5D;	GO:0050777~negative regulation of immune response	6	12	50	0.0100101854875772	0.602021014534569	1	1	0.999999999999978	0.999999999999978	1
down	ELN; ESAM; DBN1; CTTN; PFN2; ARHGAP40;	GO:0030833~regulation of actin filament polymerization	6	24	25	0.0101874208298558	0.0753417423799604	1	1	0.999999999989095	0.999999999989094	0.703059989590841
down	PLA2G2A; BDKRB2; PLA2G4A; PLA2G4F; PLA2G3; ANXA1;	GO:0050482~arachidonic acid secretion	6	24	25	0.0101874208298558	0.0753417423799604	1	1	0.999999999989095	0.999999999989094	0.703059989590841
down	PIP5K1C; AP2S1; FCHO2; GPR107; CLTB; CLTA;	GO:0072583~clathrin-dependent endocytosis	6	24	25	0.0101874208298558	0.0753417423799604	1	1	0.999999999989095	0.999999999989094	0.703059989590841
down	GSN; BMP2; SRC; NR1D1; ID1; PLK1; SIAH1; ISOC2; SOX17;	GO:0031648~protein destabilization	9	49	18.3673469387755	0.0102608777537546	0.0756202827945311	1	1	0.999999999989095	0.999999999989094	0.705659220970189
down	CIDEA; POMC; GSTP1; CD34; TSPO; CX3CL1; GAS6; GPNMB; TREM2;	GO:0032720~negative regulation of tumor necrosis factor production	9	49	18.3673469387755	0.0102608777537546	0.0756202827945311	1	1	0.999999999989095	0.999999999989094	0.705659220970189
down	CBR3; FAM107A; HOXA1; ST3GAL4; TUSC3; CYFIP1; STRA6; TMPRSS11E; SHROOM4;	GO:0050890~cognition	9	49	18.3673469387755	0.0102608777537546	0.0756202827945311	1	1	0.999999999989095	0.999999999989094	0.705659220970189
down	KIF20A; MAP2; PLK1; TPPP2; PSRC1; GAS2L1; CAPN6;	GO:0001578~microtubule bundle formation	7	32	21.875	0.0103810964975614	0.0762403124003985	1	1	0.999999999989095	0.999999999989094	0.711445097357925
down	E2F8; RAMP2; TEK; ANGPT1; PARVA; KDR; VEGFA;	GO:0002040~sprouting angiogenesis	7	32	21.875	0.0103810964975614	0.0762403124003985	1	1	0.999999999989095	0.999999999989094	0.711445097357925
down	CCNA2; GABRB3; GABRB2; HOXA1; HES1; TIFAB; SLITRK6;	GO:0090102~cochlea development	7	32	21.875	0.0103810964975614	0.0762403124003985	1	1	0.999999999989095	0.999999999989094	0.711445097357925
down	SLC9A3R1; RAP2A; RAP1A; KLF5; MINK1;	GO:0030033~microvillus assembly	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	NDUFS4; SDHAF4; SLC25A25; COX4I2; SLC25A13;	GO:0045333~cellular respiration	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	EFNA2; GJA1; EPHA2; LGR4; LRP5;	GO:0046849~bone remodeling	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	EGFR; C1QA; SMO; TREM2; BACE2;	GO:0048143~astrocyte activation	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	NOL3; CLDN1; MCU; STOML2; BOK;	GO:0051259~protein complex oligomerization	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	TH; CCND1; MAOB; AVPR1A; CDKN1A;	GO:0051412~response to corticosterone	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	ZBTB7B; BMP7; FFAR4; METRNL; SOX13;	GO:0090336~positive regulation of brown fat cell differentiation	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	VDAC1; SREBF1; SREBF2; FZD5; CTTN;	GO:1903146~regulation of autophagy of mitochondrion	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	MAPK3; NEK2; AURKB; NABP2; PKIB;	GO:1904355~positive regulation of telomere capping	5	17	29.4117647058824	0.0107604850289936	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	EYA2; FANCG; ZMPSTE24; PTTG1; CDK1; UNG; CDK2; RFC5; UBE2A; RAD51; FOXM1; INO80C; TICRR; RAD51AP1; OTUB1; NABP2; TREX2; PIF1; FBXO6; FANCL; ADPRHL2; STUB1; RUVBL2; RFC2; RECQL4; TIMELESS;	GO:0006281~DNA repair	26	228	11.4035087719298	0.0110328479008563	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	CHEK2; ROMO1; TP63;	GO:0001302~replicative cell aging	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	SHMT1; SHMT2; PSPH;	GO:0006563~L-serine metabolic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	ANG; MOGAT2; MOGAT1;	GO:0006651~diacylglycerol biosynthetic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	BMP2; BMP5; WNT4;	GO:0010894~negative regulation of steroid biosynthetic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	EDN3; KEL; XK;	GO:0010961~cellular magnesium ion homeostasis	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	SLC6A1; HMGCS1; AACS;	GO:0014074~response to purine-containing compound	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	AQP1; RHBG; RHCG;	GO:0015696~ammonium transport	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	APOE; GPIHBP1; SNX33;	GO:0017038~protein import	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	AKR1A1; SORD; CRYL1;	GO:0019640~glucuronate catabolic process to xylulose 5-phosphate	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	CARM1; PRMT1; PRMT8;	GO:0019919~peptidyl-arginine methylation, to asymmetrical-dimethyl arginine	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	RAB10; SCRIB; TP63;	GO:0030859~polarized epithelial cell differentiation	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	BMP4; IHH; FOXJ1;	GO:0033085~negative regulation of T cell differentiation in thymus	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	RAB7B; SNX12; SNX3;	GO:0034499~late endosome to Golgi transport	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	HSPB1; VEGFA; KDR;	GO:0038033~positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	EGFR; DUOXA1; DUOXA2;	GO:0042743~hydrogen peroxide metabolic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	ABCD3; SLC27A4; SLC27A2;	GO:0042760~very long-chain fatty acid catabolic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	CA2; STC1; RAB11B;	GO:0044070~regulation of anion transport	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	TOLLIP; PRDX2; PRDX1;	GO:0045321~leukocyte activation	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	BBOX1; SHMT1; ALDH9A1;	GO:0045329~carnitine biosynthetic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	KRT10; KRT2; TMEM79;	GO:0045684~positive regulation of epidermis development	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	KRT16; KRT2; LTB4R2;	GO:0051546~keratinocyte migration	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	POMC; PHLDA2; KHK;	GO:0070873~regulation of glycogen metabolic process	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	CDH1; JUP; CTNNA1;	GO:0071681~cellular response to indole-3-methanol	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	LMNA; PTN; CTNNBIP1;	GO:0072201~negative regulation of mesenchymal cell proliferation	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	TLCD2; TRIAP1; TLCD1;	GO:0097035~regulation of membrane lipid distribution	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	FOXF1; TFAP2B; STRA6;	GO:0097070~ductus arteriosus closure	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	RAP1A; ADAM9; PTGR1;	GO:0097327~response to antineoplastic agent	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	AKR1B10; AKR1A1; RDH12;	GO:0110095~cellular detoxification of aldehyde	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	TACSTD2; PFN2; KANK1;	GO:1900028~negative regulation of ruffle assembly	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	MAP2; NEFH; HAP1;	GO:1902513~regulation of organelle transport along microtubule	3	5	60	0.0111406250949635	0.0781941105779387	1	1	0.999999999989095	0.999999999989094	0.729677186011205
down	XK; SLC7A2; SLC25A29; SLC38A4; SLC6A15; SLC7A8; SLC6A14; SLC25A48;	GO:0006865~amino acid transport	8	41	19.5121951219512	0.0112254011213293	0.0786150191237405	1	1	0.999999999989095	0.999999999989094	0.733604941707877
down	ADCYAP1; UGT1A1; GPT; HMGCL; AACS; LRP11; PCK1; PCK2;	GO:0042594~response to starvation	8	41	19.5121951219512	0.0112254011213293	0.0786150191237405	1	1	0.999999999989095	0.999999999989094	0.733604941707877
up	TLR4; TLR2; IFNG; CD36; HLA-G; CD40LG; CCR7; IRF8; SCIMP;	GO:0032735~positive regulation of interleukin-12 production	9	26	34.6153846153846	0.0113251028906086	0.651741557674048	1	1	0.999999999999978	0.999999999999978	1
down	ACHE; FABP5; SLC44A4; SLC44A3; SLC44A1; PEMT; STARD10;	GO:0006656~phosphatidylcholine biosynthetic process	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
down	YKT6; CFTR; VAMP3; EXOC6B; RAB3D; RAB10; RAB13;	GO:0006904~vesicle docking involved in exocytosis	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
down	GPR4; F2RL1; RAC1; LPAR1; ADGRG1; ROBO1; LPAR4;	GO:0035025~positive regulation of Rho protein signal transduction	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
down	ENTPD5; ATP1B1; HSPA1B; ADCYAP1; AK4; SLC25A25; BAD;	GO:0046034~ATP metabolic process	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
down	NGFR; ARHGDIA; ROBO2; ROBO1; PLXNA2; PLXNB1; PLXNB2;	GO:0050772~positive regulation of axonogenesis	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
down	EYA2; ERBB3; LCN2; BAD; BCL2L10; BCL2L2; BOK;	GO:0097192~extrinsic apoptotic signaling pathway in absence of ligand	7	33	21.2121212121212	0.0119114498454348	0.0826886846882429	1	1	0.999999999989095	0.999999999989094	0.77161881262331
up	PIK3CD; F2; FYN; LYN; FGR; CSF3; CCL5; OSM; HCLS1; NCF1; SELP; EPOR; PTPN6; FLT3; TGFB2; PRR5L; PIK3AP1; PIK3R5; HCST; NTRK1;	GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling	20	87	22.9885057471264	0.0119482766152178	0.671304488776053	1	1	0.999999999999978	0.999999999999978	1
down	GPC4; FUCA1; SDC1; SDC4; GPC1; HYAL2;	GO:0006027~glycosaminoglycan catabolic process	6	25	24	0.011970078954001	0.0828235375660028	1	1	0.999999999989095	0.999999999989094	0.772877207502952
down	CEP55; CHMP4C; CHMP4B; CHMP1A; CHMP5; CHMP3;	GO:0006997~nucleus organization	6	25	24	0.011970078954001	0.0828235375660028	1	1	0.999999999989095	0.999999999989094	0.772877207502952
down	PCDH17; PTPRF; EFNA5; SPARCL1; IL1RAP; GPC4;	GO:0099560~synaptic membrane adhesion	6	25	24	0.011970078954001	0.0828235375660028	1	1	0.999999999989095	0.999999999989094	0.772877207502952
down	SERPINB3; ADRM1; SFRP2; PSENEN;	GO:0010950~positive regulation of endopeptidase activity	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	P4HB; PRDX4; ERO1A; EGLN3;	GO:0018401~peptidyl-proline hydroxylation to 4-hydroxy-L-proline	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	B3GNT8; B3GNT2; B3GNT6; B3GNT5;	GO:0030311~poly-N-acetyllactosamine biosynthetic process	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	AR; MGST1; PDGFRA; CCND1;	GO:0033327~Leydig cell differentiation	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	SRC; BDKRB2; CDH5; TEK;	GO:0043114~regulation of vascular permeability	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	BMP4; ACVRL1; ATOH8; TMEM100;	GO:0045603~positive regulation of endothelial cell differentiation	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	BCAP31; MCU; MCUR1; SLC25A23;	GO:0051561~positive regulation of mitochondrial calcium ion concentration	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	RAB27B; SYTL4; CHMP5; CHMP3;	GO:0071985~multivesicular body sorting pathway	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	NSG1; LRRC1; RAB11A; SCRIB;	GO:0098887~neurotransmitter receptor transport, endosome to postsynaptic membrane	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	CTNND1; EFNB2; CPT1C; DLG3;	GO:0099072~regulation of postsynaptic membrane neurotransmitter receptor levels	4	11	36.3636363636364	0.0124327887238089	0.0850961284357462	1	1	0.999999999989095	0.999999999989094	0.79408414621653
down	WNT9B; GLI3; BMP2; BMP4; PBX1; WNT4; NPNT; CTNNBIP1;	GO:0001658~branching involved in ureteric bud morphogenesis	8	42	19.047619047619	0.0126406555814288	0.0862394780140966	1	1	0.999999999989095	0.999999999989094	0.80475344211096
down	BMP2; BMP4; BMP7; SERPINB3; FOXC1; BAMBI; WWTR1; ZNF703;	GO:0010718~positive regulation of epithelial to mesenchymal transition	8	42	19.047619047619	0.0126406555814288	0.0862394780140966	1	1	0.999999999989095	0.999999999989094	0.80475344211096
down	CTDSPL; KLF4; FAM107A; WEE1; CDKN1A; CDKN2B; CDKN2C; GPNMB;	GO:2000134~negative regulation of G1/S transition of mitotic cell cycle	8	42	19.047619047619	0.0126406555814288	0.0862394780140966	1	1	0.999999999989095	0.999999999989094	0.80475344211096
down	MAPK13; TRIAP1; PCNA; PTN; AQP1; AURKB; PBK; RUVBL2; NOC2L;	GO:0034644~cellular response to UV	9	51	17.6470588235294	0.0127281162992661	0.0867427968868262	1	1	0.999999999989095	0.999999999989094	0.809450219093334
down	NME1; AK4; CMPK1; AK7; AK8;	GO:0006165~nucleoside diphosphate phosphorylation	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	PEX10; PEX11A; PEX11B; ABCD3; PEX19;	GO:0007031~peroxisome organization	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	C1QA; TFF1; CCND1; HIF1A; HFE;	GO:0010039~response to iron ion	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	TMPRSS2; F12; CTSE; IHH; KLK6;	GO:0016540~protein autoprocessing	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	BMP2; BMP4; AVPR1A; HES1; HES5;	GO:0021537~telencephalon development	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	PDLIM1; SRC; ELN; ITGB5; FHDC1;	GO:0043149~stress fiber assembly	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	EDN2; CTTN; NPNT; SPHK1; NMU;	GO:0045987~positive regulation of smooth muscle contraction	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	CLTA; AP2S1; FCHO2; CLTB; NSG1;	GO:0048268~clathrin coat assembly	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	TSPAN15; SERPINH1; DUOXA2; STUB1; TSPAN17;	GO:0051604~protein maturation	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	WASL; DVL1; EPHB3; ZNF365; ARC;	GO:0060997~dendritic spine morphogenesis	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
down	CXCL10; S100A7; CXCL17; LGMN; S100A14;	GO:0090026~positive regulation of monocyte chemotaxis	5	18	27.7777777777778	0.0130464720058614	0.0877797660012203	1	1	0.999999999989095	0.999999999989094	0.819126813657543
up	PRKCA; BMP6; SCIMP; CD180; LY96;	GO:0031666~positive regulation of lipopolysaccharide-mediated signaling pathway	5	9	55.5555555555556	0.0135246289655151	0.720308785361581	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; AIM2; CD36; NLRC4; TLR6;	GO:0050702~interleukin-1 beta secretion	5	9	55.5555555555556	0.0135246289655151	0.720308785361581	1	1	0.999999999999978	0.999999999999978	1
up	LAT; CRTAM; CD4; CCL5; SIT1;	GO:0050863~regulation of T cell activation	5	9	55.5555555555556	0.0135246289655151	0.720308785361581	1	1	0.999999999999978	0.999999999999978	1
down	DVL1; KALRN; ERBB2; CACNB3; PPFIBP1; PDZRN3; UNC13B;	GO:0007528~neuromuscular junction development	7	34	20.5882352941176	0.0135980589648848	0.0910079173383734	1	1	0.999999999989095	0.999999999989094	0.849250672939302
down	BMP4; CDH5; ACVRL1; HES1; HES5; TWSG1; RNF165;	GO:0030513~positive regulation of BMP signaling pathway	7	34	20.5882352941176	0.0135980589648848	0.0910079173383734	1	1	0.999999999989095	0.999999999989094	0.849250672939302
down	EGFR; PDGFRA; MAPK3; PRDX5; PRDX3; ROMO1; AGAP3;	GO:0034614~cellular response to reactive oxygen species	7	34	20.5882352941176	0.0135980589648848	0.0910079173383734	1	1	0.999999999989095	0.999999999989094	0.849250672939302
down	KLF4; MAPK3; NEK2; GRHL2; PARM1; AURKB; PKIB;	GO:0051973~positive regulation of telomerase activity	7	34	20.5882352941176	0.0135980589648848	0.0910079173383734	1	1	0.999999999989095	0.999999999989094	0.849250672939302
up	CD4; LCK; FYN; HCK; CD247; AP1S2; ELMO1; DOCK2; AP1M1;	GO:0050690~regulation of defense response to virus by virus	9	27	33.3333333333333	0.0136639371462033	0.720308785361581	1	1	0.999999999999978	0.999999999999978	1
up	LILRA5; CCL4; CCL5; ARRB2; CCR1; LILRA2; ORAI1; P2RX4; CRACR2A;	GO:0051928~positive regulation of calcium ion transport	9	27	33.3333333333333	0.0136639371462033	0.720308785361581	1	1	0.999999999999978	0.999999999999978	1
down	UGDH; DCN; BGN; CHST9; CHST3; CHPF;	GO:0030206~chondroitin sulfate biosynthetic process	6	26	23.0769230769231	0.0139611876571607	0.0928499552687141	1	1	0.999999999989095	0.999999999989094	0.866439858206615
down	RASAL1; TIMP2; PPP2CB; DAB2IP; SPRY2; SPRY1;	GO:0046580~negative regulation of Ras protein signal transduction	6	26	23.0769230769231	0.0139611876571607	0.0928499552687141	1	1	0.999999999989095	0.999999999989094	0.866439858206615
down	ADCY6; ASS1; PRKACA; GJB2; PCK1; ADCY2;	GO:0071377~cellular response to glucagon stimulus	6	26	23.0769230769231	0.0139611876571607	0.0928499552687141	1	1	0.999999999989095	0.999999999989094	0.866439858206615
down	CCL21; XCL1; RAC1; C1QBP; MCU; CCL19;	GO:0090023~positive regulation of neutrophil chemotaxis	6	26	23.0769230769231	0.0139611876571607	0.0928499552687141	1	1	0.999999999989095	0.999999999989094	0.866439858206615
down	HSPA4L; HSPB1; DNAJB1; SERPINH1; HSPE1; CHAC1; FBXO6; HSPA2; HSPA1B;	GO:0006986~response to unfolded protein	9	52	17.3076923076923	0.0141151580210425	0.0937755466848712	1	1	0.999999999989095	0.999999999989094	0.875077119183763
down	CDK1; GSTP1; ANXA3; PKM; CCNA2; UGT1A1; CDKN1A; GAS6;	GO:0031100~animal organ regeneration	8	43	18.6046511627907	0.0141822863534984	0.0940929567210856	1	1	0.999999999989095	0.999999999989094	0.878039066833334
down	MACROD2; NUPR2; TP73; CHEK2; CCND1; CDKN1A; YAP1; RAD51; PMAIP1; C17orf53; SPATA18; OTUB1; UBE2E2; ZNF385A; NPAS2; NABP2; MACROD1; EGLN3; FANCL; HPF1; DTL; VAV3; TIMELESS; FANCG; ZBTB7A; ZBTB42; POLE3;	GO:0006974~cellular response to DNA damage stimulus	27	245	11.0204081632653	0.0141926264792297	0.0940929567210856	1	1	0.999999999989095	0.999999999989094	0.878039066833334
up	DNTT; SELL; P2RX1; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0033198~response to ATP	7	18	38.8888888888889	0.0153353525203129	0.798560430021173	1	1	0.999999999999978	0.999999999999978	1
down	EDN2; LEPR; NMU; IRX3; METRNL; MRAP2; TRPV4;	GO:0097009~energy homeostasis	7	35	20	0.0154489099543462	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	GJA1; GJB2; CX3CL1; EIF4EBP1; RNLS; BCL2L2; PANX2; TREM2; STUB1;	GO:0002931~response to ischemia	9	53	16.9811320754717	0.0156106702370349	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ADCYAP1; NPY1R; MAPK3; BDKRB1; NMU; GRIN1; MRGPRX2; NDN; ALOXE3;	GO:0019233~sensory perception of pain	9	53	16.9811320754717	0.0156106702370349	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CD34; CRIP2; MELK; ANGPT1; FUT10; ROGDI; TWSG1; MECOM; RTKN2;	GO:0030097~hemopoiesis	9	53	16.9811320754717	0.0156106702370349	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	MAPK13; TLR3; IL33; ADCYAP1; TICAM1; TSLP; RAB7B; IL1RL2; IL36A;	GO:0032755~positive regulation of interleukin-6 production	9	53	16.9811320754717	0.0156106702370349	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	LTF; APOA4; NOS2; DEFB1; RPL39;	GO:0002227~innate immune response in mucosa	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NR1D1; GYS2; NHLRC1; PGM2; PPP1R3C;	GO:0005978~glycogen biosynthetic process	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	MAPK13; EGFR; SORD; MAP7; MARVELD3;	GO:0006970~response to osmotic stress	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DDAH1; DDAH2; APOE; MT1M; NOS2;	GO:0007263~nitric oxide mediated signal transduction	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DLX3; DLX5; DLG3; SCRIB; LRRC1;	GO:0009790~embryo development	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NGFR; PSEN2; HM13; APH1A; PSENEN;	GO:0031293~membrane protein intracellular domain proteolysis	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	RARG; PTN; PTPRZ1; HES5; NKX6-2;	GO:0031641~regulation of myelination	5	19	26.3157894736842	0.0156387585580446	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	REN; CTSG; CPA3; ACE2;	GO:0002003~angiotensin maturation	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	AK4; SHMT2; SLC25A23; COX7A2;	GO:0002082~regulation of oxidative phosphorylation	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DDAH1; AR; PLCB3; KLK1;	GO:0003073~regulation of systemic arterial blood pressure	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	BMP4; BMP5; HNF4A; SMO;	GO:0003323~type B pancreatic cell development	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ALDH2; ADH7; ALDH3B2; SULT1E1;	GO:0006068~ethanol catabolic process	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	G6PD; PGD; PGM2; DERA;	GO:0006098~pentose-phosphate shunt	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	GINS1; GINS3; POLD2; MCM4;	GO:0006271~DNA strand elongation involved in DNA replication	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	FBXO27; FBXO17; FBXO6; NCCRP1;	GO:0006516~glycoprotein catabolic process	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ALDH7A1; CRYM; AADAT; SLC25A21;	GO:0006554~lysine catabolic process	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CCNB2; CDK1; CCNB1; PLK1;	GO:0007077~mitotic nuclear envelope disassembly	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DHRS3; MAPK3; PBX1; INTU;	GO:0030278~regulation of ossification	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	APOE; APOC1; APOA4; ABCA12;	GO:0033700~phospholipid efflux	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	TLR3; COLEC12; SCARA3; TICAM1;	GO:0034138~toll-like receptor 3 signaling pathway	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ANG; WNT7B; SMAD1; RHCG;	GO:0042592~homeostatic process	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	EEF1E1; PLA2R1; PMAIP1; SPRED2;	GO:0043517~positive regulation of DNA damage response, signal transduction by p53 class mediator	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SRC; GPIHBP1; MAL2; RAB17;	GO:0045056~transcytosis	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SPTLC1; ACER1; ACER3; SPHK1;	GO:0046512~sphingosine biosynthetic process	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ZMPSTE24; VEGFA; CXADR; MYOM3;	GO:0048739~cardiac muscle fiber development	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NTF3; PRKCZ; CADM4; SFRP2;	GO:0050732~negative regulation of peptidyl-tyrosine phosphorylation	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SOCS6; DUSP3; GPNMB; VTCN1;	GO:0050868~negative regulation of T cell activation	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	GIPC1; P4HB; HDGF; RAD23B;	GO:0098761~cellular response to interleukin-7	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SEMA3F; PLXNA2; PLXNB2; PLXNB1;	GO:1902287~semaphorin-plexin signaling pathway involved in axon guidance	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	UBE2C; PLK1; CDC20; GORASP1;	GO:1904668~positive regulation of ubiquitin protein ligase activity	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SPINT2; TACSTD2; FBLN1; CTNNA1;	GO:2000146~negative regulation of cell motility	4	12	33.3333333333333	0.0157601436900989	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	MPST; TST; TXN2;	GO:0000098~sulfur amino acid catabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ANXA2; EMP2; S100A10;	GO:0001765~membrane raft assembly	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	BMP4; VANGL2; FZD1;	GO:0003150~muscular septum morphogenesis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	GOT2; ASS1; GOT1;	GO:0006531~aspartate metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PHGDH; SHMT1; SHMT2;	GO:0006544~glycine metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SPTLC1; SGMS2; PEMT;	GO:0006686~sphingomyelin biosynthetic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	TH; CD9; LRP11;	GO:0009414~response to water deprivation	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	POR; CROT; CPT1C;	GO:0009437~carnitine metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PRDX2; RAC1; NOXA1;	GO:0010310~regulation of hydrogen peroxide metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	MT-CO2; TSPO; HEBP2;	GO:0010940~positive regulation of necrotic cell death	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CYP2E1; CYP2C9; CYP2C19;	GO:0016098~monoterpenoid metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	METAP2; METAP1; PDF;	GO:0018206~peptidyl-methionine modification	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DCN; BGN; EGFLAM;	GO:0019800~peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SLC1A3; TIFAB; SLITRK6;	GO:0031223~auditory behavior	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ARF4; ARL1; PRKCZ;	GO:0031584~activation of phospholipase D activity	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SERPINB7; LUM; CX3CL1;	GO:0032914~positive regulation of transforming growth factor beta1 production	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PLPP3; ADAM9; NPNT;	GO:0033631~cell-cell adhesion mediated by integrin	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	AFMID; IDO2; IDO1;	GO:0034354~'de novo' NAD biosynthetic process from tryptophan	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	APOE; APOC1; VLDLR;	GO:0034447~very-low-density lipoprotein particle clearance	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CXCL13; GAS6; HSD3B7;	GO:0035754~B cell chemotaxis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PKM; AGXT; HOGA1;	GO:0042866~pyruvate biosynthetic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	EFNA1; EPHA2; ACVRL1;	GO:0043535~regulation of blood vessel endothelial cell migration	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	LDB2; EMP2; SLAMF8;	GO:0043549~regulation of kinase activity	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	HIF1A; EPAS1; ANKRD2;	GO:0043619~regulation of transcription from RNA polymerase II promoter in response to oxidative stress	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PRMT5; PRMT1; COPRS;	GO:0043985~histone H4-R3 methylation	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PLK1; ESPL1; PTTG1;	GO:0045143~homologous chromosome segregation	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	FGF1; POR; SREBF1;	GO:0045542~positive regulation of cholesterol biosynthetic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ACVRL1; ID1; XDH;	GO:0045602~negative regulation of endothelial cell differentiation	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CYP2E1; UGT1A1; CYP2C19;	GO:0046483~heterocycle metabolic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	PLTP; CPTP; GLTP;	GO:0046836~glycolipid transport	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	TMED10; TMED2; TMED9;	GO:0048205~COPI coating of Golgi vesicle	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	KLF4; FGFR2; FLG2;	GO:0048730~epidermis morphogenesis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	KRT76; ZDHHC21; ACER1;	GO:0048733~sebaceous gland development	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CHMP4C; CHMP4B; CHMP3;	GO:0050792~regulation of viral process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ALOX15B; ALOX12B; ALOXE3;	GO:0051122~hepoxilin biosynthetic process	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SNX3; NDFIP2; SNX12;	GO:0051224~negative regulation of protein transport	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NDC80; CDT1; CENPH;	GO:0051383~kinetochore organization	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NMU; TFF2; PTGER3;	GO:0060455~negative regulation of gastric acid secretion	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CRYAB; FZD5; SCRIB;	GO:0060561~apoptotic process involved in morphogenesis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	BMP4; BMP7; RXRA;	GO:0060687~regulation of branching involved in prostate gland morphogenesis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ARHGEF15; RHOJ; CLIC4;	GO:0061299~retina vasculature morphogenesis in camera-type eye	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ETHE1; SUOX; SLC25A10;	GO:0070221~sulfide oxidation, using sulfide:quinone oxidoreductase	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	ASNA1; SGTA; GET4;	GO:0071816~tail-anchored membrane protein insertion into ER membrane	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	NFIA; FOXF1; SOX17;	GO:0072189~ureter development	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SLC31A1; RAD51; TIMELESS;	GO:0072719~cellular response to cisplatin	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SLC6A1; SLC6A11; SLC29A1;	GO:0098810~neurotransmitter reuptake	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	DSP; TJP1; CGNL1;	GO:0150105~protein localization to cell-cell junction	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	MYO1C; SMOC2; ROBO1;	GO:1900748~positive regulation of vascular endothelial growth factor signaling pathway	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	EGFR; ERBB2; LGMN;	GO:1901185~negative regulation of ERBB signaling pathway	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CDH5; ACTG1; TJP1;	GO:1902396~protein localization to bicellular tight junction	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	LMNA; MLIP; ERRFI1;	GO:1903243~negative regulation of cardiac muscle hypertrophy in response to stress	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CLDN5; CLDN1; EPHA2;	GO:1903348~positive regulation of bicellular tight junction assembly	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	CEACAM1; GLUL; RHOJ;	GO:1903670~regulation of sprouting angiogenesis	3	6	50	0.0159317654502062	0.0962588459708362	1	1	0.999999999989095	0.999999999989094	0.898250307312817
down	SLC27A2; HSD17B4; OSBPL6; HSD3B7; CYP39A1; AMACR;	GO:0006699~bile acid biosynthetic process	6	27	22.2222222222222	0.0161718341205761	0.0970616331971698	1	1	0.999999999989095	0.999999999989094	0.905741607104416
down	MT-ATP6; MT-ATP8; ALDOA; PKM; UQCC3; SLC25A13;	GO:0006754~ATP biosynthetic process	6	27	22.2222222222222	0.0161718341205761	0.0970616331971698	1	1	0.999999999989095	0.999999999989094	0.905741607104416
down	NME1; AK4; CMPK1; RRM2; AK7; AK8;	GO:0015949~nucleobase-containing small molecule interconversion	6	27	22.2222222222222	0.0161718341205761	0.0970616331971698	1	1	0.999999999989095	0.999999999989094	0.905741607104416
down	GJA5; BDKRB1; RNLS; ADM2; RNPEP; NOS2;	GO:0045776~negative regulation of blood pressure	6	27	22.2222222222222	0.0161718341205761	0.0970616331971698	1	1	0.999999999989095	0.999999999989094	0.905741607104416
down	AP2S1; AP1S1; RAC1; AP1B1; AP1S3; AP1M2;	GO:0050690~regulation of defense response to virus by virus	6	27	22.2222222222222	0.0161718341205761	0.0970616331971698	1	1	0.999999999989095	0.999999999989094	0.905741607104416
up	FN1; ITGB2; INHBA; ITGA5; ITGA4; MMP9; HMGA2; LAMA3; MIXL1;	GO:0035987~endodermal cell differentiation	9	28	32.1428571428571	0.0163415553355473	0.820922838621021	1	1	0.999999999999978	0.999999999999978	1
up	PSTPIP1; NUAK1; PLXNC1; LPXN; ADA; CD4; FN1; ITGB3; ITGB2; GP1BA; HCK; ITGA5; ITGAM; CCL4; CCL2; SELL; SELP; CD36; PRKCA; CD22; ITGAL; ITGAX; S1PR1; CD72; IL32; FPR2; ITGB7; L1CAM; CCR1; THBS2; ACTN2; GP5; CD96; PXN; CX3CR1; CXCR3; CCR3; BMX; CDH11; SRPX; SPOCK1; SLAMF1; LAMC2; SELPLG; ADGRE1; NEDD9; MYBPC3; COL19A1; FBLN7; THEMIS2; OLFM4; CSF3R; FEZ1; OMD; EMILIN2; LY9; CASS4; NTM; SIRPG; CD300A; ADGRE2; CLEC4A; CTNND2; LOXL2; NINJ2; ICAM2; SIGLEC14; FES; SIGLEC9; SIGLEC16; CD33; ICAM5; NINJ1; TGFBI;	GO:0007155~cell adhesion	74	454	16.2995594713656	0.0168501945750394	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
down	TRABD2B; VEGFA; LGALS3; CDH5; BIK; DAB2IP; BRK1; AJUBA; CDT1;	GO:0031334~positive regulation of protein-containing complex assembly	9	54	16.6666666666667	0.0172192178336552	0.103152554470422	1	1	0.999999999989095	0.999999999989094	0.962579727802173
down	MT-CO2; CXCL10; ACADVL; HSPA2; METRNL; LRP11; ACOT11;	GO:0009409~response to cold	7	36	19.4444444444444	0.01747173811387	0.104566455302841	1	1	0.999999999989095	0.999999999989094	0.975773703321208
up	PTPRC; IL7R; HLA-G; LILRB1;	GO:0001915~negative regulation of T cell mediated cytotoxicity	4	6	66.6666666666667	0.0175865131405228	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; PLCL2; CD180; GAPT;	GO:0002322~B cell proliferation involved in immune response	4	6	66.6666666666667	0.0175865131405228	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	LYN; FGR; FPR2; BTLA;	GO:0002768~immune response-regulating cell surface receptor signaling pathway	4	6	66.6666666666667	0.0175865131405228	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	PIK3CD; PECAM1; PRTN3; JAML;	GO:0072672~neutrophil extravasation	4	6	66.6666666666667	0.0175865131405228	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
down	TLR3; S100A8; S100A9; CTSB; S100A1; SFTPD; SFTPA2; LGMN;	GO:0002224~toll-like receptor signaling pathway	8	45	17.7777777777778	0.0176683073266884	0.105444191936489	1	1	0.999999999989095	0.999999999989094	0.983964401983367
down	TP73; CHEK2; EPHA2; SFN; BAD; BCL2L10; BCL2L2; BOK;	GO:0008630~intrinsic apoptotic signaling pathway in response to DNA damage	8	45	17.7777777777778	0.0176683073266884	0.105444191936489	1	1	0.999999999989095	0.999999999989094	0.983964401983367
down	ANXA2; COL5A3; LUM; FMOD; FOXC1; SFRP2; DPT; SERPINH1;	GO:0030199~collagen fibril organization	8	45	17.7777777777778	0.0176683073266884	0.105444191936489	1	1	0.999999999989095	0.999999999989094	0.983964401983367
up	TESPA1; VNN1; ADA; IL7R; ADAM8;	GO:0033089~positive regulation of T cell differentiation in thymus	5	10	50	0.0184861311478458	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
down	NGFR; NR1D1; FOXA3; KLF15; HK1;	GO:0001678~cellular glucose homeostasis	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	MTX2; SLC25A10; SLC25A13; TMEM14C; TMEM14A;	GO:0006839~mitochondrial transport	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	CCND1; CDKN1A; RAD51; XRCC4; ANXA1;	GO:0010165~response to X-ray	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	RPS6KA4; VEGFA; SYT14P1; ADGRF1; LPAR5;	GO:0032793~positive regulation of CREB transcription factor activity	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	PSMD10; GSTP1; EFNA1; DUSP3; CASC2;	GO:0043409~negative regulation of MAPK cascade	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	RAPGEF3; PRKACA; SFN; GAS6; GTSE1;	GO:0046827~positive regulation of protein export from nucleus	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	CEACAM1; LGALS3; DUSP3; PAWR; PHPT1;	GO:0050860~negative regulation of T cell receptor signaling pathway	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	TP73; SHMT2; KCNC3; TRPM1; TP63;	GO:0051262~protein tetramerization	5	20	25	0.0185528207734149	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; FGFR2; BMPR1A; ROBO2; PARVA; ROBO1;	GO:0003148~outflow tract septum morphogenesis	6	28	21.4285714285714	0.0186125254490871	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; ELN; EFNA1; ROBO2; DLL4; ROBO1;	GO:0003180~aortic valve morphogenesis	6	28	21.4285714285714	0.0186125254490871	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	GRIN1; ATP13A4; PIEZO2; ATP10D; TRPC6; PANX2;	GO:0006812~cation transport	6	28	21.4285714285714	0.0186125254490871	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	FANCG; LRP5; TXN; CCL11; BACE1; FKBPL;	GO:0009314~response to radiation	6	28	21.4285714285714	0.0186125254490871	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	LRP5; TGFA; EDN3; BTC; EPGN; SPHK1;	GO:0045840~positive regulation of mitotic nuclear division	6	28	21.4285714285714	0.0186125254490871	0.109532206403263	1	1	0.999999999989095	0.999999999989094	1
down	ASNA1; YIF1A; LMNA; ACADVL; HDGF; PDIA6; MYDGF; FKBP14; ERN2;	GO:0036498~IRE1-mediated unfolded protein response	9	55	16.3636363636364	0.018945283620888	0.111283788312501	1	1	0.999999999989095	0.999999999989094	1
down	SPRY2; BMP2; FGFR2; GAS1; WNT7B; WNT9B; SOX13; WNT4; SOX2;	GO:0045165~cell fate commitment	9	55	16.3636363636364	0.018945283620888	0.111283788312501	1	1	0.999999999989095	0.999999999989094	1
up	PTPRC; HLA-F; IL12RB1; P2RX7; FCGRT; CD1D; HLA-G; MICB; HLA-H;	GO:0001916~positive regulation of T cell mediated cytotoxicity	9	29	31.0344827586207	0.0193835351264557	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	VIL1; HCLS1; WAS; AIF1; CORO7; LMOD2; CATIP; PREX1; MSRB1;	GO:0030041~actin filament polymerization	9	29	31.0344827586207	0.0193835351264557	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; ORM1; BPI; IL10; PTPN6; ARRB2; NCKAP1L; SLAMF1; KLF2;	GO:0032715~negative regulation of interleukin-6 production	9	29	31.0344827586207	0.0193835351264557	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
down	RPS6KA4; GPNMB; TWSG1; NDRG2;	GO:0001818~negative regulation of cytokine production	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IGHA1; CD34; MYO1E; ADGRF5;	GO:0003094~glomerular filtration	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	MOGAT2; MOGAT1; COQ3; GK5;	GO:0006071~glycerol metabolic process	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	XDH; NT5C; NUDT15; GDA;	GO:0006195~purine nucleotide catabolic process	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ZBTB7B; KRT6B; BMPR1A; GRHL3;	GO:0007398~ectoderm development	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	RPS6KA4; CDK1; CCNA2; CDK2;	GO:0016572~histone phosphorylation	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	EPN2; DAB2IP; CADM4; MMRN2;	GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PFN2; ID1; LIMK1; CX3CL1;	GO:0032233~positive regulation of actin filament bundle assembly	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	RAB6A; TMED9; EHD3; SNX8;	GO:0034498~early endosome to Golgi transport	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	VEGFA; KDR; FOXC1; GAB1;	GO:0038084~vascular endothelial growth factor signaling pathway	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ARF4; SHROOM2; SHROOM3; VANGL2;	GO:0045176~apical protein localization	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	APOC1; CEACAM1; ACADVL; TRIB3;	GO:0045717~negative regulation of fatty acid biosynthetic process	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PLPP1; PLPP3; PLPP2; PLPP6;	GO:0046839~phospholipid dephosphorylation	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ID4; HES1; HES5; TMEM98;	GO:0048715~negative regulation of oligodendrocyte differentiation	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	REN; BACE1; BACE2; PSEN2;	GO:0050435~amyloid-beta metabolic process	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GABRB2; GABRA4; GABRA3; GABRE;	GO:0051932~synaptic transmission, GABAergic	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	DHRS3; BMP7; BMP5; HEY1;	GO:0060411~cardiac septum morphogenesis	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; MAPK3; ID1; WNT7B;	GO:0060425~lung morphogenesis	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; TFAP2A; GRHL3; STRA6;	GO:0061029~eyelid development in camera-type eye	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	VARS2; DTD1; DTD2; TARS2;	GO:0106074~aminoacyl-tRNA metabolism involved in translational fidelity	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	TACSTD2; FBLN1; EFNA5; KANK1;	GO:1900025~negative regulation of substrate adhesion-dependent cell spreading	4	13	30.7692307692308	0.0195963927076372	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PLXNA2; PAX1; BMPR1A; TCF15; FOXF1; FOXC1; MESP2; MESP1;	GO:0001756~somitogenesis	8	46	17.3913043478261	0.0196241633760216	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NFIB; BMP2; BMP4; FGFR3; BMPR1A; HES5; CYTL1;	GO:0002062~chondrocyte differentiation	7	37	18.9189189189189	0.0196739850518094	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0002292~T cell differentiation involved in immune response	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	HLA-G; LILRB2; LILRB1;	GO:0002767~immune response-inhibiting cell surface receptor signaling pathway	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	LYN; LILRB2; LILRB1;	GO:0002774~Fc receptor mediated inhibitory signaling pathway	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	CLEC4D; CLEC4E; FCER1G;	GO:0038094~Fc-gamma receptor signaling pathway	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	TLR2; CD14; TLR1;	GO:0071727~cellular response to triacyl bacterial lipopeptide	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	MPP1; BST1; JAM3;	GO:0090022~regulation of neutrophil chemotaxis	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	TYROBP; ITGAM; STAP1;	GO:1904151~positive regulation of microglial cell mediated cytotoxicity	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	LILRA5; LILRB1; TLR8;	GO:2001183~negative regulation of interleukin-12 secretion	3	3	100	0.0204014334198592	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
up	CFD; SERPINA1; FN1; ORM1; ALB; PPBP; PF4; ITGB3; SERPINE1; LYN; ITGA2B; PLEK; SRGN; F5; SELP; PECAM1; CD36; ORM2; ACTN2; CTSW; TGFB2; ITIH3; LHFPL2; FERMT3; SCG3;	GO:0002576~platelet degranulation	25	124	20.1612903225806	0.0204331536910843	0.823109115669152	1	1	0.999999999999978	0.999999999999978	1
down	PSMD3; PSMD10; PSMC3; PSMB6; PSMB5; PSMC2; PSMD8; PSMB2; FBXL7;	GO:0010972~negative regulation of G2/M transition of mitotic cell cycle	9	56	16.0714285714286	0.0207932514504492	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CLDN1; CLEC3B; FGFR2; ACVRL1; XCL1; WNT4; HYAL2; OVOL2; PDGFD;	GO:0071560~cellular response to transforming growth factor beta stimulus	9	56	16.0714285714286	0.0207932514504492	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
up	CCL24; SH2D1A; GRAP2; FGF18; TSHB; GHRH; LTA; WNT1; ITGB2; INHBA; PTHLH; CCL4; CCL5; CD33; TRH; ADORA2A; CCR1; SSTR3; CD70; TNFSF8; CXCL5; PTGIR; CX3CR1; PGF; CCR5; CCL7; CRB1; LTB; GRAP; LILRB2; SH3KBP1; FCRL2; TSPAN32; SIRPG; CCL26; GPR101; PANX3; PTH; ADRA1D; FGFBP2; DRD3;	GO:0007267~cell-cell signaling	41	230	17.8260869565217	0.0212299180401004	0.847212617114289	1	1	0.999999999999978	0.999999999999978	1
down	UBE2A; HS3ST6; ARHGDIG; ASF1B; PEMT; C6orf141;	GO:0001835~blastocyst hatching	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	XCL1; CD1B; CD1C; HFE; CD1E; CD1A;	GO:0001916~positive regulation of T cell mediated cytotoxicity	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	UQCRQ; FGFR2; NDST1; HES1; SMAD1; WLS;	GO:0030901~midbrain development	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; HRAS; CDK1; PCNA; RAC1; CDT1;	GO:0045740~positive regulation of DNA replication	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ERBB2; CNP; GLI3; PTPRZ1; CDKN2C; BOK;	GO:0048709~oligodendrocyte differentiation	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	HFE; STEAP3; STEAP2; EPAS1; STEAP1; HEPH;	GO:0055072~iron ion homeostasis	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NRG2; EGFR; ERBB2; ERBB3; BTC; CADM4;	GO:2000145~regulation of cell motility	6	29	20.6896551724138	0.0212931190712591	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	BMP7; BMP5; DLL4;	GO:0003344~pericardium morphogenesis	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	TH; NHLH2; MAPK8IP2;	GO:0007617~mating behavior	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CYP1A1; TH; LCN2;	GO:0009635~response to herbicide	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CYP1A1; UGT1A7; UGT1A8;	GO:0009804~coumarin metabolic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	TSPO; ADAM9; FIBIN;	GO:0010042~response to manganese ion	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	MIF; MMP28; SLAMF8;	GO:0010760~negative regulation of macrophage chemotaxis	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ERBB3; GPC1; ADGRG6;	GO:0014037~Schwann cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	HYAL2; GAS6; NECTIN2;	GO:0019064~fusion of virus membrane with host plasma membrane	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GALK1; GALE; PGM2;	GO:0019388~galactose catabolic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GPD2; GK5; TPI1;	GO:0019563~glycerol catabolic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	OPHN1; MTPN; KNDC1;	GO:0021707~cerebellar granule cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; HES1; HES5;	GO:0021861~forebrain radial glial cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NPR3; AQP1; AQP5;	GO:0030157~pancreatic juice secretion	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	ALOX15B; PRLR; CD24;	GO:0030856~regulation of epithelial cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NFASC; CD9; UGT8;	GO:0030913~paranodal junction assembly	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	E2F8; CHMP4C; AURKB;	GO:0032466~negative regulation of cytokinesis	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IL33; TSLP; IL1RAP;	GO:0032754~positive regulation of interleukin-5 production	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IGSF3; FGFR2; FOXC1;	GO:0032808~lacrimal gland development	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GSTP1; FOXM1; PBK;	GO:0032873~negative regulation of stress-activated MAPK cascade	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IDO1; ADCYAP1R1; LRP11;	GO:0033555~multicellular organismal response to stress	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CXCL13; SRC; RASIP1;	GO:0033625~positive regulation of integrin activation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PSEN2; APH1A; PSENEN;	GO:0035333~Notch receptor processing, ligand-dependent	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	FOXP2; STRA6; CNTNAP2;	GO:0042297~vocal learning	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IYD; DIO2; CRYM;	GO:0042403~thyroid hormone metabolic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	HOXA7; GRHL2; TP63;	GO:0045617~negative regulation of keratinocyte differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	AK4; AK3; AMPD1;	GO:0046033~AMP metabolic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CA2; TPD52; RIMS1;	GO:0046903~secretion	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	FOXN1; FST; KRT17;	GO:0051798~positive regulation of hair follicle development	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	OAT; PYCR1; ALDH18A1;	GO:0055129~L-proline biosynthetic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	KALRN; LDOC1; CYP1A1;	GO:0060137~maternal process involved in parturition	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CACNA1G; SCN2B; GJA5;	GO:0060371~regulation of atrial cardiac muscle cell membrane depolarization	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	WNT7B; FOXJ1; ERRFI1;	GO:0060428~lung epithelium development	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	FGFR2; FOXF1; GRHL2;	GO:0060463~lung lobe morphogenesis	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	YAP1; FOXA1; GRHL2;	GO:0060487~lung epithelial cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	BMP7; BMP5; WNT7B;	GO:0060710~chorio-allantoic fusion	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; ACVRL1; HOXA1;	GO:0060840~artery development	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PDGFRA; ACVRL1; HIF1A;	GO:0061298~retina vasculature development in camera-type eye	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NR1D1; SGPP2; ERRFI1;	GO:0061469~regulation of type B pancreatic cell proliferation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	IL33; CX3CL1; TREM2;	GO:0061518~microglial cell proliferation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; EFNA1; HIF1A;	GO:0070244~negative regulation of thymocyte apoptotic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	TSPO; AQP5; TRPV4;	GO:0071476~cellular hypotonic response	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	KLF4; ASS1; SREBF2;	GO:0071499~cellular response to laminar fluid shear stress	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	SOX18; YAP1; SOX17;	GO:0072091~regulation of stem cell proliferation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PROM1; CD24; KLF15;	GO:0072112~glomerular visceral epithelial cell differentiation	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	AQP1; RHCG; RHBG;	GO:0072488~ammonium transmembrane transport	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NUPR1; IL33; IL18;	GO:0150078~positive regulation of neuroinflammatory response	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	SPINK6; SPINK5; ANXA8L1;	GO:1900004~negative regulation of serine-type endopeptidase activity	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	VEGFA; ACVR1B; C1QBP;	GO:1901165~positive regulation of trophoblast cell migration	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	AP4M1; RAB10; PDZD11;	GO:1903361~protein localization to basolateral plasma membrane	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CX3CL1; P2RY12; TREM2;	GO:1904141~positive regulation of microglial cell migration	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; GAS6; CCL19;	GO:2000669~negative regulation of dendritic cell apoptotic process	3	7	42.8571428571429	0.0217022249180709	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	TCN1; PRSS3; MMAB; AMN; MMADHC;	GO:0009235~cobalamin metabolic process	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	GOT2; SRD5A1; HIF1A; PERM1; METRNL;	GO:0014850~response to muscle activity	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PDGFRA; TSPO; PBX1; WNT4; STRA6;	GO:0030325~adrenal gland development	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	CYP1A1; G6PD; SREBF1; HSD11B2; SLC25A25;	GO:0032094~response to food	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	MT-ATP6; MT-ATP8; STOML2; COX5B; CYC1;	GO:0042776~mitochondrial ATP synthesis coupled proton transport	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	NOS1AP; APOE; NPR3; S100A1; HIF1A;	GO:0051000~positive regulation of nitric-oxide synthase activity	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	PLK1; UBE2N; TRIB3; STUB1; DCUN1D5;	GO:0051443~positive regulation of ubiquitin-protein transferase activity	5	21	23.8095238095238	0.0218025984218277	0.111678352950537	1	1	0.999999999989095	0.999999999989094	1
down	APOA4; RBP1; HNF4A; ABCA12; PNPLA3; ABHD4; PNPLA4;	GO:0055088~lipid homeostasis	7	38	18.4210526315789	0.0220627583401144	0.111688308593966	1	1	0.999999999989095	0.999999999989094	1
down	SYT7; PIP5K1C; ANXA1; ANXA3; ICAM3; LEPR; GAS6; ELMO3; TYRO3;	GO:0006909~phagocytosis	9	57	15.7894736842105	0.0227673897281486	0.11497985346375	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; BMP4; FGFR2; NAMPT; CX3CL1; IL18; HES5; PDGFD; NOTCH3;	GO:0048661~positive regulation of smooth muscle cell proliferation	9	57	15.7894736842105	0.0227673897281486	0.11497985346375	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; SDC1; CCND1; SLC6A1; ADAM9; AQP3; BAD; S100A16; SLC25A13;	GO:0051592~response to calcium ion	9	57	15.7894736842105	0.0227673897281486	0.11497985346375	1	1	0.999999999989095	0.999999999989094	1
down	MEIS3P1; ZNF860; ZNF727; ZNF732; KRBOX1; BHLHE40; SOX15; GAS7; FZD7; RPS6KA4; ZFPL1; ZNF205; ZBTB7A; CHEK2; ESRRA; BMP2; ZNF35; HOXB1; CRABP2; ACVR1B; ACVRL1; SOX2; RCAN1; ESRRG; HMGN5; EFEMP1; NFIA; ELAVL2; FOXC1; HIF1A; PERM1; CARM1; ZNF676; ZNF454; L3MBTL4; RNF141; ARNTL2; TFAP2B; KHSRP; VGLL1; CDCA7; NKX6-2; WWTR1; BLZF1; ZNF768; SOX17; ZNF703; ZNF395; ZNF556; ARNT2; CELSR2; PAK6; SLC2A4RG; ZNF219; GTF2IRD1; ZNF112; SOX13; LZTS1; ATF5; MAFB; SOX21; MLF2; SPIN4; HMGA1; AJUBA; DRAP1; PRMT5; SOX7; SOX18; MLF1; ZNF296; HR;	GO:0006355~regulation of transcription, DNA-templated	72	824	8.7378640776699	0.0232971400158295	0.117374621160833	1	1	0.999999999989095	0.999999999989094	1
up	CYBA; NCF1; NCF2; PREX1; NCF1B; NCF1C; NCF4;	GO:0006801~superoxide metabolic process	7	20	35	0.0233378960317996	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	HSD17B4; ACOT4; CYP4F12; SLC27A6;	GO:0000038~very long-chain fatty acid metabolic process	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	HOXA5; YWHAZ; TCF15; NDN;	GO:0003016~respiratory system process	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	GOT2; GOT1; ALDH18A1; AADAT;	GO:0006536~glutamate metabolic process	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	GPRC5A; VPS25; ERRFI1; CBLC;	GO:0007175~negative regulation of epidermal growth factor-activated receptor activity	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	PBX1; HNF4A; CENPI; DMRT3;	GO:0007548~sex differentiation	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	APOE; FABP1; SLC27A4; SLC27A6;	GO:0015909~long-chain fatty acid transport	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; RAC1; CYFIP1; CORO1B;	GO:0031529~ruffle organization	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	PRDX2; MAP3K6; PRDX1; PRDX4;	GO:0033554~cellular response to stress	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	P2RY2; P2RY13; GPR87; P2RY12;	GO:0035589~G protein-coupled purinergic nucleotide receptor signaling pathway	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	NPR3; BTC; HYAL2; TFAP2B;	GO:0035810~positive regulation of urine volume	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	SRPX2; CD24; PPP1R14C; PPP1R14B;	GO:0042325~regulation of phosphorylation	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	ALDH1A3; AKR1C1; SDR16C5; BCO1;	GO:0042574~retinal metabolic process	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	NR1D1; HES1; DLK2; PTPRQ;	GO:0045598~regulation of fat cell differentiation	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	CDK1; SOD3; SORD; S100A13;	GO:0046688~response to copper ion	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	ADRA2A; PLN; STC1; PACSIN3;	GO:0051926~negative regulation of calcium ion transport	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	SLC9A3R1; GNA14; GNA15; GNA11;	GO:0060158~phospholipase C-activating dopamine receptor signaling pathway	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	CLDN1; AFDN; TJP1; RAB1B;	GO:0090557~establishment of endothelial intestinal barrier	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	GJA1; NPPC; ACVRL1; CDKN1A;	GO:2000279~negative regulation of DNA biosynthetic process	4	14	28.5714285714286	0.0239601264945351	0.119011976271444	1	1	0.999999999989095	0.999999999989094	1
down	NUPR1; EIF4E; NAMPT; LEPR; CPTP; RASIP1; TREM2; DAPL1;	GO:0010507~negative regulation of autophagy	8	48	16.6666666666667	0.0239889130008144	0.119061652779297	1	1	0.999999999989095	0.999999999989094	1
down	OVOL1; TBX6; VEGFA; IRX3; TCF15; MEST;	GO:0007498~mesoderm development	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	ABCC3; CEACAM1; RXRA; AKR1C1; SLC10A7; SLC10A6;	GO:0015721~bile acid and bile salt transport	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	VPS37C; CHMP4C; MVB12A; CHMP4B; CHMP5; CHMP3;	GO:0019058~viral life cycle	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	DVL1; PIGR; PTN; LRRC1; SCRIB; DLG3;	GO:0043113~receptor clustering	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	ID1; NEK2; SUMO3; MDFI; SMO; CTNNBIP1;	GO:0043392~negative regulation of DNA binding	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; GJA1; ADRA2C; GJA5; TRPM4; AVPR1A;	GO:0045907~positive regulation of vasoconstriction	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	SRC; PTN; TRIP13; PAQR7; HORMAD1; PAQR5;	GO:0048477~oogenesis	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	MATN2; APOD; CDK1; ARF4; TXN2; P2RY12;	GO:0048678~response to axon injury	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
down	SGTA; HSPB1; PDIA4; PEX19; FKBP4; UNC45A;	GO:0061077~chaperone-mediated protein folding	6	30	20	0.0242227608415976	0.11919554209165	1	1	0.999999999989095	0.999999999989094	1
up	ITGB2; ALOX5; CCR6; ADAM8; JAM3;	GO:0002523~leukocyte migration involved in inflammatory response	5	11	45.4545454545455	0.0245103996271629	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	IL2RA; IL2RG; STAT5A; STAT5B; JAK3;	GO:0038110~interleukin-2-mediated signaling pathway	5	11	45.4545454545455	0.0245103996271629	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD3E; PTPRC; CCR7; ZAP70; DOCK2;	GO:0045060~negative thymic T cell selection	5	11	45.4545454545455	0.0245103996271629	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	GNA15; GPR157; LPAR1; LPAR3; GPR4; LPAR4; F2RL1;	GO:0051482~positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway	7	39	17.9487179487179	0.0246447939466558	0.121084266692949	1	1	0.999999999989095	0.999999999989094	1
down	EFNA1; ERBB3; CD24; GAS6; NCAPG2; DLG3; SRCIN1;	GO:0061098~positive regulation of protein tyrosine kinase activity	7	39	17.9487179487179	0.0246447939466558	0.121084266692949	1	1	0.999999999989095	0.999999999989094	1
up	PTPRC; STAT5B; NCKAP1L; LEF1;	GO:0045588~positive regulation of gamma-delta T cell differentiation	4	7	57.1428571428571	0.0252741859857821	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	PGRMC1; HMBS; ALAS1; TSPO; TMEM14C;	GO:0006783~heme biosynthetic process	5	22	22.7272727272727	0.0254004063540163	0.124218962555367	1	1	0.999999999989095	0.999999999989094	1
down	FOXE1; HOXA3; HOXA5; MAPK3; HOXD3;	GO:0030878~thyroid gland development	5	22	22.7272727272727	0.0254004063540163	0.124218962555367	1	1	0.999999999989095	0.999999999989094	1
down	RASSF10; FZD9; ELL3; DLL4; ADGRG1;	GO:2000179~positive regulation of neural precursor cell proliferation	5	22	22.7272727272727	0.0254004063540163	0.124218962555367	1	1	0.999999999989095	0.999999999989094	1
down	CRYAB; TFAP2A; G6PD; VDAC1; HIF1A;	GO:2000378~negative regulation of reactive oxygen species metabolic process	5	22	22.7272727272727	0.0254004063540163	0.124218962555367	1	1	0.999999999989095	0.999999999989094	1
down	C2CD4B; GSN; PRLR; FUT1; GPR4; FUT2; IL18; SPINK5;	GO:0030155~regulation of cell adhesion	8	49	16.3265306122449	0.026408115705997	0.128848835523179	1	1	0.999999999989095	0.999999999989094	1
down	DVL1; KLK8; NFASC; C1QA; WNT7B; PCDHGC3; PPFIA3; PPFIBP1;	GO:0050808~synapse organization	8	49	16.3265306122449	0.026408115705997	0.128848835523179	1	1	0.999999999989095	0.999999999989094	1
down	FZD9; GALR2; EGFR; S100B; GM2A; PTPRZ1; GATM; CCL11; ZNF385A;	GO:0007611~learning or memory	9	59	15.2542372881356	0.0271105785378676	0.131769054273777	1	1	0.999999999989095	0.999999999989094	1
down	AGR2; HSPA1B; BMP4; BMP7; ADCYAP1R1; NPAS2; TMEM109; CHMP4B; IMPACT;	GO:0060548~negative regulation of cell death	9	59	15.2542372881356	0.0271105785378676	0.131769054273777	1	1	0.999999999989095	0.999999999989094	1
down	ALDOA; TPI1; GPI; HK1; PKM; GAPDH;	GO:0006096~glycolytic process	6	31	19.3548387096774	0.0274098309886341	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	MRPS12; MRPS34; MRPL51; MRPS18A; MRPS2; MRPS16;	GO:0032543~mitochondrial translation	6	31	19.3548387096774	0.0274098309886341	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	CLDN5; PDGFRA; PAX9; DLX5; STRA6; CRISPLD1;	GO:0060325~face morphogenesis	6	31	19.3548387096774	0.0274098309886341	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	BMP2; BMP7; FGFR2; WNT4; FOXF2; HIF1A; FAM83D;	GO:0001837~epithelial to mesenchymal transition	7	40	17.5	0.0274264216324023	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	ESYT3; B3GALNT1; GM2A; UGT8; CPTP; SUMF1; GLTP;	GO:0006687~glycosphingolipid metabolic process	7	40	17.5	0.0274264216324023	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	ADCY6; ADCYAP1; EDNRA; CAP2; ADCY2; RXFP1; LGR4;	GO:0007190~activation of adenylate cyclase activity	7	40	17.5	0.0274264216324023	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	CHP2; CDK1; GLI3; CDH1; JUP; HYAL2; SMO;	GO:0042307~positive regulation of protein import into nucleus	7	40	17.5	0.0274264216324023	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
down	GAPDH; NGFR; ERBB3; SIAH1; FAM162A; TP63; BOK;	GO:0051402~neuron apoptotic process	7	40	17.5	0.0274264216324023	0.132491356940675	1	1	0.999999999989095	0.999999999989094	1
up	NLRP2B; CARD16; NLRP7; NLRP3; NLRC4; CARD8;	GO:0050713~negative regulation of interleukin-1 beta secretion	6	16	37.5	0.0274884674862077	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CALCA; NTRK1; ARRB2; EPHB1; CXCR4; ANO1;	GO:0050965~detection of temperature stimulus involved in sensory perception of pain	6	16	37.5	0.0274884674862077	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	SASH3; CD3E; RARA; GATA3; CD40LG; FCER1G; NLRP3;	GO:0032753~positive regulation of interleukin-4 production	7	21	33.3333333333333	0.0282531925991956	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	LIPF; MDH2; ME1;	GO:0006108~malate metabolic process	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SULT1C2; CYP1A1; AOC1;	GO:0009308~amine metabolic process	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	ADRA2A; ADRA2C; P2RY12;	GO:0010700~negative regulation of norepinephrine secretion	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	YAP1; OVOL2; EPB41L4B;	GO:0010837~regulation of keratinocyte proliferation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	NOL3; RYR1; TMEM38A;	GO:0014808~release of sequestered calcium ion into cytosol by sarcoplasmic reticulum	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SLC9A3R1; FGFR2; NKX2-3;	GO:0022612~gland morphogenesis	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	HTR3A; TRPC6; WNK4;	GO:0032414~positive regulation of ion transmembrane transporter activity	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	IL33; TSLP; IL1RAP;	GO:0032736~positive regulation of interleukin-13 production	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	RPS6KA4; CCNB1; MAPK3;	GO:0033129~positive regulation of histone phosphorylation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CCND1; IQGAP3; ZNF703;	GO:0033601~positive regulation of mammary gland epithelial cell proliferation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	PLPP3; CEACAM5; XG;	GO:0034109~homotypic cell-cell adhesion	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	HOXD9; BMPR1A; TFAP2B;	GO:0035137~hindlimb morphogenesis	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CTNND1; CDH1; SRC;	GO:0035635~entry of bacterium into host cell	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	MT1G; HYAL2; ADAM9;	GO:0042117~monocyte activation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	NR1D1; CCND1; LEPR;	GO:0044321~response to leptin	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SLC27A2; ACSL3; SLC27A4;	GO:0044539~long-chain fatty acid import into cell	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	TIMM10; TIMM13; ROMO1;	GO:0045039~protein insertion into mitochondrial inner membrane	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	HOXB1; FOXA1; DLX5;	GO:0048646~anatomical structure formation involved in morphogenesis	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	OPHN1; SLC1A3; HES1;	GO:0048667~cell morphogenesis involved in neuron differentiation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	PDGFRA; EFNB2; P2RY12;	GO:0050920~regulation of chemotaxis	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	EXOC3L4; EXOC3L2; STXBP6;	GO:0051601~exocyst localization	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	COBL; PLS3; PLS1;	GO:0051639~actin filament network formation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	AR; PRLR; PSAPL1;	GO:0060736~prostate gland growth	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	VEGFA; CD34; KDR;	GO:0061042~vascular wound healing	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	ATP2C2; WNT4; WNT7B;	GO:0061180~mammary gland epithelium development	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	AOC1; GABRB3; GABRB2;	GO:0071420~cellular response to histamine	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SLC2A1; AQP1; ERRFI1;	GO:0071474~cellular hyperosmotic response	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CDKN1A; HYAL1; HYAL2;	GO:0071493~cellular response to UV-B	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	BANF1; HMGA1; XRCC4;	GO:0075713~establishment of integrated proviral latency	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	"NAMPT; CACNB3; AQP3;"	GO:0090650~cellular response to oxygen-glucose deprivation	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	GLTP; GLTPD2; CPTP;	GO:0120009~intermembrane lipid transfer	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	GLTPD2; CPTP; GLTP;	GO:1902389~ceramide 1-phosphate transport	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	NECTIN1; MARVELD3; LAMTOR3;	GO:1902414~protein localization to cell junction	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	FOXE1; CEP55; TP63;	GO:1904888~cranial skeletal system development	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SRC; MAPK3; CHMP3;	GO:2000641~regulation of early endosome to late endosome transport	3	8	37.5	0.0284591170610079	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	HMGA1; RAD51; RECQL4; MCM4;	GO:0006268~DNA unwinding involved in DNA replication	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	ICA1; SLC6A15; SLC6A14; GABRQ;	GO:0006836~neurotransmitter transport	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	UGT2B7; HSD17B4; HSD17B8; DHRS9;	GO:0008209~androgen metabolic process	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	MAPK3; CXCL17; RARRES2; TRPV4;	GO:0010759~positive regulation of macrophage chemotaxis	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	MUC13; STRAP; TFF2; TFF1;	GO:0030277~maintenance of gastrointestinal epithelium	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	XCL1; IL20RB; HOMER2; VSIG4;	GO:0032703~negative regulation of interleukin-2 production	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; ADAM9; SFRP2; P2RY12;	GO:0033630~positive regulation of cell adhesion mediated by integrin	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SOX18; GJA5; FOXC1; SOX17;	GO:0035050~embryonic heart tube development	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	ADCYAP1; ADCYAP1R1; FFAR4; GPR62;	GO:0043950~positive regulation of cAMP-mediated signaling	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	LGALS3; EPHA3; SNX33; PACSIN3;	GO:0045806~negative regulation of endocytosis	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	IDH1; CA2; SPP1; PAQR7;	GO:0048545~response to steroid hormone	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	TACSTD2; SERPINB5; HES1; HES5;	GO:0050678~regulation of epithelial cell proliferation	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CIDEA; FCGR2B; FFAR4; LGR4;	GO:0050710~negative regulation of cytokine secretion	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CIDEA; APOC1; ADRA2A; HCAR2;	GO:0050995~negative regulation of lipid catabolic process	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	MEIS1; TP73; GJA1; CXADR;	GO:0060044~negative regulation of cardiac muscle cell proliferation	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	IHH; FRZB; SMO; MEOX2;	GO:0061053~somite development	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	PRKCZ; FIBIN; PLVAP; ADGRG1;	GO:0070528~protein kinase C signaling	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	RCAN1; FHL2; MYOZ1; HOMER2;	GO:0070885~negative regulation of calcineurin-NFAT signaling cascade	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	SRPX2; GLI3; MYH14; CNTNAP2;	GO:0071625~vocalization behavior	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	KLF4; MEOX2; MMRN2; DLL4;	GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	KLF4; ID1; KLF5; KLF15;	GO:1901653~cellular response to peptide	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	CCT6A; CCT3; NHP2; RUVBL2;	GO:1904874~positive regulation of telomerase RNA localization to Cajal body	4	15	26.6666666666667	0.028865472128228	0.133539680546503	1	1	0.999999999989095	0.999999999989094	1
down	FOXP2; DCN; ELN; HOXD9; MEOX2; MYH14; MYOZ1; CFL2;	GO:0007519~skeletal muscle tissue development	8	50	16	0.0289916737783659	0.133830464972529	1	1	0.999999999989095	0.999999999989094	1
down	EPN2; ELF3; HES1; HES5; MESP1; TP63; DLL4; RFNG;	GO:0045747~positive regulation of Notch signaling pathway	8	50	16	0.0289916737783659	0.133830464972529	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; RYR1; XCL1; ERO1A; CCL19; PLCD1; PLCB3; PLCD3;	GO:0051209~release of sequestered calcium ion into cytosol	8	50	16	0.0289916737783659	0.133830464972529	1	1	0.999999999989095	0.999999999989094	1
down	PCNA; RRM2; CCNA1; CDC6; CDT1;	GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; VEGFA; CX3CL1; HIF1A; SMO;	GO:0002052~positive regulation of neuroblast proliferation	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	RAB6A; RAB5B; RAB10; HFE; CD209;	GO:0019882~antigen processing and presentation	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOC1; APOA4; STX12; ABCG4;	GO:0033344~cholesterol efflux	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	PRKACA; KDR; BCAP31; DEFB1; HOMER2;	GO:0035584~calcium-mediated signaling using intracellular calcium source	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	RAB27B; CFTR; VSNL1; SYTL4; CADPS2;	GO:0045921~positive regulation of exocytosis	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; BMPR1A; GAS1; KDF1; STRA6;	GO:0048589~developmental growth	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	MMP7; UBE2A; DSG1; DSG2; IHH;	GO:0060135~maternal process involved in female pregnancy	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	NGFR; TPD52L1; DAB2IP; TRAF7; CRADD;	GO:2001235~positive regulation of apoptotic signaling pathway	5	23	21.7391304347826	0.0293568693702644	0.13453639773589	1	1	0.999999999989095	0.999999999989094	1
down	PSMD3; SNX3; USP2; PSMD10; IL33; CDK1; AR; CFTR; PSMC3; CCNA2; PSMB6; PSMB5; PSMC2; USP5; PSMD8; PSMB2; RAD23B; CCNA1; CDC20; KEAP1; SMAD1; ADRM1; HIF1A; INO80C; USP43; RNF128; OTUB1;	GO:0016579~protein deubiquitination	27	263	10.2661596958175	0.0295398815698605	0.135277290021515	1	1	0.999999999989095	0.999999999989094	1
up	TLR4; HP; PPBP; LPO; IL10; GNLY; FPR2; CFP; SLC11A1; CAMP; IRF8; DEFB108B; CLEC4D; NLRP1; NLRC4; CLEC4E; TLR6; IGHV3-48; IGHV3-13; TRBC1; IGHG1; IGHV1-2; TRBC2; IGHV3-30; IGLC2; IGHV2-5; IGHD; IGHV3-74; IGHV1-18; IGHV4-34; IGHV3-35; FCER1G; IGHV4-31; IGKC; IGHM; MPO; IGHV3-11; IGHV3-33;	GO:0042742~defense response to bacterium	38	216	17.5925925925926	0.0299852544077821	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	FZD9; PRKACA; RYR1; PLN; BOK; CALB2; TRPC6;	GO:0051480~regulation of cytosolic calcium ion concentration	7	41	17.0731707317073	0.0304135334583714	0.139177599320692	1	1	0.999999999989095	0.999999999989094	1
down	HOXA3; BGN; ACVRL1; FOXC1; EPAS1; DLL4;	GO:0001974~blood vessel remodeling	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	SLC6A15; SLC6A14; SLC6A1; SLC6A9; SLC6A11; TMEM184A;	GO:0006810~transport	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	PHGDH; SRD5A1; PTN; MPST; VIT; ROBO2;	GO:0021510~spinal cord development	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	RAB10; VAMP2; VAMP3; AMN; BLZF1; NSF;	GO:0043001~Golgi to plasma membrane protein transport	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	FAM107A; EPHA3; EFNA5; RASSF7; BICD2; CAMSAP3;	GO:0070507~regulation of microtubule cytoskeleton organization	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	CDKN1A; NAMPT; RAD51; SWI5; RAD51AP1; TNKS1BP1;	GO:0071479~cellular response to ionizing radiation	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	PLXNB2; PLXNB1; PLXNA2; ARHGDIA; RAC1; SEMA3F;	GO:0071526~semaphorin-plexin signaling pathway	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; CYP1A1; HYAL1; UBE2E2; ANXA1; CCND1;	GO:1900087~positive regulation of G1/S transition of mitotic cell cycle	6	32	18.75	0.030861897949272	0.140418312421023	1	1	0.999999999989095	0.999999999989094	1
up	TLR4; TLR2; CD14; CD36; BTK; TLR1; TLR8; TLR6; LY96;	GO:0002755~MyD88-dependent toll-like receptor signaling pathway	9	32	28.125	0.0309360257690878	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	HLA-G; HLA-F; MICB; HLA-H; FCGRT;	GO:0002476~antigen processing and presentation of endogenous peptide antigen via MHC class Ib	5	12	41.6666666666667	0.031662520207153	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	HLA-G; HLA-H; FCGRT; MICB; HLA-F;	GO:0002486~antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent	5	12	41.6666666666667	0.031662520207153	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD4; TRPC3; P2RX5; P2RX4; P2RX7;	GO:0010524~positive regulation of calcium ion transport into cytosol	5	12	41.6666666666667	0.031662520207153	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	SPRY2; LTF; RALB; SRC; STK3; DAB2IP; MLST8; HIGD1A;	GO:0071902~positive regulation of protein serine/threonine kinase activity	8	51	15.6862745098039	0.0317441064812213	0.144328656296973	1	1	0.999999999989095	0.999999999989094	1
up	SH3KBP1; IGHD; IGHM; IGHG1; IGHV3-13; IGHV1-2; TRBC1; IGHV1-18; IGHV3-74; IGHV3-48; IGHV3-11; TRBC2; IGHV3-33; IGLC2; IGHV4-31; IGHV4-34; IGKC; IGHV3-35; IGHV3-30; IGHV2-5;	GO:0050871~positive regulation of B cell activation	20	98	20.4081632653061	0.0320060970357058	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CORO1A; SRPX; P2RX7;	GO:0001845~phagolysosome assembly	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ITGAL; FGL2; APBB1IP;	GO:0002291~T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	HLA-G; TGFBR2; LILRB2;	GO:0002666~positive regulation of T cell tolerance induction	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; PLEK; SELP;	GO:0010572~positive regulation of platelet activation	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD22; MZB1; IKZF3;	GO:0030888~regulation of B cell proliferation	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD247; FCER1G; SLC11A1;	GO:0032623~interleukin-2 production	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	IFI30; CLEC4A; FCER1G;	GO:0042590~antigen processing and presentation of exogenous peptide antigen via MHC class I	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ITGB2; ITGAM; PTAFR;	GO:0043315~positive regulation of neutrophil degranulation	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	TLR2; TLR1; TLR6;	GO:0071221~cellular response to bacterial lipopeptide	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	GATA3; CCR6; TBX21;	GO:0072676~lymphocyte migration	3	4	75	0.0328213541779165	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	LYNX1; ADH7; HFE; LYPD6; GPIHBP1; DKK4; DKK2;	GO:2000272~negative regulation of signaling receptor activity	7	42	16.6666666666667	0.0336115555145842	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	HSPA2; CCNA1; TRIP13; MEIOB; SLC2A8;	GO:0007141~male meiosis I	5	24	20.8333333333333	0.0336808790172416	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	CX3CL1; CXCL10; CXCL11; CXCL13; CXCL9;	GO:0030595~leukocyte chemotaxis	5	24	20.8333333333333	0.0336808790172416	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	MEIS2; HNF1B; FOXF1; HES1; IHH;	GO:0031016~pancreas development	5	24	20.8333333333333	0.0336808790172416	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	PCNA; RFC2; RFC5; POLD2; POLE3;	GO:0032201~telomere maintenance via semi-conservative replication	5	24	20.8333333333333	0.0336808790172416	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	CYP1A1; CYP2E1; CYP2C9; GSTM4; ELOVL6;	GO:0042759~long-chain fatty acid biosynthetic process	5	24	20.8333333333333	0.0336808790172416	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
up	PIK3CD; NCR3; NCR1; ITGB2; CD2; IL18R1; IL21R;	GO:0030101~natural killer cell activation	7	22	31.8181818181818	0.0338235332977548	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	FGF12; CNKSR3; GPD1L; PRSS8;	GO:0010765~positive regulation of sodium ion transport	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	ALOX15B; ALOX12B; ALOXE3; PLA2G3;	GO:0019372~lipoxygenase pathway	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	HYAL1; HYAL2; CEMIP; LYVE1;	GO:0030214~hyaluronan catabolic process	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	MMP7; PCNA; PTN; ANXA1;	GO:0044849~estrous cycle	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	EGFR; RAP2A; F2RL1; MAPK8IP2;	GO:0046328~regulation of JNK cascade	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	APOE; S100B; DBN1; ARC;	GO:0048168~regulation of neuronal synaptic plasticity	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	RARG; RXRA; ESRRG; CYP26B1;	GO:0048384~retinoic acid receptor signaling pathway	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; FOXF2; RARRES2; STRA6;	GO:0048566~embryonic digestive tract development	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	SAA1; KRT20; RHBDF1; LLGL2;	GO:0050708~regulation of protein secretion	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	NR1D1; EFNA5; HMGN3; LRP5;	GO:0061178~regulation of insulin secretion involved in cellular response to glucose stimulus	4	16	25	0.0343222075611287	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOC1; CYP2E1; LIPF; NKX2-3; GK5;	GO:0006641~triglyceride metabolic process	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	APOE; NTF4; PRKCZ; GRIN1; ARC; CPEB3;	GO:0007616~long-term memory	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	TH; DES; S100A1; PLN; CYP2J2; DMPK;	GO:0008016~regulation of heart contraction	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	ERBB2; ERBB3; TYRO3; C1QBP; NYAP1; PREX2;	GO:0014065~phosphatidylinositol 3-kinase signaling	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	ADCYAP1; IL1RN; HNF1B; FAM3B; PCLO; ANXA1;	GO:0030073~insulin secretion	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
down	AP2S1; SPHK1; SNX12; PACSIN3; RAB5B; OPHN1;	GO:0030100~regulation of endocytosis	6	33	18.1818181818182	0.0345856800313754	0.145937839752407	1	1	0.999999999989095	0.999999999989094	1
up	CD36; IGHV3-11; IGHV3-74; IGHG1; IGHV3-30; IGHV1-2; TRBC2; IGHV3-35; IGHV1-18; IGHV3-13; IGHM; IGHV2-5; IGHD; TRBC1; IGLC2; IGKC; IGHV4-31; IGHV3-48; IGHV4-34; IGHV3-33;	GO:0006910~phagocytosis, recognition	20	99	20.2020202020202	0.0346408432557915	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	MS4A1; ORAI1; CRACR2A; ORAI2;	GO:0002115~store-operated calcium entry	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD160; HLA-G; HLA-F; KIR2DL4;	GO:0002729~positive regulation of natural killer cell cytokine production	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	P2RX1; P2RX5; P2RX4; P2RX7;	GO:0035590~purinergic nucleotide receptor signaling pathway	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	IL2RG; JAK3; IL21; IL21R;	GO:0038114~interleukin-21-mediated signaling pathway	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PRTN3; NLGN2; MYADM; PARD6A;	GO:0045217~cell-cell junction maintenance	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PRKCB; NFAM1; CMTM3; STAP1;	GO:0050861~positive regulation of B cell receptor signaling pathway	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PTH; PTAFR; SNCA; CD244;	GO:0060732~positive regulation of inositol phosphate biosynthetic process	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CCL5; IL7R; CD27; DOCK8;	GO:0070233~negative regulation of T cell apoptotic process	4	8	50	0.0346862771468588	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	GLUL; SLC1A3; SLC6A9;	GO:0001504~neurotransmitter uptake	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	ILVBL; SLC27A2; ALDH3A2;	GO:0001561~fatty acid alpha-oxidation	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; ERBB3; FOXF1;	GO:0003197~endocardial cushion development	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	UBE2N; UBE2V2; WRNIP1;	GO:0006282~regulation of DNA repair	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	CHMP4B; SGTA; ASNA1;	GO:0006620~posttranslational protein targeting to endoplasmic reticulum membrane	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	GPAA1; KDELR1; KDELR2;	GO:0006621~protein retention in ER lumen	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	TLR3; HNMT; AQP1;	GO:0006972~hyperosmotic response	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	GPI; ZNF385A; P2RY12;	GO:0007599~hemostasis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	ST3GAL4; B3GNT6; A4GNT;	GO:0009101~glycoprotein biosynthetic process	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOC1; APOA4;	GO:0010873~positive regulation of cholesterol esterification	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	PRDX4; CHCHD4; ERO1A;	GO:0022417~protein maturation by protein folding	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	PLK1; CDC6; UBE2C;	GO:0030071~regulation of mitotic metaphase/anaphase transition	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	NDST1; SLC10A7; ANGPT1;	GO:0030210~heparin biosynthetic process	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	F2RL1; DSTN; CFL2;	GO:0030836~positive regulation of actin filament depolymerization	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	CCND1; YAP1; SMO;	GO:0030857~negative regulation of epithelial cell differentiation	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	SREBF1; SREBF2; ARHGEF10L;	GO:0032933~SREBP signaling pathway	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	NR1D1; DAB2IP; RAB7B;	GO:0034144~negative regulation of toll-like receptor 4 signaling pathway	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOA4; GPIHBP1;	GO:0034371~chylomicron remodeling	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	ALOX15B; FABP5; STARD10;	GO:0035360~positive regulation of peroxisome proliferator activated receptor signaling pathway	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	HRAS; IL18; EBI3;	GO:0042088~T-helper 1 type immune response	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	FCGR2B; ADGRF5; VSIG4;	GO:0043031~negative regulation of macrophage activation	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	SOX18; ID1; EMP2;	GO:0043534~blood vessel endothelial cell migration	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	MVB12A; CHMP4B; CHMP5;	GO:0046755~viral budding	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	HMGCL; HMGCS2; AACS;	GO:0046951~ketone body biosynthetic process	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	RARG; ALDH1A3; EFEMP1;	GO:0048048~embryonic eye morphogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; HOXA1; NDST1;	GO:0048702~embryonic neurocranium morphogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	ID1; GORASP1; TRPC6;	GO:0050774~negative regulation of dendrite morphogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	MAD2L1; MISP; PARD3;	GO:0051660~establishment of centrosome localization	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	BAIAP2; BAIAP2L1; BAIAP2L2;	GO:0051764~actin crosslink formation	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	FZD7; CLDN1; MMP12;	GO:0060054~positive regulation of epithelial cell proliferation involved in wound healing	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	FZD7; WNT4; TCF15;	GO:0060231~mesenchymal to epithelial transition	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	RAB25; RAB11A; VAMP2;	GO:0060627~regulation of vesicle-mediated transport	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	SPINT1; FGFR2; FZD5;	GO:0060670~branching involved in labyrinthine layer morphogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	ZMPSTE24; WWTR1; VANGL2;	GO:0060993~kidney morphogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	RAB11B; RAB11FIP5; IMPACT;	GO:0071468~cellular response to acidic pH	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	RAB11A; TSPAN17; LAMP3;	GO:0072594~establishment of protein localization to organelle	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	RAB10; RAB11A; RAB11B;	GO:0090150~establishment of protein localization to membrane	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	PDLIM4; GRIN1; SHISA6;	GO:0098976~excitatory chemical synaptic transmission	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	PCNA; RFC2; RFC5;	GO:1900264~positive regulation of DNA-directed DNA polymerase activity	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	GPR37; TXN; PYCR1;	GO:1903206~negative regulation of hydrogen peroxide-induced cell death	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	VEGFA; APLNR; FGFBP1;	GO:1903589~positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	PRKCZ; LGALS9C; LGALS9B;	GO:2001181~positive regulation of interleukin-10 secretion	3	9	33.3333333333333	0.0361952386645221	0.146025093988378	1	1	0.999999999989095	0.999999999989094	1
down	DLX3; CEACAM1; GJA4; FOXF1; STRA6; SPHK1; APLNR;	GO:0001568~blood vessel development	7	43	16.2790697674419	0.0370254229454535	0.148900463596627	1	1	0.999999999989095	0.999999999989094	1
down	RGS12; RGS5; RAMP2; RGS11; ADCYAP1; RGS4; HOMER2;	GO:0008277~regulation of G protein-coupled receptor signaling pathway	7	43	16.2790697674419	0.0370254229454535	0.148900463596627	1	1	0.999999999989095	0.999999999989094	1
down	PLSCR1; BANF1; OAS1; LTF; SLPI; TRIM6; OAS3;	GO:0045071~negative regulation of viral genome replication	7	43	16.2790697674419	0.0370254229454535	0.148900463596627	1	1	0.999999999989095	0.999999999989094	1
down	CLIC1; HSPB1; PDGFRA; METAP1; ACTG1; TYRO3; P2RY12;	GO:0070527~platelet aggregation	7	43	16.2790697674419	0.0370254229454535	0.148900463596627	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; ADCYAP1; SDC4; CDKN1A; RAP1A; VLDLR; GAS6; CCL19;	GO:0045860~positive regulation of protein kinase activity	8	53	15.0943396226415	0.0377722072680463	0.151519145357517	1	1	0.999999999989095	0.999999999989094	1
down	UBE2C; IFI27; UBE2A; UBE2E1; UBE2G1; RNF187; ZNRF1; UBE2E2;	GO:0070936~protein K48-linked ubiquitination	8	53	15.0943396226415	0.0377722072680463	0.151519145357517	1	1	0.999999999989095	0.999999999989094	1
down	ATP1B1; PRKACA; RYR1; NPPC; DMPK; FXYD3; ACE2; EHD3;	GO:1903779~regulation of cardiac conduction	8	53	15.0943396226415	0.0377722072680463	0.151519145357517	1	1	0.999999999989095	0.999999999989094	1
up	TNFSF14; CORO1A; STAT5B; JAK3; NCKAP1L; P2RX7; GPR174; SIT1;	GO:0043029~T cell homeostasis	8	28	28.5714285714286	0.0381004352283905	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	BEST1; CD4; GNAI2; ADORA2A; P2RX1; CXCR4; IL16; ORAI1;	GO:0051924~regulation of calcium ion transport	8	28	28.5714285714286	0.0381004352283905	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	GALR2; NPR3; P2RY13; GPR87; LTB4R2;	GO:0007194~negative regulation of adenylate cyclase activity	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	PIP5K1C; VAMP2; RIMS1; PCLO; SYT8;	GO:0016079~synaptic vesicle exocytosis	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	CD34; XCL1; IL20RB; TSLP; TREM2;	GO:0032733~positive regulation of interleukin-10 production	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	SERPINB7; BMP4; WNT4; IHH; CREB3L1;	GO:0032967~positive regulation of collagen biosynthetic process	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	CYB5A; CDK1; PCNA; GOT1; SORD;	GO:0046686~response to cadmium ion	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	CDK1; CCNB1; FGFR2; BMPR1A; YAP1;	GO:0060045~positive regulation of cardiac muscle cell proliferation	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	HRAS; CD24; CDKN1A; PMAIP1; BAD;	GO:0097193~intrinsic apoptotic signaling pathway	5	25	20	0.0383795706546861	0.153276445374544	1	1	0.999999999989095	0.999999999989094	1
down	MAPK3; CCT6A; CCT3; NEK2; AURKB; PKIB;	GO:0032212~positive regulation of telomere maintenance via telomerase	6	34	17.6470588235294	0.0385870147700219	0.153620916841959	1	1	0.999999999989095	0.999999999989094	1
down	PLVAP; TCF15; COMT; ROGDI; SFTPA2; SFTPD;	GO:0032502~developmental process	6	34	17.6470588235294	0.0385870147700219	0.153620916841959	1	1	0.999999999989095	0.999999999989094	1
down	DVL1; ZBTB7A; LMNA; BMP4; BMP7; SMO;	GO:0034504~protein localization to nucleus	6	34	17.6470588235294	0.0385870147700219	0.153620916841959	1	1	0.999999999989095	0.999999999989094	1
down	SASH1; ARHGEF5; FZD5; DAB2IP; VANGL2; FZD10;	GO:0043507~positive regulation of JUN kinase activity	6	34	17.6470588235294	0.0385870147700219	0.153620916841959	1	1	0.999999999989095	0.999999999989094	1
down	DAB2IP; ERO1A; TRIB3; CHAC1; TMEM117; ERN2;	GO:0070059~intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress	6	34	17.6470588235294	0.0385870147700219	0.153620916841959	1	1	0.999999999989095	0.999999999989094	1
up	CRYBA1; IL10; SLC11A1; BTK; CLEC4A;	GO:0001818~negative regulation of cytokine production	5	13	38.4615384615385	0.0399903412531357	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	VNN1; APOA2; TREM1; HP; HPR;	GO:0002526~acute inflammatory response	5	13	38.4615384615385	0.0399903412531357	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD27; IL13RA2; INPP5D; TLR8; FCER1G;	GO:0016064~immunoglobulin mediated immune response	5	13	38.4615384615385	0.0399903412531357	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD4; IL2RG; STAT5A; STAT5B; JAK3;	GO:0035723~interleukin-15-mediated signaling pathway	5	13	38.4615384615385	0.0399903412531357	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CD27; STAT5B; NCKAP1L; BTK; INPP5D;	GO:0045579~positive regulation of B cell differentiation	5	13	38.4615384615385	0.0399903412531357	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CPNE6; SYT1; CXCR4; RNF157; SYT4; CPNE5; UNC13A;	GO:1903861~positive regulation of dendrite extension	7	23	30.4347826086957	0.0400773884342644	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	EIF6; WDR12; FBXW9; NHP2;	GO:0000470~maturation of LSU-rRNA	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	CCL21; CXCR1; TRPM4; CCL19;	GO:0002407~dendritic cell chemotaxis	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	VIT; SCARA3; MATN2; VWA2;	GO:0003429~growth plate cartilage chondrocyte morphogenesis	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	UQCRH; COX7A2; UQCRC1; CHCHD10;	GO:0006119~oxidative phosphorylation	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	GCAT; GGT5; ACY1; PHGDH;	GO:0006520~cellular amino acid metabolic process	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	IMPA2; INPP1; PPA1; PPA2;	GO:0006796~phosphate-containing compound metabolic process	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	SLC25A4; PPP2CB; AIFM2; BIK;	GO:0008637~apoptotic mitochondrial changes	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	NFASC; DMRT3; CNTNAP2; CACNG4;	GO:0019226~transmission of nerve impulse	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	PIR; BMP4; MT1G; VEGFA;	GO:0030224~monocyte differentiation	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	C1R; F12; PRSS3; KLK1;	GO:0031638~zymogen activation	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOC1; APOA4; PLTP;	GO:0034375~high-density lipoprotein particle remodeling	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	G6PD; AKT1S1; TRIM2; EGLN3;	GO:0043523~regulation of neuron apoptotic process	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	SPRY2; NRG2; BARX2; SPRY1;	GO:0048513~animal organ development	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	GNAI1; GPSM2; PSRC1; TPX2;	GO:0060236~regulation of mitotic spindle organization	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	RARG; MAPK3; ALDH1A3; GRHL2;	GO:0060324~face development	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	GRM6; ATP2C2; LGALS3; STC1;	GO:0090280~positive regulation of calcium ion import	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	CLDN18; TRIM29; DCLK3; TMEM98;	GO:1900181~negative regulation of protein localization to nucleus	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	CEACAM5; SRC; CEACAM6; TLE1;	GO:2000811~negative regulation of anoikis	4	17	23.5294117647059	0.0403359273040613	0.158689700343352	1	1	0.999999999989095	0.999999999989094	1
down	TLR3; SASH1; EGFR; IL18; TRIP6; RTKN2; CCL19; SPHK1; TREM2;	GO:1901224~positive regulation of NIK/NF-kappaB signaling	9	64	14.0625	0.0404463180721173	0.15902528780464	1	1	0.999999999989095	0.999999999989094	1
down	WNT9B; PLXNB2; NDUFS4; HSPB1; CDH5; RAD51; CADM4;	GO:0001932~regulation of protein phosphorylation	7	44	15.9090909090909	0.0406595583123457	0.159665601352941	1	1	0.999999999989095	0.999999999989094	1
down	RCAN1; DMPK; RCAN2; PTPA; PPP4R1; PPP1R16A; PPP2R2C;	GO:0043666~regulation of phosphoprotein phosphatase activity	7	44	15.9090909090909	0.0406595583123457	0.159665601352941	1	1	0.999999999989095	0.999999999989094	1
down	SLC6A9; SLC6A15; SLC6A14; SLC38A4; SLC7A5; SLC7A8;	GO:0003333~amino acid transmembrane transport	6	35	17.1428571428571	0.0428708357651253	0.167829127288057	1	1	0.999999999989095	0.999999999989094	1
down	SRC; RAB25; RAB11A; HYAL1; DOCK1; HIF1A;	GO:0010634~positive regulation of epithelial cell migration	6	35	17.1428571428571	0.0428708357651253	0.167829127288057	1	1	0.999999999989095	0.999999999989094	1
down	PCNA; RFC2; RFC5; POLD2; USP43; DTL;	GO:0019985~translesion synthesis	6	35	17.1428571428571	0.0428708357651253	0.167829127288057	1	1	0.999999999989095	0.999999999989094	1
down	AZIN1; SNX3; EGFR; NOS2; MAD2L1; SNX12;	GO:0042177~negative regulation of protein catabolic process	6	35	17.1428571428571	0.0428708357651253	0.167829127288057	1	1	0.999999999989095	0.999999999989094	1
down	HSPA1B; PRDX2; CTNNA1; CX3CL1; UNC5B; EYA2;	GO:2001240~negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	6	35	17.1428571428571	0.0428708357651253	0.167829127288057	1	1	0.999999999989095	0.999999999989094	1
down	ANXA9; APOE; LYNX1; NQO1; CHRNB4;	GO:0007271~synaptic transmission, cholinergic	5	26	19.2307692307692	0.0434583190587071	0.169605188543156	1	1	0.999999999989095	0.999999999989094	1
down	TRIAP1; PLTP; PITPNA; TNFAIP8L3; OSBPL10;	GO:0015914~phospholipid transport	5	26	19.2307692307692	0.0434583190587071	0.169605188543156	1	1	0.999999999989095	0.999999999989094	1
down	FZD7; EGFR; ANG; AR; MIF;	GO:0042327~positive regulation of phosphorylation	5	26	19.2307692307692	0.0434583190587071	0.169605188543156	1	1	0.999999999989095	0.999999999989094	1
down	GOT2; RGS4; GRIN1; PEA15; MAP1LC3A;	GO:0043278~response to morphine	5	26	19.2307692307692	0.0434583190587071	0.169605188543156	1	1	0.999999999989095	0.999999999989094	1
down	FZD7; FOLR1; KREMEN1; SOX7; ZNF703;	GO:0060828~regulation of canonical Wnt signaling pathway	5	26	19.2307692307692	0.0434583190587071	0.169605188543156	1	1	0.999999999989095	0.999999999989094	1
down	TLR3; CASP14; CRADD; FASTK; TICAM1; PAWR; UACA; IFI27; DAPL1;	GO:0097190~apoptotic signaling pathway	9	65	13.8461538461538	0.0435646358628469	0.169915484368445	1	1	0.999999999989095	0.999999999989094	1
down	"NAV2; RITA1; MESP1; CHAC1; ROGDI; HAP1; BTBD2;"	GO:0022008~neurogenesis	7	45	15.5555555555556	0.0445178533040842	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CDC6; CDT1; TIMELESS;	GO:0000076~DNA replication checkpoint	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	PDGFRA; CD24; SLURP1;	GO:0001775~cell activation	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	AGPAT2; GAS6; TSLP;	GO:0001961~positive regulation of cytokine-mediated signaling pathway	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CPE; FOXF1; SFRP2;	GO:0003214~cardiac left ventricle morphogenesis	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	WASL; ANXA2; S100A10;	GO:0006900~vesicle budding from membrane	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	OPHN1; CTTN; P2RY12;	GO:0006930~substrate-dependent cell migration, cell extension	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CHMP4C; CHMP4B; NDFIP2;	GO:0007034~vacuolar transport	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CDC20; CDCA5; NAA50;	GO:0007064~mitotic sister chromatid cohesion	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	BANF1; LMNA; REEP4;	GO:0007084~mitotic nuclear envelope reassembly	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	PSEN2; APH1A; PSENEN;	GO:0007220~Notch receptor processing	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	NDC80; AURKB; AURKC;	GO:0008608~attachment of spindle microtubules to kinetochore	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	GCAT; ALDH1L1; AADAT;	GO:0009058~biosynthetic process	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	EPHA2; RAC1; TWF1;	GO:0010591~regulation of lamellipodium assembly	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	EDN3; EDN2; EDNRA;	GO:0014824~artery smooth muscle contraction	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; FOXA1; SMO;	GO:0021904~dorsal/ventral neural tube patterning	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	TBX6; TMED2; NRARP;	GO:0032525~somite rostral/caudal axis specification	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CLTA; AP2S1; VLDLR;	GO:0032802~low-density lipoprotein particle receptor catabolic process	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	GSTP1; MAPK3; PRDX1;	GO:0032872~regulation of stress-activated MAPK cascade	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	PCSK6; TYRO3; ABCA12;	GO:0032940~secretion by cell	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CYC1; CCNA2; SREBF1;	GO:0033762~response to glucagon	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	APOE; APOA4; P4HB;	GO:0034378~chylomicron assembly	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	ACVRL1; MMP12; AJUBA;	GO:0035313~wound healing, spreading of epidermal cells	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	FGFR3; STC1; IHH;	GO:0035988~chondrocyte proliferation	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	MCU; MCUR1; SLC25A23;	GO:0036444~calcium import into the mitochondrion	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CEACAM1; RHBDF1; MVB12A;	GO:0042058~regulation of epidermal growth factor receptor signaling pathway	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	LGALS3; TNFSF9; CD209;	GO:0042129~regulation of T cell proliferation	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	ADRM1; POMP; PSMG2;	GO:0043248~proteasome assembly	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	IGFBP4; SERPINB1; BAD;	GO:0044342~type B pancreatic cell proliferation	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	HOXA5; NCAPG2; MAFB;	GO:0045647~negative regulation of erythrocyte differentiation	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	TGFA; ADRA2A; EPGN;	GO:0045741~positive regulation of epidermal growth factor-activated receptor activity	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CNP; PMAIP1; BAD;	GO:0046902~regulation of mitochondrial membrane permeability	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	NDC80; KIF2C; CDT1;	GO:0051315~attachment of mitotic spindle microtubules to kinetochore	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	DCN; TSPO; KDR;	GO:0051901~positive regulation of mitochondrial depolarization	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	GABRB3; GABRB2; USH1C;	GO:0060119~inner ear receptor cell development	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	BMP4; BMP7; HYAL1;	GO:0060272~embryonic skeletal joint morphogenesis	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	SLC1A3; SLC1A1; CXADR;	GO:0070633~transepithelial transport	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CLDN1; PCNA; FIBIN;	GO:0071548~response to dexamethasone	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	HSPA1B; DNAJB1; HSPA2;	GO:0090084~negative regulation of inclusion body assembly	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CYP1A1; CYP2C9; CYP2C19;	GO:0097267~omega-hydroxylase P450 pathway	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	ZNF205; CHCHD10; BOK;	GO:1901030~positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	CHMP4C; CHMP4B; CHMP3;	GO:1902188~positive regulation of viral release from host cell	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	PMAIP1; RNF183; BOK;	GO:1902237~positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	EPN2; CREB3L1; EPN1;	GO:1903671~negative regulation of sprouting angiogenesis	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	RAB11B; HFE; RAB11FIP5;	GO:2000008~regulation of protein localization to cell surface	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
down	HSPB1; LGMN; SMOC2;	GO:2001028~positive regulation of endothelial cell chemotaxis	3	10	30	0.0448914524168322	0.170270511919738	1	1	0.999999999989095	0.999999999989094	1
up	NCR3; CRTAM; CD5; PECAM1;	GO:0008037~cell recognition	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	IL2RG; STAT5A; STAT5B; JAK3;	GO:0038113~interleukin-9-mediated signaling pathway	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	FES; LYN; RAC2; ADGRE2;	GO:0043304~regulation of mast cell degranulation	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	IGHD; ORM1; ORM2; PANX3;	GO:0050716~positive regulation of interleukin-1 secretion	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	TLR4; CD36; HLA-G; LILRB1;	GO:0060907~positive regulation of macrophage cytokine production	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	UCP1; PM20D1; SORL1; UCP2;	GO:1990845~adaptive thermogenesis	4	9	44.4444444444444	0.0458603785867092	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	BMP2; BMPR1A; ACVRL1; HEY1;	GO:0003203~endocardial cushion morphogenesis	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SPRY2; SPRED2; CADM4; PARD3;	GO:0010801~negative regulation of peptidyl-threonine phosphorylation	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SYT8; SYT7; SYT17; SYT15;	GO:0017158~regulation of calcium ion-dependent exocytosis	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	FUT3; SOX2; AFDN; MAGI1;	GO:0022409~positive regulation of cell-cell adhesion	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SOX18; SREBF1; HIF1A; SOX17;	GO:0042789~mRNA transcription by RNA polymerase II	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	FGD1; FGD4; RAB17; ARHGEF4;	GO:0046847~filopodium assembly	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; VEGFA; AQP5; SHROOM2;	GO:0048593~camera-type eye morphogenesis	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	BMP7; BMP5; PLN; SGCG;	GO:0048738~cardiac muscle tissue development	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	FAM107A; APOD; SRC; ACVRL1;	GO:0051895~negative regulation of focal adhesion assembly	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	PLXNA2; BMP7; BMP5; RIPPLY3;	GO:0060037~pharyngeal system development	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	APOE; PRKACA; RHBDF1; NUDT15;	GO:0061136~regulation of proteasomal protein catabolic process	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	CLEC3B; MAP2; IQGAP3; MAPK3;	GO:0071310~cellular response to organic substance	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	HMGCS1; AACS; GRAMD1C; SMO;	GO:0071397~cellular response to cholesterol	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	VPS26A; RAB11B; MICALL1; SNX31;	GO:1990126~retrograde transport, endosome to plasma membrane	4	18	22.2222222222222	0.0469082478095928	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
up	CCDC88B; PF4; IL10; SLC11A1; IRF8; IRF4; TSPAN32;	GO:0042832~defense response to protozoan	7	24	29.1666666666667	0.0470380888307084	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	SDHD; CS; IDH1; MDH2; IDH2; FAHD1;	GO:0006099~tricarboxylic acid cycle	6	36	16.6666666666667	0.0474411567336459	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SOCS6; NR1D1; PMAIP1; PSMB2; PSMB6; PSMB5;	GO:0010498~proteasomal protein catabolic process	6	36	16.6666666666667	0.0474411567336459	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	PLPP1; SCGB2A1; AR; CDK7; FKBP4; FHL2;	GO:0030521~androgen receptor signaling pathway	6	36	16.6666666666667	0.0474411567336459	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	AR; EDN3; BTC; SOX2; PPP1R13L; SOX17;	GO:0045597~positive regulation of cell differentiation	6	36	16.6666666666667	0.0474411567336459	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
up	IL13RA2; ZPBP2; FCRL3;	GO:0002638~negative regulation of immunoglobulin production	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PTH; SSTR3; METTL21C;	GO:0008628~hormone-mediated apoptotic signaling pathway	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	STAT5A; STAT5B; BAAT;	GO:0019530~taurine metabolic process	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	MILR1; CD300LF; CD84;	GO:0033004~negative regulation of mast cell activation	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ACOD1; LYN; TLR6;	GO:0034136~negative regulation of toll-like receptor 2 signaling pathway	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	OXT; SLC4A1; AVPR2;	GO:0035811~negative regulation of urine volume	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ALOX5; NLRP12; DOCK8;	GO:0036336~dendritic cell migration	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ITK; MICB; JAML;	GO:0046629~gamma-delta T cell activation	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PTH; FLT3LG; LEF1;	GO:0071866~negative regulation of apoptotic process in bone marrow cell	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	CST7; CARD16; CARD8;	GO:0097340~inhibition of cysteine-type endopeptidase activity	3	5	60	0.0483035077118981	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
down	INHA; BMP4; NCAPG2; SMAD5; EPAS1; TMEM14C; C15orf41;	GO:0030218~erythrocyte differentiation	7	46	15.2173913043478	0.0486036537788047	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	ADRA2A; GHR; IGFBP2; ROBO2; RAMP2; RAMP3; AVPR1A;	GO:0032870~cellular response to hormone stimulus	7	46	15.2173913043478	0.0486036537788047	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SPRY2; SPRY1; HRAS; ADCYAP1; TMED2; DAB2IP; FZD10;	GO:0034260~negative regulation of GTPase activity	7	46	15.2173913043478	0.0486036537788047	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	SLC9A3R1; KLF4; EPHA2; XDH; HYAL2; TRIB3; PHLDA3;	GO:0051898~negative regulation of protein kinase B signaling	7	46	15.2173913043478	0.0486036537788047	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	TLR3; C1QA; NAMPT; CX3CL1; TREM2;	GO:0001774~microglial cell activation	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	GABRB3; GABRB2; GABRA4; GABRA3; GABRE;	GO:0007214~gamma-aminobutyric acid signaling pathway	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	GLI3; PBX1; TP63; CYP26B1; HOXD9;	GO:0009954~proximal/distal pattern formation	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	DUSP3; F2RL1; MECOM; SH3RF2; MARVELD3;	GO:0046329~negative regulation of JNK cascade	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	RHOD; SRC; CTTN; TRIP6; AJUBA;	GO:0048041~focal adhesion assembly	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	CDK1; NGFR; SRC; PLK1; GTSE1;	GO:1900182~positive regulation of protein localization to nucleus	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
down	TSPO; CDKN1A; XDH; ROMO1; ACE2;	GO:2000379~positive regulation of reactive oxygen species metabolic process	5	27	18.5185185185185	0.048920750799749	0.176279693348947	1	1	0.999999999989095	0.999999999989094	1
up	TYROBP; GNAI2; ITGB2; ITGAM; CYBA; FPR2;	GO:0032930~positive regulation of superoxide anion generation	6	19	31.5789473684211	0.0491815766335645	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	ITGA4; SELL; SELP; ITGB7; CX3CR1; SELPLG;	GO:0050901~leukocyte tethering or rolling	6	19	31.5789473684211	0.0491815766335645	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PTH; CD33; CAV3; LILRB2; LILRB1;	GO:0051926~negative regulation of calcium ion transport	5	14	35.7142857142857	0.0495241416608208	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
up	PRL; LYN; STAT5A; STAT5B; JAK3;	GO:0060397~growth hormone receptor signaling pathway via JAK-STAT	5	14	35.7142857142857	0.0495241416608208	0.888820681492953	1	1	0.999999999999978	0.999999999999978	1
